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ABSTRACT 
Most of the tissue substitute materials currently used in- 
clinical radiation dosimetry are designed to simulate muscle or 
bone when irradiated with photons A few materials have been 
developed for neutron dosimetry, but substitutes speci fically 
designed for beams of high energy charged particles are not to be 
found in the literature. 
This thesis deals with the formulation and manufacture of, 
tissue substitutes for particulate radiations and the subsequent 
application of these substitutes in dlectron, pion, proton and 
neutron dosimetry. The method of "elemental equivalence" was 
used and over 80 solid, gel and liquid substitutes have been 
produced2 which simulate the most important tissues (adipose, 
blood, bone, muscle, etc), body organs (brain, lungj etc) and 
tissue components (fat, protein, water). Most of these materials 
are "tissue equivalent" and are useful for all types of radiations. 
The compilation of selected chemical compounds (compound 
library) used for the formulatign; and the computer programs 
written for the theoretical evaluation of the new materials are 
described and discussed. The experimental comparison of some 
selected substitutes with the corresponding real tissues, using 
fast neutrons, high energy protons, cobalt-60 gamma rays and 
120 kVP X-rays., verified the high precision of the simulation 
procedures. The results of depth dose measurements in various 
tissue substitutes ý as well as water, using 7.5 MeV neutrons 
150 MeV protons, 70 MeV negative pions , 10 MeV electrons and 
cobalt-60 gamma rays are presented. The effect of tissue 
heterogeneities on the dose distributions from thesý radiations was 
2 
investigated. Isodose shift factors for air, lung, fat and bone 
were derived for all the above radiation modalities and detailed 
lung correction factors were measured for 7.5 MeV neutrons and 
cobalt-60 gamma rays. 
In view of the proposed use of the 160 MeV proton beam of 
the Atomic Energy Research Establishment (Harwell, JJ. K) for 
patient treatment, a complete series of pre-therapeutic measure- 
ments was performed with this proton beam facility using the new 
materials, and the results are presented and discussed in detail. 
Finally, the applications of the new substitutes in other 
practical clinical aspects are described and some examples of 
such applications given. 
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CHAPTER 1 
AN INTRODUCTION TO THE THESIS 
The distribution of absorbed dose in the boky of a patient 
undergoing radiotherapy can be obtained either by calculation or by 
measurement in tissue substitute materials under simulated 
irradiation conditions. If it were possible to design materials 
with elemental composition and density identical to that of various 
human tissues, then "body pbaitoms " could be manufactured which 
would absorb and scatter radiation in the same way as the human 
body. Such body phantoms would be useful not only for photons and 
electrons but also for heavy particle s"such, as protons, neutrons, 
pions and alpha particles. Many of the so-called "TISSUE 
EQUIVALENT" materials used in dosimetric studies with X-rays, 
gamma rays and electrons in the past, give poor simulation of the 
corresponding real tissues. 
", 
This thesis-deals with the -general- problem of tissue simulation 
for particulate radiations, used in radiotherapy. Themethodof. 
'elemental equivalenC6ýis employed to formulate a family of new 
tissue substitutes which simulate- the important tissues and body 
organs, in the liquid, gel and solid states. Most of these systems 
have the same elemental composition and density as that of the 
corresponding real tissues. Consequently they are useful for all 
types of radiations. 
The formulation and manufacture of the new tissue substitutes is 
described in Chapters 2 and 3 and the theoretical and experimental 
verification of their "tissue equivalencei is presented in Chapter 4. 
Some of these materials were'selected and used in dosimetric studies 
with protons negative pions, electrons ) 
fast neutro! is as well as 
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cobalt-60 gamma rays. The effect'of tissue heterogeneities such' 
as lung, fat and bone on the dose distributions of the above types of 
radiations was investigat, ed and the results are discussed in, 
Chapters 5 and 6. Some I applications of the new tissue substitutes 
are given in Chapter 7. - 
THE MEANING OF "EQUIVALENCE" AND THE NEED FOR 
TISSUE SUBSTITUTES SUITABLE FOR PARTICULATE 
RADIATIONS 
With the use of neutrons and charged particles such as electron's v 
protons, negative pions and heavy ions in radiotherapy, it is becoming 
increasingly important to establish depth dose, and beam prohle data 
acceptable for radiotherapy, and to understand the influence of 
tissue heterogeneities on the dose distribution sobtained, when these 
radiation modalities are used. In order to facilitate these 
investigations "TISSUE EQUIVALENT", materials are needed for 
the construction of both radiation detectors and realistic body 
phantoms. 
The term "TISSUE EQUIVALENT" is often misused and, 
materials which have acceptable physical density but unknown 
composition are frequentlýr. referred to as tissue equivalent. A 
typical example is the use of pressdwood as tissue equivalent 
material. Reports of measurements using cork to represent lung 
tissue and aluminium to represent bone, continue to be published, 
even to the present day (e. g. SONTAG and CUNNINGHAM 1' 1977). 
Several authors have indicated that such materials should not be calied 
"TISSUE EQUIVALENT" , -, but often no attention has been paid to 
the advice given. (ROSSI and FAILLA'q 1956; SHONKA et al,, 
1958; FRIGERIO et al. 1 1972). 
11 
In-his'detailed study WHITE-(1974), stressed this point further 
and suggested that for matcrials -that approximate tissue in their 
absorption of energy, from all or some of the directly and indirectly 
ionising radiations, the term "TISSUE SUBSTITUTE" should be 
used. In this respect,, he produced phantom materials which 
simulate the corresponding tissues very accurately for photons of 
energies from 10 keV to 100 MeV and for low energy electrons I 
These materials, however, have no resemblance to tissue as far as 
elemental composition is concerned and could give large errors if 
used in neutron and high energy charged particle dosimetry. - - This' 
is also the case for most of the phantom materials used in the past; 
most of them were designed forphotons and very few for neutron 
interactions. Materials designed specifically for heavy charged 
particle dosimetry are not to be found in the literature. 
CRITERIA FOR TISSUE E2, UIVALENCE 
A material is said to simulate accurately another material, 
kI 
if the two absorb and- scatter radiation' in exactly the same, way. 
The following quantities must be identical for the phantom 
material and the tissue that it simulates, if the two are to absorb 
and scatter any type of radiation in'the same *way: 
Photon mass attenuation and mass energy absorption 
coefficient. 
(n) Electron mass stopping power and mass angular scattering 
power, 
(iii) Mass stopping power and mass angular scattering power 
for heavy charged particles and heavy ions. 
12 
(iv) Neutron'interaction cross section's or kerma factors. 
(v) If equal masses of two materials are to have the same 
volume, then the, mass densities of the two must also be 
the, same. 
It is obvious that the above can only be achieved if the material 
is made to have the same elemental constituents and in the same 
proportion by weight as the real tissue; it is only for such materials 
that the term "'TISSUE EQUIVALENT" should be used. 
The new substitutes developed during this study were formulated 
so that. 9 wherever possible, their elemental composition and relative 
density is exactly the same as that of the tissue which they were 
designed to sinlulate. - This was easier to achieve with liquid 
substitutes and water-based gels than with solids., especially when 
epoxy resins and polymers were used, due to the fact that these 
materials are very rich in carbon and poor in oxygen. 
SOME GENERAL PROBLEMS - CRITICAL TISSUE 
ELEMENTS 
It'was realised, 'at an early stage of this'wOrk, that partial 
replacement of oxygen by carbon had to be accepted in the case of 
solid substitutes and the mechanisms with ýrhich various par I ticulate 
radiations interact with matter were considerecll'in order to find- 
which of the elements present in various tissues are the most 
critical for each type of radiation. As fast neutrons are already 
used in radiotherapy on aroutine basis, their interactions with 
matter are of great interest. 
Neutrons interact primarily with nuclei and tissue equivalence 
in a phantom requires the right nuclei to be present in the right 
proportions; the achievement of the correct effective atomic number,, 
13 
an adequate criterion for X-ray phantoms, is not adequate for 
neutron phantoms. 
Since the interactions of fast neutrons with hydrogen account 
for 70-90% of the total dose in soft tissue (JONES, 1974), the 
prime consideration is to have the right proportion of hydrogen; 
for slow neutrons both the hydrogen and nitrogen content are 
1 important, due to the absorption reactions H(n )2 H and 
14N(n, 
p)14c. - 
Hydrogen is also the most critical element for 
the interactions of heavy charged, particles with matter; these 
will. be dis, cussed in a following section. 
The relative proportion of carbon and oxygen in tissue was found 
to be less critical and the replacement of part of oxygen by carbon in 
most of the solid epoxy resin-based su bstituteS was found not to affect 
the neutron attenuation significantly. Trace elements were also 
found, both by experiment and by calculation, to play no significant 
role in the absorption of fast neutrons. high energy protons or 
negative pions. 
For those substitutes in which all elements are correct except 
for carbon (C) and oxygen (0) , but with the sum (C + 0) the same as 
that of the real tissue, the term "QUASI-EQUIVALENT" could be 
used. The term "TISSUE SUBSTITUTE" will be gen*erally used 
to cover both those materials which are tissue equivalent and those 
materials which are claimed to approximate a tissue in their response 
to radiation. It should be mentioned here that the elemental 
composition of many biological tissues is either not precisely known 
or it varies with age and this makes the task of simulation more 
difficult. If the composition is known to vary over a given range, 
then a family of substitutes should be formulated to cover this range. 
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, Another problem arises 
from the fact, that physical, phase effects 
and differences in molecular binding between solids and liquids, or 
vapours of the same chemical composition I may affect the stopping 
powers of the substitutes for the various charged particles through 
which energy is deposited in tissue. There is fragmentary and, at 
times, conflicting evidence for such phase effects in organic 
materials., TWAITE S and WATT (1978) reviewed the available 
data and concluded that there is a definite phase effect in the 
stopping of low energy charged particles, decreasing their stopping 
power in condensed state'media as compared to their corresponding 
gasýs or'vapours (e. g. polyethylene -ethylene), ' but lack of extensive 
data makes the evaluation of the-'errors involved difficult. 
Frequently 'the 'Bragg additivity rule' . (BRAGG and XLEEMAN, 
1905) is usea to derive the radiation characteristics of a compound 
or a mixture from. those of its components. . BOURLAND and 
POWERS (1971), and more recently PALMER (1973) , experimented 
with alpha particles of energies'up to 8 MeV and they'found no major 
differences in m olecular stopping powers due to -chemical binding; 
they also showed that the "Bragg rule is obeyed In'gases for all 
molecules 'except those containing a triple bond. Accordingto 
BICHSEL (1977), '& application of thp Bragg rule in the 
calculation_ of stopping powers for protons, ... is. valid only with 
an uncertainty, which could exceed 3*1o 
It is -conceivable that'the mol*cc-alar binding in real tissues is 
much more complex than in the liquids, resins, polymers and 
inorgan . ic compounds used to manufacture the tissue 'substitutes- 
and it can be argued that it is futile to simulate to better than 
± 2*/o 
a tissue whose composition varies considerably from one set of 
published tissue data to another. 
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Nearly 80 different formulations had been published before 1974 
which were claimed to simulate muscle, lung, fat and bone., 'All 
too frequently- these materials gave large errors in the energy 
ranges for-which they were designed. However, the family of 
substitutes for photon interactions recently produced by WHITE 
(1974) j- were found to give errors smaller than 4- 50% for all photon 
energies from 10 keV up to 100 MeV. 
Few'liquid substitutes were developed specifically for neutron 
dosimetry in the past. In 1956 ROSSI and FAILLA introduced 
their liquid system comprising a mixture of water /glycerol /urea 
sucrose, 
which 
represented elementally an approximate formula 
for soft tissue C5H 40 01 1N This was later improved by 
GOODMAN (1969) who. removed sucrose. . More -recently, 
FRIGERIO, et al., (1972) , produced liquid systems closely 
simulating the formula of muscle given by ICRIJ (N BS1 19 64). 
Solids developed for neutron studies include the conducting 
plastics of SHONKk, 'et al., 
(1958), and an epoxy resin substitute 
(WILSON and WHITE, 1974). The components and elemental 
composition of the most important- substitutes developed in the past 
are given in Appendix 4. 
Figures 1.. 1 and 1.2 show the central-axis depth dose curves of 
different radiation modalities, namelyq 7.5 MeV neutrons, 150 MeV 
10 protons, 10 MeV electrons, 70 MeV negative. pi ns and cobalt-60 
gamma rays, measured (luring the course of this study in water and 
in muscle equivalent liquid (MS /L1). (For coding see next section). 
Although it is claiine(I'that with respect to dose cI omposition in the 
BRAGG peak there are no great differences between water and soft 
tissue (DUTRANOIS ct al., 1972), Figu . res 1.1 an4 1.2 show that 
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the depth of the B ragg peak is not the same and this is important 
in precision radiotherapy. Bearing in mind, however, that the 
choice of substitute for a particular investigation is frequently 
governed by finance and availability and looking at the poor 
characteristics of some of the existing substitutes, it is fortunate 
that water had remained the most popular substitute in the past. In 
the case of 7.5 MeV neutrons, the depth doses that were measured 
in water, were found to be closer to those measured in the muscle 
equivalent liquid MS/L1 than are the datalin unit density musclei 
reported in B. J. R. Supplement 11, for the same neutron beam. 
Obviously,, the higher hydrogen content of water almost compensates 
for the higher density of muscle. 
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1.1 (iii) TERMINOLOGY 
The symbols and nomenclature referred to in this thesis 
are summarised in Appendix 1. 
The term "S'UBSTI'rLUTE" will be used to describe any material 
which has been or could be used to simulate a tissue. 
The word "COEFFICIENT" will be used in a general sense to 
describe both the total and partial photon interactions. Similarly, 
the term "POWER" will be taken to generally mean collision and 
radiation stopping powers and mass angular scattering powers Of 
a material for charged particles. 
The new substitutes will be coded and numbered for easy 
I reference and their phase will be indicated: /SR-= solid rigidt 
I 
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/SF - -solid 
flexible, /G --' Gel and /L - liquid. MS/SR1', for 
example, mean's the muscle substitute number 1, which is solid 
- rigid. BRN/L6'is the'brain substitute number 6 which is liquid. 
The following termswill also be used and their definition will be 
given in the text: Linear Energy Transfer (LET), Relative 
Biological Effectiveness" (RBE) , Oxygen Enhancement Ratio 
(OER) 
Therapeutic Ratio (TR) , KERMA (K) , KERMA'FACTOR 
(KF) , etc. 
1.2 , PHYSICAL ASPECTS 
In order to design tissue substitutes for particulate radiations 
it is important to understand the interaction mechanisms followed when 
these radiations'interact with matter. Obviously these mechanisms 
differ between charged particles and neutrons. ' For this reason a 
'** 7, brief review of the'theory of interaction of charged particles and 
neutrons with matter will follow. Protons are treated as representative 
of heavy_, charged particles and electrons aslight ones. 
The type of interaction that takes place when a medium, is 
irradiated, depends on the type and-energy of the radiation and on 
the composition of the medlU*m. 'Energies up to 1000 MeV will be 
considered for protons., up to 100. MeV for electrons and up to 
30 MeV for neutrons. 
INTERACTIONS OF CHARGED PARTICLES WITH MATTER 
At very low energies (below 0.1 MeV for protons and below a 
few eV for. electrons), the incident particle interacts with the atom 
as a whole, in contrast to the situation at higher energies where 
the transfer of energy is not affected appreciably by the coupling 
between the atomic electrons and the nucleus. - 
19, 
In the Intermediate energy region (up to the rest mass energy.. 
MC2 of the particle, i. e. for proton kinetic 
_energies 
below about 
1000 MeV and for electron kinetic energies below 0. *5 MeV), 
the principal interaction is between the incident particle and the 
atomic electrons of the stopping medium. Unlike protons which are 
deflected through very small angles and lose only a small fraction 
of their energy in each such interaction, incident electrons can 
lose a large fraction of their energy in a single event and- can be 
deflected through large angles'. 
As the energy of the particles increases v interactions with the 
nuclei Of tlýe target'become m"ore, and more important; 'for proton .s" 
of 1000 MeVj only"a fraction of less than 1% would reach the end 
of their range without having' a nuclear interaction. 
In the case of electrons, interactions with the nuclei of the 
stopping medium lead to radiative, loss of energy (Brems strahlung) 
4- 
which becomes important at higher energies; a critical energy Tc 
can be defined, at which the energy loss due to collisions with 
atomic electrons is equal to the radiative loss: 
Tc 700 -MeV 
Z+1.2 
where Z is the atomic number of the stopping medium. For human 
tissuel Tc is about 85 MeV. 
With protons, Bremsstrahlung becomes, important at energies 
well above their rest mass energy (T>MP2). At these high energies, 
the bulk properties of the medium (dielectric. constant etc. ), influence 
the stopping of the particles, so as to decrease thexate of energy 
loss (stopping. power). This phenomenon is called the "density 
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effect" and is taken into account by adding the correction term -8 ' 
in the Bethe fundamental stopping power formula (equation 1.2 for 
protons and 1.4 for electrons). With electrons the density effect 
becomes important at energies above 0.5 MeV but protons of even 
1000 MeV are not significantly influenced'by it. (BICHSEL, 1968). 
The major uncertainty in equation (1.2) is the mean excitation 
energy I of the atoms of the target. The oscillator strengths fi 
are not well known and I is determined from- stopping power 
measurements. 
Ci The term in equation (1.2) represents the "shell corrections', 
which are necessary due to the fac-fth'a't the at omic electrons 
contribute less -to the stopping power of the medium if the velocity 
of the incident particle is comparable to their velocities in their 
orbits. These corrections are important for low-energy particles 
but little is known about them. For protons of I MeV in aluminium, 
shell corrections amount to about Olo. In medium and high Z elements, 
shell corrections are even more substantial (about 10%) for 4 MeV 
protons in lead). 
In the case of electrons of energy above 0.1 MeV, shell corrections 
amount to less than 1% and the term is often omitted from the stopping. 
power formula. 
As electrons show relativistic effects at energies above about 
0.5 MeV, the collision mass stopping powers for electrons ))Coll 
ýP 
which were needed for the comparison of -tissue substitutes to the 
corresponding real tissues (see Chapter 4), were calculated using 
the relativistic formula 1.4. (BERGER and SELTZER, 1964; 
WHITE, 1974). ' In the case of compounds, the values of -3ý and A 
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MASS STOPPING POWER- - HEAVY CHARGED PARTICLES 
The mass stopping power -ý! of a material with atomic number Z P 
and atomic weight A for a charged particle containinj z protons 
is given by the Bethe equation: 
S 4Trz2e4 NAZ 2Mev2 2 Ci 
8- 
MeV. CM2 
rne V2A 
- In, 
1(1_p2) 
Pz-9 (1.2) 
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where : NA , 6oO225 x 10 atoms/mole (Avogadro number) 
P= v/c, v- velocity of the particle 
Me = mass of e. lectron, II 
density of material in g. cm-j 
mean excitation energy of the atom defined by: 
Zlnl f. In E. 
where f oscillator strength for the transition with 
excitation energy 'E 
is the term for "shell corrections" z 
is the term for the 
_"density 
effect" 
(1.3) 
Figure 1.3 Principal formulae for proton stopping powers 
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MASS STOPPING POWERS - ELECTRONS 
(S 2T'TNAre2mec2 Z In T(T + 
2')' 
2+ F( 
,T (1.4) 
-IP)COll p2 A 2(, /me C2) 
where F- T) =, l 
2+T 2-(2T 
+1). ln2](T +, )-2 
[T 
T *+ 2) 
1`020 
T+ velocity 
c 
2 
meC= rest energy 0.510976 MeV 
T, = kinetic energy in units of mc2 e 
A atomic weight 
p density 
mean excitation e nerg Iy Z(9-76 58.8 Z-1.19 eV 
density effect' correction 
NA -'Avogadroý 
.s 
number 
2- 2 
c2)2 7.9403 x, 10 
26 
cm 
2 
re 
(e 
/me 
< -K ,* . 4F, W i(z. 
). '' , - A> =-. A1 (1.5) 
ln<I> W In I 
(A)j 
rad rad (1 7 
(P 
iP 
1 element. where w' i is the proportion by weight of the Ith 
Figure 1.4 Formulae used for electron mass 
stopping powers 
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In1 were replaced by < ýZ > and In <I> calculated from elemental 
.A 
data using equations 1.5 and 1.6. The density effect corrections 
were derived using the procedures suggested by KIM (1973). 
R adiati On stopping powers for electrons were calculated from the 
elemental data of BERGER and SELTZER (1964), and PAGES et 
al. j (1970) and applying the Bragg acIditivity rule (equation 1.7). 
The multiple scattering of electrons travelling a path length 
in amaterial of density p is described by the mean square 
scattering angle, (3 2 The elemental mass angular scattering 
powers were derived from equations 1.8 and 1.9 as suggested, 
P 
by ICRU (1972). The choice of equation depends on the elemental 
atomic weight AI and the momentum pe of the electron. The mass 
angular scattering powers for compounds'were calculated from 
elemental data and the additivity rule (equation 1.10). 
1.2(ii) INTERACTIONS OF NEUTRONS WITH MATTER 
Neutrons are uncharged particles and, like photons, are 
indirectly ionising particles. While photons are attenuated by 
photoelectric, Compton and pair production processes, neutrons 
are attenuated by, inmractions with atomic nuclei of the medium, 
giving rise to a complex spectrum of secondary charged particles 
through which energy is deposited in the medium. 
In the case of biological tissues, the most important nuclear 
interactions for neutron energies up to 3 30 MeV have been summarised 
in ICRU report 26 (1977). Their characteristics had previously, been 
reviewed by AUXIER, et al. , (1968) who listed over 30 possible 
processes. These interactions include: 
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MASS ANGULAR SCATTERING"POWERS '-' ELECTRONS 
(a) ELEMENTS 
280 me C2 
A 1/3 PC c 
z ec2 
2 
e2 2ý 
167TN W. r2 p 
In 196f3 6 Ae PC 
(1.8) 
I 
A) pf e 
2 2 80 MCC 
AW 1/3, PC c 
1/2 
(D2 z2 137p c- 
16 TTN - r. 
2 In e (1-9) 
pAA Pec Z1/3 Me C2 
(b) COMPOUNDS 
E) 2 (1.10) 
p pl 
Figure 1.5 Principal formulae. 'used for electron 
mass angular scattering powers (symbols 
defined in Appendix 1) 
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a) Capture processes, b) Elastic scattering, c) Inelastic 
scattering (in which the neutron is, re-emitted accompanied by a 
nuclear de-excitation gamma ray), d) Nonelastic scattering 
I 
(interaction with a nucleus resulting in the emission of particles 
other than a single neutron) and e) Spallation (the nucleus is'). ' 
fragmented ejecting several particles and nuclear fragments). 
The type of interaction which takes place depends on the neutron 
energy, the elastic -scattering with hydrogen being by far the most 
important for all-energies useful in radiotherapy. For energies up 
to 14 MeV, recoil protons deliver about 70*/o-90% of the absorbed dose, 
with the contribution decreasing with increasing neutron energy. 
(BEWLEY, 1963). 
The capture processes 1 H(n, y) 
2H 
and 
14 N(n, P) 14 C are of 
particular importance at low and thermal neutron energies; the 
first gives a 2.2 MeV gamma -ray and 
the second gives a 0.58 MeV 
proton which is absorbed, at the capture site., 
12 12. - 16 16 At higher energies the elastic C(n, n) C, O(nn) Oandthe 
nonelasticl 
60 (n 
'a)13C processes become very important in tissue. 
One problem that complicates the derivation of the absorbed 
dose and its spatial distribution in tissue arises from the fact that' 
neutrons transfer their energy to charged particles in the first 
step and these particles dissipate their kinetic energy at some point 
further away in the second step. Part of this energy, howeverp can', 
escape from the irradiated medium. ý. -III-. -ý 
The Liternational Commission on Radiological Units and 
Measurements in tro cluced the concept of kerma in order to treat the 
above problem in an approximation which does not take into account 
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the energy transport, by the charged particles. The kerma K 
is defined as the quotient dEtr by dm, where dEtr is the sum of 
the initial kinetic energies of all charged particles, liberated by 
indirectly ionising particles in a volume element of the specified 
material, and dm is the mass of the matter in that volume element. 
dEtr 
dm 
Under conditions of charged particle equilibrium the kerma is equal 
in magnitWe to the absorbed dose. 
Tissue substitutes used in neutron dosimetry should be elementally, 
correct so that they absorb and scatter both. the neutron an(! the gamma 
ray* component I which is present in all fast neutron beams I in the 
sameway as the real tissue. 
ý. 2 (iii) BASIC ELEMENTAL DAT AUSED IN THIS WORK 
In the case of photons (X - and gamma rays) interaction, 
cross sections, attenuation and absorption coefficients and other 
requirements exist in tabulated form and are readily available. 
The elementatcross sections of HUBBELL (1969Yand STORM'"' 
and'ISRAEL'(1970) compiled'by WHITE (1974) on magnetic tape were 
u'Scd to calculate the total'mass attenuation and ener&'absorption 
., 
for coefficients at 33 energy points in the range 10 keV-100 MeV. 
both the substitutes and the, real, tissues. 
Electron collision mas's stopping power's, radiation stopping 
powers, and mass angular scattering'powers for the same 33 energy 
points Were calculat-ed using elemental data and the formulae' 1.4 
to 1.10 as described in the previous section. 
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Stopping powers for protons were compiled and stored on magnetic 
tape 38 energy points were considered in the energy range from 
0.01 to 1000 MeV. For energies below 2 MeV, the values given 
by OLDENBURG and BOOZ (1972) were used. In the energy 
range from 2 to 1000 MeV the data were taken from BARKAS and 
BERGER (1964), and BERGER et al. , (1966). 17 elements were 
considered in all, namely, 
1H 
26C 9 
7N 
18O, 
9F, "Na, 12 Mgt 13AI I 
14Sij15pj16Sf17Clq19 K9 20 Ca 126 Fe, 
32 Cu and 
581. For those 
elements for which no mass stopping powers existed readily availableg 
the two-variable tables given by BARKAS and BERGER (1964) were 
used to obtain the proton mass stopping powers. The powers are 
given in these tables as a function of the proton kinetic energy and 
the mean excitation energy 1. For this application it was necessary 
to know the correct I value for each element. ladj - values, 
adjusted to take into account shell corrections were obtained from 
TURNER (1964), who gives Iadj/Z as a function of the atomic number 
Z, and averaged with the corresponding values given by BICHSEL 
(1968). Since only the logarithm of I enters the theory directlyl 
(equation 1.2) a large uncertainty in the value of 1, introduced 
only a small uncertainty in the value of the stopping powers. Based 
on the accuracy claimed for the data in the above z; eferences , the 
stopping powers obtained by using tlxem will be accurate to within 
2*/o. 
Figures 1.6 and 1.7 show the electron and proton mass stopping 
powers respectively, for hydrogen, carbon and nitrogenj plotted 
as a function of energy. It is evident that while the data for 
carbon and oxygen are very similar, the data for hydrogen are 
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Figure 1.7, Mass stopping powers for protons 
in hydrogen, carb6n, and oxygen 
much higher due to the fact that 
z for hydrogen is twice the _Z AA 
for other elements (equations 1.2 and 1-ý4). - This supports'the' 
previous arguments on the significance of the hydrogen content of' 
the substitutes, 
The difference in the neutron interaction cross sections of 
carbon, nitrogen, oxygen and hydrogen was'also investigated. 
Neutron ýross sections were obtained from the Neutron Data 
Compilation Centre'(CCDN '9 1 _GIF -SUR -YVETTE, B. P. No. 9, 
FRýANCE), on magnctic'tape. Data from the Evaluated Neutron 
Data File (ENDF/B-IV) and from the Lawrence Livermore Evaluatcd 
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Neutron Pata Library (ENDL 1 1970) were used., The. ENDF /B-IV 
can be used as a self -cons istent. s ource of cross sections, but 
unfortunately the crýoss, sections in the resonance region are not 
explicitly given, but a set of parameters is listed from which the 
cross sections can be calculated by a rather time consuming computer 
program. In the resonance region the data fro'm' the ENDL`wCre used 
and the curves for the neutron cross sections'for H,, C, N', O versus 
energy are'given'in Figure 1.8. For enýrgies below 20 MeV, 'the 
data are based on a combination of experimental and theoretical 
results., Above 20 MeV, there'are experimental data'available to 
describe neutron-hydrogen collisions, but the available data on 
other nuclei are scant and the', data are based on theoretical models. 
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Figure 1.8 Neutron cross sections (CIt ) for 
HIC IN 10 as a function of energy' 
Apart from the resonance region (0-3-9 MeV for oxygen, 
2-9 MeV for carbon) where oxygen has some resonance peaks not 
present in the cross section ( Crt ) of carbon, the total cross sections 
of C' and 0 are very close to-one another(4-5 bArns at 0.01 eV and 
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about I barn, at 10 Mev); so, when C replaces 0' in the plastic 
substitutes, the absence of some peaks will be compe nsated for 
by the slightly higher cit of C at lower energies and the neutron 
dose will not be affected significantly. 
1, CRU(report26,1977) us ed the ENDF /B-IV total neutron 
cross sections and calculated the keima factors from 10 eV up to 
30 MeV for 19 elements most of which appear in various tissues. 
(116 values of kerma factors for each element). 
, The kerma factor is defined as the quotient of the kerma (K) 'I 
., 
by the particle fluence (P (E), and for a given energy it is equal 
to the -product of the mass energy transfer, coefficient 11 tr P) 
and the neutron energy En. (ICRU i report 26). 
KV tr 
(P (E) F-En 
The use, of the kerma factors in neutron dosimetry requires 
some comment . The walls of the detectors usedi 
, do not have, 
exactly the same composition as the real tissue';. it is ne cessary, 
therefore, to 'Multiply the response of the dosimeter by the ratio of 
kerma factor. in tissue to kerma factor in the instrument, averaged 
over the neutron spectrum at the point of measurement, if accurate 
values of the kerma or the absorbed dose in tissue are to be obtained. 
It is obvious that if the accuracy aimed is a few percent., it is 
important to take into account the exact composition of the tissue 
(or substitute) in which the dose is estimated. 
Kerma factor ratios (substitute /real tissue) have been calculated- 
for all the substitutes produced in this work and tlýbse for the 
recommended materials . are given in Chapter 
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THE ADVANTAGES OF VARIOUS TYPES OF RADIATIONS 
IN RADIOTHERAPY 
cancerous tissue i*s formed of body cells growing out of control. 
While surgery aims to. remove these cells, the aim in radiotherapy is 
to kill them by inflicting as, much damage to the tumour as possible 
and at the same time minimising the dose delivered to the surrounding 
healthy tissues and, 
-thus 
sparing them. Sparing normal tissues is 
the feature that makes radiotherapy preferable to surgery in some 
cases. 
What matters most in each case is the Therapeutic Ratio (T. R. ) j 
which'is defined as the ratio of the normal tissue tolerance dose 
(N. T. T. D. ) to the tumour lethal dose (T. L'qD'*). Above N. T. T. D. 
necrosis of the normal. tissue starts to increase rapidly while above 
T. L. D. almost all the tumours are destroyed. (JOHNS and 
CUNNINGHAM (1969). 
The ratio of tumour kill to normal tissue damage, can be improved 
either through better spatial dose distribution or through using a 
radiation with a larger Relative Biological Effectiveness at the 
tumour volume (RBE tumour) and a lower Oxygen Enhancement 
Ratio (OER), or through both. 
_These 
concepts will be discussed 
in the following section. 
The rationale for using particulate radiatIons in radiotherapy, 
is to increase this therapeutic ratio, and the criterion for. the choice 
of the type of radiation to be used in each case, is the performance 
of each with regard to the above factors ; by op timising the dose' 
distribution, dose fractionations RBE and OERf it is hoped to 
inflict the greatest possible amount of damage to the cancerous 
cells. 
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1.3(i) PHYSICAL FACTORS 
Figure 1.9 shows the central ax is depth dose curves 
derived from our measurements in the muscle equivalent liquicIp 
MS/Llp with 5 different radiation modalities. (see also 
Figures 1.1 and 1.2). All the important physical characteristics 
of these radiations are clearly shown. Apart from adequate 
tissue penetration for a radiation modality, it is desirable to have 
controlled penetration and sharpness of dose distribution, so that 
sensitive healthy tissues near the tumour can be protected. 
Furthermore it is desirable to, have the entrance dose smaller than 
the dose at, any, depth if possible. 
100 In muscle/U 
1.10 MeV Electrons 
90 2.7.5. MeV Neutrons 
3.1.25 MeV Photons ICO-60) 
0 
'so 4.150 MeV Protons 
S. 70MeVW- Mesons 
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Figure 1.9. Central axis per cent depth doses in 
muscle, for various types of radiation 
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The above advantageous features are exactly what high energy 
beams of charged particles like protons, heavy ions'and negative 
pions have. The depth of the peak can be controlled by energy 
absorbers, the beam allows a significant reduction of the dose to 
the tissue outside the target volume and beam collimation is 
relatively easy. It is obvious that protons have a more definite 
range, a narrower peak and a much sharper cut off; by 
superimposing many such beams (of varying range), one can treat .j 
extended tumour volumes to a uniform dose. 
With pions the peak is wider and tails off resulting in some 
exit dose, due to the, presence-of, electrons and muous in the beam, 
Pions have a unique property that makes them promising in 
radiotherapy; at the end of their range, negative pions are 
captured by the host nuclei which then disintegrate (star, ', 
Iormation) emitting a number of, par ticlest such as neutrons, 
protons,, deuterons and other1eavier fragments with high Linear 
Energy, Transfer (LET). , LET -or LET., is defined as the energy 
transferred per unit length of track and is usually expressed in 
keV/pm); most of these secondary charged particles deposit their 
energy locallyl resulting in a lower oxygen enhancement ratio 
(OER). Consequently, the killing of hypoxic cells is more effective 
in the peak region of the pion beam. ý (see following section). 
With cobalt gamma rays and fast neutrons the dose falls off 
exponentially with depth, resulting in so I me exit (lose; the depth 
of maximum dose depends on the energy and %vlicn megavoltage 
photons a nd neutrons are used the desirable skin sparing effect is 
observed. (Cobalt gamma rays.,: depth of maximum buildup, 
0.5 cm; neutrons of energy = 7.5 -McV : depth of maximum buildup - 
0.2 cm). In practice, neutrons have no physical 4dvantages over 
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megavoltage X-and gamma rays, 
Electrons in the useful energy range are easily scattered and 
absorbed in the irradiated medium'. - Electron beams of energy 
3-10 MeV give such a dose distribution that allows the treatment 
of a superficial tumour to a nearly uniform dose while sparing 
the underlying deeper regions. The rapid fall off in the absorbed 
dose after the first few cm of tissue, however, is lost if higher 
I 
energy electrons are. used to treat deep seated. lesions. Lower 
energy electrons are also very useful for treating skin tumours. 
1.300 -BIOLOGICAL 
FACTORS 
The presence of hypoxi-a but viable cells in many tumours 
has always been a serious P'roblemin'racliotherapyl because, these, 
cells'are very resistant to X-rays. The sensitivity of cells to 
radiation was found to inc I rease in the presence of oxygen and 
this is known as Oxygen Effect. The Oxygen'Enhancement Ratio 
is defined asAhe ratio of doses under hypoxic and oxygenated 
conditions needed to produce the same biological effect% 
-It is also known that equal doses of two different types of 
radiations do'not always produce the same biolo'ýical'effect. 
The Relative Biological Effectiveness of radiation is defined 
by the relation: 
(RBE)A Dose of standard radiation for a biological effect 
Dose of radiation A needed for the same effect 
in most comparisons, the standard radiation is cobalt-60 gamma rays 
or 250 kVpX rays. 
RBE and OER depend on the LET of the radiation. In essence 
LET describes the quality of the radiation. Table 1-I summarises 
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the range of LET valueslor the various types'of radiaitions. 
TABLE 1-I 
', LET VALUES OF VARIOUS RADIATIONS 
Radiation, Range of LET, keV/Vm 
Electrons, X, y 
_ 
1 -'30 ' 
Protons 5- loo 
Pions, fast neutrons 3-900 
Alpha particles 40-250 
Heavy recoils 100 
As the., LET of a radiation increases, the OER is reduced 
and approaches unity at about'200 keV/pm, while the RBE Ancreases 
and. reaches a maximum at about 100 keV/Vm; with further increase 
in LET. the RBE decreases below its maximum because of dose 
saturation. 
The RBE of charged particles in the Bragg peak ionisation 
region is known to be greater than that of charged particles in the 
plateau regioul'because of the higher LET of the particles towards 
the end of their range., Thus the ratio RBEpeak/. RBF? Iateau is 
expected to be greater than unity. Consequently, if the Bragg 
peak region is made. to coincide with the tumour containing volume, the 
ratio RBEtumour/RBFliormal tissue will be greater for beams of 
heavy charged particles than for X-rayp gamma ray, electron or 
neutron beams. - -- 
it is desirable to have OER values as close to unity as possible. 
For radiations that have a wide LET spread, even a small fraction 
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of high LET component is effective in reducing the OER 
significantly. 
With the presence of more particles with higher -LET in the 
peak region of heavy charged particle beams than in the, plateau 
region, reduced OER and less -recovery from sublethal damage 
are to be expected in the tumour region compared to the 
surrouTiding healthy tissues (ELLIS , etý al. , 
i976). 
X-rays and electrons are considered generally as low-LET 
radiations; their mean LET values are very similar and 
consequently the biological effectiveness of electrons is not 
expected to be different from that of megavoltage X-rays. 
High-energy protons deposit an important part of their energy 
below 30 keV/Fn andso behave to some extent like low-LET 
radiation(i. e. X-rays). - (BEWLEY, 1971). 
The RBE of fast neutrons is generally larger than unity and 
depends on the neutron energy spectrum. BIANCHI et al. , (1978) 
used vicia faba roots (10-day growth) and found an RBE = 5.4 
for 14 MeV neutrons; for higher energies the RBE value was, 
found lower. RBE values derived from studies with mammalian 
cells, however, vary from 2.5-3.0. The OER of fast neutrons 
was investigated by a number of authors who report OER values 
ranging from 1.2 to 1.8 depending on the energy and on the 
biological system used; PARNELL, et al (1965) for example, 
used five mammalian systems and all their' results lie in the 
region 1.6-1.8 for the OER of the neutron beam of the Medical 
ý Research Council cyclotron. These figures are less than the 
values of X-rays by a factor of 1.6 
tO. 1 (Gain factor). The 
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rationale for usingý fast neutrons in radiotherapy was cen . tcred 
originally almost exclusively on their reduced' OER , hence 
iheir 
effectiveness in killing hypoxic cells. 
In the case of negative pions 
. 
RBE values reported in the 
literature range from 2-3 and OER values range from 1, -5 to 
1.8. Table 1-11 summarises the RBE and OER values 
derived from studies with mammalian cells, for all types of 
radiations used for therapeutic purposes. (PARNELL , et al. , 
1965; RAJU and RICHMAN, 1972; ARCHAMBEAU,, et al., 1974; 
ELLIS, et al., 1976; RAJU and PHILLIPS. 1977). 
TABLE 1-11 
RBE & OER VALUES FOR VARIOUS TYPES OF-RADIATION 
Radiation RBE OER 
X-and gamma rays 
and electrons 1 3.0 
Protons (100-200 MM Plateau 1 Plateau 3.0 
Peak 1 Peak 2.5 
Neutrons (1-20 MeV) 2.5-3.0 
Negative pions (70 MeV) PI . ateau 1.0-1.5 Plateau 3.0 ,, Peak 1.9-2.1 Peak 1.8 
ELLIS, et al. , (1976), studied the distribution of high and low,, 
LET events in a perspex phantom irradiated with 70 MeV negative 
pions. Nuclear emulsions were placed at the surface of the 
phantom as well as in the plateau and peak position and the number, -ý 
length and thickness of the observed tracks was considered. This 
work confirmed the existence of high LET events in the plateau 
region caused by interactions with pions in flight. SimiIar work 
with nuclear emulsions(L' EMBER I at al., 1975) , showed that low 
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and medium LET events (clusters and light tracks) are uniformly 
distributed through the whole range of the stopping negative plons. 
Heavy tracks in the peak region, ' however, were about three times 
the number in the plateau region. Determinations of event size 
distributions using a lithium drifted silicon detector and a ROSSI 
spherical, "tissue equivalent" chamber showed a similar trend. 
The peak/plateau ratios for high LET events are between 4 and 
and are dependent on the position in the plateau region; by comparing 
these high LET peak/plateau ratios with the overall values of 
1.3-1.6, the effect of the low LET component is demonstrated', 
(ELLIS and PERRY, 1972, ELLIS, et al. , 1976). 
To conclude, the use of heavy charged particles is be-ing 
proposed for treatment of cancer -mainly for three reasons: 
1) StLperior depth dose distribution. 
2) Higher RBE in the region of the Bragg-peak. 
Lower OER and less recovery in the tumour. 
'Fast neutrons do not have the first advantage. Table 1-111 shows 
a comparison of the various types of radiations. The high cost of 
the installations producing high energy heavy charged particles. 
some difficulty in localising the peak and, with pions the low dose 
rates available at present are the main reasons why some people 
might argue against the use of high energy particle beams in 
radiotherapy. 
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nr, ý -in ir -r- -I -rlrir 
COMPARISON OF VARIOUS RADIATION MODALITIES 
Type of 
radiation 
Spatial dose 
distribution 
RBE tumour 
RBE normal 
ý-tissue 
OER tumour 
OER normal 
tissue 
X-and Exponential 
gamma rays attenuation 
Electrons Good for 
(5-15. MeV) superficial 
tumours 
Fast neutrons Exponential 
(1-20 MeV) attenuation 
Protons Very good for 
(100-200 MeV) deep-seated 
''tumours 1.2 
Negative Good for deep- 
pions (70 MeV) seated tumours 1.4 1.6 
-A 
If the is made to coincide vrith the tumour area,, 
then: 
RBE ]2e RBE tumour and 
OER pe OER tumour 
RBE plateau RBE normal OER plateau OER normal 
tissue tissue 
i 
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CHAPTER 2 
SIMULATION PROCEDURES AND THE FAMILY 
-, OF NEW TISSUE SUBSTITUTES 
Various' procedures can be applied to the simulation of body 
tissues, such as the "effective atomic number method", the 
"basic data method" and the'method of "elemental equivalence". The 
effective' atomic number method is applicable only to photon 
interactions and is the techrfLque mostly employed before WHITE (1974) 
introduced the basic data method; the'latter is applicable to photons 
and electrons. 
A recent review of the literature (CONSTANTINOU and 
WHITE., 1977), has shown that some 80 tissue substitutes had been 
developed before 1974 and these simulate mainly muscle, lung and 
bone (46,14 and 13 substitutes respectively). WHITE (1974) extended 
the rangF of simulated tissues by producing substitutes for fat, breast, 
sking liver and thyroid as well as musclelung and bone. All these 
substitutes, howeverl were designed for photon and electron 
interactions. ' The number of 
'substitute 
materials suitable for 
particulate radiation dosimetry and in particular neutrons, was very 
limited, "- 
After a brief description of the first two simulation procedures, 
the application of the elemental equivalence method will be discussed and 
theyhole range of liquid,, gel and solid tissue substitutes produced 
in this work, most of which are TISSUE EQUIVALENT, will be 
presented. 
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2.1 THE EFFECTIVE ATOMIC NUMBER METHOD 
AND THE BASIC DATA METHOD 
The atomic cross section for a photon interaction (photo 
electric absorption r Compton scattering or pair production), 
generally depends on the photon energy and the elemental atomic 
number; the dependence on the atomic number Z can be expressed 
by the relationship 
atomic cross section cc Z' (2.1) 
where- the value of the power- x depends on the type of the process 
analysed; and is reported to vary from 1 to 5 (HUBBELL, 1969). 
A compound, may be regarded as a'single element with an effective, 
atomic number given -by 
iýx Zazx (2.2) 
where ai is the fractional electron content of the i 
th constituent 
element with atomic number Z. 
In the effective atomic number Z method, the composition 
of the substitute is adjusted so that the value of its isý as close as 
possible to that of the material being simulated. The mass 
attenuation coefficient 
11 
-for a compound, however, depends not P% 
only on the effective atomic number raised to a power x., but also 
on the electron density no , to which it ig directly proportional 
(SPIER S1 1946). 
x 
P cc no (2.3) 
The reasons for the large errors in the properties of the 
substitutes produced by applying the Z method in the past are the 
following: 
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a) The method was usually applied only for photoelectric 
absorption, 
b) The electron, density (no) was not always considered in 
the simulation; this introduced errors especially in the energy range 
where Compton scattering predominates. 
c) A single exponent is not en . ough to give adequate agreement 
between the substitute and the real tissue over a wide energy range. 
As the photon energy changes, different exponents are required. 
WHITE (1974) calculated values of the exponent x for the photoelectric 
process ranging from 3.5 at 10 keV to 3.9 at 100 keV instead of the 
popular 2.94. An exponent of 1.7 for coherent -scattering has been 
found (WEBER and van den BERGE, 1969) 'while the pair production 
exponent has always been taken to be unity, although it has been shown 
that- it decreases with energy (WHITE, 1977). 11ýI 
In the 21basic data" method, fundamental photon and electron 
interaction data are used to establish the proportions of the compounds 
which make up the substitute. Once a base material has'been chosen 
corrective additives are selected., which have coefficients (or powers) 
complementary to those of the base material ý when base material and 
additives are mixed in the correct proportions.. the radiation 
characteristics of the mixture will match those of the real tissue. 
The selection of the corrective additives is based on the slopes 
of the "coefficient versus energy" curves. These coefficients (or 
cross sections for elements) on a log-log plot against energy form 
linear parts over certain energy ranges. ' The slope of these graphs 
for a compound depends upon the slopes of the graphs of the elements 
that make'up the compound and the final slope for a substitute depends 
on the constituent compounds and their percentage weights. Figure 2.1 
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Figure 2.1 A schematic diagram to explain the principle 
of the "basic data" method of tissue simulation 
explains this principle's chematically for photoelectric mass 
attenuation coefficients. U3 is the substitute that simulates a 
tissu -eX and is composed'of two components' A and B' and if the' 
additivity rule is obeyed, then the corresponding coefficients 
rT, )x VT 
P 
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where and are the proportions of A and B (by L)A Ca B 
weight); but WA + Ca B ý-' 1 and therefore, 
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The agreement for other energies and other partial interactions 
will depend on the choice of materials. The limitations of the basic 
data method are: a) the additivity rule must be obeyed and b) the 
relationship between the coefficients (or stopping powers) and energy 
must be,, or closely approximate to a linear function on a log-16g 
scale. 
In an attempt to calculate exponents for proton and pion 
Sx 
interactions, the power law PZ was applied. 
The least 
squares method for Z'-Values from 1 to 20 was used and a linear 
relationship of the form In(mass stoppingpower) =Ina+ x In Z was 
fitted to the available data. This gave values of the exponent x 
from -0.26 to -0.75 for protons , and from -0.25'to -0 - 37 fo 
-r pions. 
The fitting, however. was not good (coefficient of correlation about 
0.75 for most energy levels). Consequently, the Z, method was 
considered not useful for the formulation of tissue substitutes for 
I 
particulate radiations. 
As the proton mass stopping, powers versus energy'show some 
linearity on a log-log scale for certain energy ranges, it should be, - 
feasible to use the "basic data" method to produce substitutes for 
protons. This method, however., is not useful for neutrons because 
of the resonances in the neutron cross sections. ý It became clear, 
early in this work, that the best method to be applied to the formulation 
of tissue substitutes for particulate radiations, is that of "elemental 
equivalence". This method is discussed in the following section of 
this chapter. 
0 
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2.2 ý, THE ELEMENTAL EQUIVALENCE METHOD 
The criteria for tissue equivalence have. already been 
discussed and it has been made clear that the only way in which tissue 
substitutes suitable for all types of particulate radiations and, photons 
. 
can. be formulated, is to make them have the same elemental composition 
and the same density as that of the real tissue. Consequently, the 
method of elemental equivalence was the simulation procedure of choice 
in the present work. 
-, If a substitute is elementally correct and has the correct 
dqnsity, the only source of error in the determination of the (lose 
absorbed in the real tissue will-be due to "phase" differences, i. e. 
differences in chemical binding, the effect of which is expected to be 
minimal. Despite this les s than 100% of the published substitutes 
have been formulated using the elemental equivalence method. 
2.2(i) APPLICATION OF THE ELEMENTAL EQUIVALENCE 
METHOD IN THE PAST 
ROS SI and F AIL LA (19 56)'were the first to apply the 
elemental equivalence method; in an attempt to reproduce an approximate 
formula for soft tissue (C H 016N), they formulated a liquid system 5 40 
comprising a mixture of water /glycerol /U rea / sucrose, which had 
the formula CH0N 5 37.5 18 0.97 The'method of arriving at thiS 
formula, however, was not explained in their publication., GOODMAN 
I 
(1969), improved that liquid by removing sucrose. 
The first solid tissue substitutes produced with the requirements 
of neutron dosimetry in mind were those formulated and manufactured 
by SHONKA at al. , (1958). ý 
The muscle substitute they produced 
consisted of polyethylene, nylon, carbonp calcium fluoride and silica, 
which were combined at temperatures of approximately 1800C in a 
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special mixer. A later variation - of, that product , in which the silica 
is excluded, is widely known, as plastic A-150 (see Appendix 4). 
The plastic substitutes produced by Shonka presented electrical 
conductivities of a suitable magnitude (i. e. resistivity <5x 10 
0-cm) and this is the main reason why A-150 is, up to the present 
dayl a popular material for the construction of ionisation chambers. 
The cOmpositio'n bf the'orig'-L'nal muscle'iubsiitute was -decided 
from a set of simultaneous equations derived to satisfy a) the hydrogen 
content., b) the nitrogen content , c) the electrical, conductivity 
d) Compton interactions and e) photoelectric interactions. The 
introduction offree carbon (13.5% by weight) for optimal conductivity 
resulted in an oxygen deficiency that was compensated for by the 
addition 
; 
of smaller amounts of calcium silicon, and fluorine., to match 
the radiation attenuation characteristics of the simulated tissues. 
FRIGERIO et al... (1972), used a simplified version of the 
GIBBSý 
I 
method of canonical components -(HUTCHINSON 1964) and 
produced liquid systems which, had the same elemental composition as 
the ICRU muscle. According to this method, the formula of each 
compound can be written as the sum of two or more components; for 
example i glycerol and urea can The written as C3 HSO 3" C3 H2(H20)3 
and NH 2 CONH 2 '-- CHýN2(H 20) respectively. In this way,. the, 
approximate soft tissue formula C5H 4-0 0,, N can be written as: 
C5 ýIýN (H 20)18* If urea is used to satisfy the needed one mole of 
nitrogenp then: 
C! ý1400 ýN = 0.5 C H2N 
-2(H20) 
C 4. ýH3 (H20)17.5 
0.5 moles 'Urea 
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+- 
But the component B 1.5 CP2(H 20)3 + 13(H 2 0) 
1.5 molýs glycerol + 13'moles water. 
Consequently, ' 
I mole 
I 
CýH 40018ýM 0.5 moles Urea + 1.5 moles glycerol 
+ 13 moles water. 
The formula weight is 402.378 so, to make onekilogram of mixture, 
1000/402-378 times as many moles of each component as indicated 
above, have to be used. , 
'The above two variations of the method of element , al equivalence, 
with slight modifications were used extensively during this work and 
as a result, over 80 substitutes were formulated, which simulate 
various tissues,, tissue components and body organs very closely. 
These formulations will be presented in the last section of this chapter. 
2.2(ii) THE ELEMENTAL EQUIVALENCE METHOD AS 
'APPLIED 
IN THIS WORK - SOME GENERAL COMMENTS 
The formulation of the new substitutes was based on the 
following general principles: 
a) The number of components should be kept to the minimum 
possible. 
b) The components which are suitable for addition to a specified 
base material should be chosen from a "compound library", i. e. a 
group of'chemical. compounds selected to meet certain criteria 
(acscribed in the next section). 
C) The 
I 
procedure should accurately establish the proportions (by 
weight) of the components of a tissue substitute. 
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d) The materials and techniques to be used shouldr be such that' 
the new substitutes can be manufactured in any ordinary workshop 
ýarith a minimum'requirement -of simple equipment. 
As it is not always possible to find a single rigorous solution 
in each case, the simulation procedure was'not fully automated,. ' A 
computer can be used interactively, saving time by doing calculations 
that are repetitive I in'this case solving sets of 'simultaneous equations, 
but leaving it to the operator to choose the right compounds on the basis 
of compatibility I's olubility I availability and likely cost'factors. 
The base materials used throughout this work were water for 
the liquid substitutes and epoxy resins for the solids, for reasons which 
are discussed in the following section. The viscosity and elemental 
composition of the resins, ', however, made the partial replacement of ' 
oxygen by carbon in the solid substitutes inevitable. 4 Apart from that, 
resins proved to. be. very good insulators. 'A 
preliminary attempt to 
get conducting substitutes failed., Many samples of "resin + graphite" 
mixtures, with graphite up to 15% by weight, showed infinite resistance. 
The number of graphite grades is very large and for this reason the 
grade VULGAN XC - 72 used by-Shonka in his conducting plastics., 
was also'testecl. ' The resistivity of the resulting sample was 800 times 
larger than that of a similar sa'mple of A- 150 plastic (8 X, 104 cm 
as compared to 100 
The, application of the elemental e quivalenc e, method in the 
formulation of tissue substitutes during this work, followed a number 
of steps which are summarised here. Examples of the act tual 
calculations are given in Appendix 2. 
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STEP 1: From the given elemental composition of the tissue to be 
simulated., derive its empirical formula and/or the number of moles 
needed per kilogram of substitute, for each constituent element 
(HOLDERNESS and LAMBERT. 1977). 
STEP 2 Scan the compound library (procedure not computerised) 
to find if there is a single compound with the'same formula (or the same 
"percentage ±0.5% by weight" for each constituent element, considering 
hydrogen as the critical element). If such a compo1iril is found, use it 
as a "single component substitute with no trace elements in it". 
provided that its density does not differ from that of the real tissue 
by more than 2-3*/,,. 
STEP 3: Decide" on the com, pounds which will be used to satisfy the 
requirements for trace elements, i. e. elements whose proportion in the 
tissue is less than 0.5% by weight. 
STEP, 4 Subtract the quantity of C, H, N., 0 already introduced with 
the compounds selected in Step 3 from the number of moles/kg derived in 
Step 1 for each element. Derive the empirical formula for the remaining 
Cl H, N, 0.1 
STEP 5_: Write the formula derived in Step 4 as the sum of two- 
compound components (A and B). Consider water, gelatine, or the 
selected epoxy resin system as an obligatory component (part A) for 
a liquid, a gel or a solid substitute respectively. Again, scan the 
library to find compounds with CIHIN90 contents equal to or 
bracketing those of part B. If no, single compound having the same 
composition as part B is found, then the base material and the compounds 
with Cl Hl N, 0 contents bracketing those of part B are used in Step 
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STEP 6 Solve a set of simultaneous equations written to 'satisfy 
the requirements for C, H9 Nj 0 given in Step 4. Derive the exact 
proportions by weight of the various compound components. - 
STEP 7: Calculate'the density of the formulated substitute using 
equation 2.6, assuming that the volumes of pure substances are 
additive. This is an approximation which is partly responsible for 
the difference observed between calculated and measured density 
values. 
(F mi loo (2.6) P, 
where p- density of the mixture and 
m, = percentage by weight of the i 
th 
constituent compound 
whose density is PI 
The search of the compound library for a "single component" 
substitute usually produced a few interesting materials but rarely gave 
ideal systems. 
All the trace elements put together, usually account for less 
than 1% of the total weight, but they should be included if absolute 
completeness is desirable. As it was difficult to find many alternative 
salt systems equally soluble and stable to satisfy the trace elements of 
a particular tissue, the same set was used whenever more than one 
liquid substitutes were formulated for the same tissue. The compounds 
for traces in gel systems are different from those for the corresponding 
liquids because gelatinev used as the main gelling agent, has sulphur as 
an impurity. Similarly, one single set of compounds was calculated for 
all the solid substitutes which simulate the same tissue. 
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The problem of matching the density of the real tissue, proved 
not to be a difficult one. In the case of liquids it was almost always 
possible to find alternative combinations of -liquid components to 
formulate substitutes of lower, equal and higher density than that, of the' 
real tissue. In the case of epoxy resin based substitutes, the use of 
phenolic microspheres (PMS) with a relative density of approximately 
0.2, solved the problem. Relatively small, quantities of these hollow,, 
gas-filled microspheres added to the resins reduced the bulk relative 
densities to below unity. The percentage of PMS (by weight) 
needed in each case, was derived from equation 2.6. 
I 
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2.3 THE COMPOUND LIBRARY 
A comprehensive library of selected chemical compounds 
was compiled at the beginning of this study, to facilitate the 
formulation of new tissue substitutes. , I- I 
The following criteria were used in the selection of compounds 
for the library: 
A compound must not be carcinogenic (or suspected 
carcinogenic), corrosive,, toxic, explosive, volatilep deliquescent, 
or unpleasant to use. 
-A compound must not undergo internal reaction or, absorb 
C02 from the air. I 
A compound must be stable to radiation and with time, 
inert., commercially available and moderate in cost. 
Compounds with melting point below 750C were excluded 
from the list of solid compounds for use as additives in polymers and 
resins. Solids of lower M. P could be used either in wax-based 
substitutes or, if soluble in water, for the formulation of liquid 
substitutes. -Liquid compounds, with boiling point (B. P), -below 
650C 
were excluded. --ýI 
Advice was sought on the toxicity and carcinogenic properties 
of the selected compounds and those which had dubious properties were 
rejected (H. M. S. 01 1967; THE CHESTER BEATTY RESEARCH 
INSTITUTE, 1966; BROWNING, 1965). The compounds in the 
library were divided into five groups . namely , a) INORGANIC SOLIDS , 
b) ORGANIC SOLIDS, c) POLYMERS AND RESINS, d) LIQUIDS and 
e) SPECIAL AGENTS. High purity chemicals such as "Analar" grades 
were always used when these were available. 
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The list of inorganic compounds was compiled from the 
HANDBOOK OF CHEMISTRY AND PHYSICS (1971); the' 
catalogue of HOPKINS AND WILLIAMS and BDH chemicals were 
consulted to ensure availability and acceptable cost (not more than 
F-1 for 1g). 
The above references together with the catalogues "ORGANIC 
CHEMICALS" (EASTMAN KODAk. Co), were the main sources 
for the organic compounds in, the library. The compound library 
given by WHITE (1974) wai also considered. The group of polymers 
and resins in that library, compiled from commercial literature and 
advice of experts in the field, was used in the new library with only 
few additions. The majority of the rest of WHITE's compound 
library, 4owever, was rejected either, on cost grounds or because 
they included elements not present in the real tissues. 
A listing of the most useful compounds in the new library is 
given in Appendix 6. For, convenience. this tabulation was generated 
via a computer -lin ked microfilm plotter. 
The four epoxy resin systems CB1, CB2, CB3 and CB. 4 and 
the phenolic microspheres (PMS) used, have been described by 
)AMITE et al., (1977). The nature of some of the special agents used 
in this work, however, require some comment. 
The production of solid lung substitutes was made possible by 
the use of the liquid foaming agent DC1107'and the surfactant 
D690/50. 
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DC1107 is a polymethyl hydrosilane cross-linking agent 
of the following syntactic formula: 
CH 
1 
CH 3'- si 
CH 3 
CH 3, CH 3, 
II 
-0- ý- Si -, 0- Si - Cli 
II 
LHJ ný CH 3 
t 
reactive hydrogen 
where n= 40-45 typically. The hydrosilane groups Si - H) 
react with acids, bases andamines liberating hydrogen. The formula 
Iý of DCý00/50 is . similar,, . except that the reactive'hydrogen is replaced 
by a methyl group( CH 3)* 
Suppliers of the above products are listed in Table 2 of 
Appendix, 5. 
Water loaded polyester resins were not used because their 
composition is not stable, due to water loss. 
The gelling agent of choice for the manufacture'of gel substitutes 
was gelatine because its composition and density is very close to that 
of protein, a tissue component. Although gel substitutes usually find 
short-term applications., the addition oIf bacterioýtatic agents (e. g. * 
sodium azide) in tracer quantities, preserves them for longer periods. 
Other gelling ýgents like Agar (a sulfated polysaccaride) v Guar 
(another polysaccaride gelled with borax) etc. , were not used because 
of large uncertainties in their elemental composition. ' 
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2.4 ELEMENTAL COMPOSITION OF THE SIMULATED 
HUMAN BODY TISSUES 
Recent publications on the elemental composition of biological 
tissues have indicated that there are large differences in the 
elemental contents of the tissues found in the human body. The 
composition of each tissue is subject to changes from the day to day 
metabolism and also variations with ageing. Liver, for example, 
undergoes rapid changes in size and protein metabolism (glycogen 
in particular). The composition of bone also varies both within and 
between various age groups. The relative density and the calcium 
content of young bone are less than that of mature bone but with 
further ageing these change again. Values for the calcium : 
phosphorus molar ratio and for the relative density of bone., varying 
from 1.37 to 1.. 80 and from 1.6 to 2.04 respectively, have been found 
in the literature. These differences are of significance for particulate 
radiation dosimetry, especially with neutrons. 
Data for the most important human tissues and organs 
simulated in this work, were obtained from ICRU (NBS, '1964), 
KIM (1974), WOODARD (1964), and from the ICRP Reference Man 
document (ICRPp 1975). This document provides elemental data 
obtained from many sources on 81 organs, tissues and tissue 
components; it also gives their relative densities as well as their 
water : fat : protein contents. The ICRP task group had often, 
but not always, selected the average or the median of the available 
measurements. The percentage. s by weight of the constituents of 
some of the tissues given, however, total either more or less than 
100%. In such cases either the oxygen or the carbon content was 
modified to bring the total to 100%. 
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The above correction is justified since oxygen and carbon 
are the most prevalent elements and a small subtraction or addition 
to them will cause the least overall change in density and absorbed 
close. 
The formula for "inner bone" was calculated from data 
supplied by SPIERS (WHITE, 1974); it is based on the ratio 
22.4% hard bone to 77.6% red marrow, i. e. the average ratio of 
hard bone to red marrow in trabecular bone structures' *(percentages 
by weight). 
,- In the case of breast tissue.. a search for reliable formula 
showed that there are large variations in the composition of breast 
with age and subject. Apparently,, breast tissue varies between the 
f extremes of fat and muscle. In order to resolve the dilemma., 
WHITE (1974) considered a formula based on 5%. R-AT-50% WATER 
by weight and formulated solid substitutes useful, for low energy 
photon mammography measurements. A formula for breast tissue, 
howeverp should contain, at the very least, nitrogen, phosphorus 
and sodium. Bearing this and the great variability of breast tissue 
in mind., it was decided to consider three different groups, namely: 
AV. BR. 1 for young age : 25%FAT-75/o MUSCLE 
AV. BR. 11 for middle age : 50% FAT-50% MUSCLE 
AV. BR. 111, for old age : 75% FAT-25*/o MUSCLE 
The elemental composition of all the simulated human body tissues is 
given in Appendix 3. 
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2.5 THE RANGE OF TISSUE SUBSTITUTES 
DEVELOPED DURING THIS STUDY 
Five groups of tissue substitutes were producedl namely, 
substitutes for Principal soft tissues (adipose, blood., muscle), 
Principal skeletal tissues (hard bone, inner bone, red marrow),, 
Body organs (brain, kidney, liver., lung, thyroid), Average tissues 
(average breast, total soft tissue., total skeleton), and Tissue 
components (fat, protein., water). Tables 2-1 to 2-V(pp 65,75) give the 
constituents of these substitutes, together with the percentage 
weights bracketed after each compound. The compounds for trace 
elements in each group of substitutes are given immediately after 
the first substitute of the group. Although the presence of trace 
elements was not found to affect the results of the depth dose 
measurements significantly, they are given for completeness. if 
a substitute was formulated to be used without trace elements in it, 
this will be indicated with the words "no traces". 
About 60% of all substitutes given in this chapter are 
TISSUE EQUIVALENT and the remaining are QUASI-EQUIVALENT, 
except for the solid water substitute WT/SR1 described in section 
2-5E. The elemental composition of these materials is given - in 
Appendix 3, with that of the corresponding real tissues. Nearly all 
have been manufactured. Those formulae for which no relative 
density is given have not been manufactured but, from the experience 
gained in this study, they are considered to be practically feasible. 
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2.5A PRINCIPAL SOFT TISSUES 
Sixteen new substitutes were produced to simulate. three 
principal, soft tissues, i. e. 4 for adipose, 3 for blood and 9 for 
muscle; they are grouped in Table 2-1. 
(see 
pages 65 -75 for Tables 2-1 to 2-V). 
The very lo-%,, r nitrogen and high hydrogen content of adipose 
tissue excluded the use of the epoxy systems CB1, CB2 and CB4 
in the formulation of solid substitutes for adipose. The epoxy system 
CB3, however., proved to be particularly good and, in fact, it was 
selected as an adipose substitute from a"single material" search. of the 
complete compound library (AP/SF2). Similarly, Ethoxyethanol and 
the epoxy system CB2 were selected as "single component" liquid 
adipose (AP/L1) and solid blood (BL/SRI) substitutes respectively. 
The attempt to produce two-component gel substitutes for 
muscle (i. e. water + gelatine) gave products in which some of the 
carbon was replaced by oxygen. The introduction of an alcohol as 
a third component (ethanol or propanol) resulted in gel substitutes for 
muscles both elementally correct and not subject to bacterial infection. 
(MSIGI and MS/G2). 
2.5B' PRINCIPAL SKELETAL TISSUES 
. 
Matching the low hydrogen and high calcium and phosphorus, 
contents of hard bone presented serious problems both in the liquid 
and solid phase. Formulae for liquid substitutes simulating hard 
bone (cortical) are not given because all of them suffered from the 
problem of insolubility of the best additives. The most soluble 
phosphate compound found in the compound library is di-potassium 
I 
hydrogen phosphate; -a solution of 160 grams ýf this compound per 
100 rnI of water is the best liquid substitute that could be manufactured 
to simulate hard bone. The 'K :P ratio is close to the Ca :P ratio 
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in bone (about 1.67), and the measured relative density of such a 
solution was found to be 1.68. This substitute was first proposed 
by WITT and CAMERON (1975), who used it as a general bone 
standard for the calibration and intercomparison of the systems : they 
developed for measuring the bone mineral in vivo. This solution is 
stable. at room temperature (200C),, Attempts to improve it by adding 
other soluble salts to satisfy the requirements for nitrogen., magnesiuni, 
sodium and sulphur, resulted in an oversaturated solution which, in 
less than a day, precipitated part of its solutes. 
For solid bone substitutes, the low hydrogen content meant 
that the percentage of base material (epoxy resin system) that could 
be used was lower than needed to hold the calculated quantity of fillers, 
and many formulaiions representing elementally correct bone substitutes, 
gave a dough rather than a pourable mixture and had to be rejected. 
By relaxing the limit for the hydrogen requirement, the formulae of nine 
hard bone substitutes were produced with hydrogen up to 4.9% by 
weight and relative densities ranging from 1.58 to 1.82. The formulae 
of these substitutes are given in Table 2-11. 
The use of Ca(NOý2 in HB/SR1 seems to catalyse the reaction 
between resin and hardener and the curing process is completed in 
about one hour. This should be noted if this formula is used. HB/SF3 
is very viscous but is pourable; HB/SR6 and HB/SR9 are so viscous 
that one should be careful when casting because the possibility of 
trapping air is high. The remaining hard bone substitutes are moderate 
in viscosity and present no problem in their manufacture; HB/SR4 seems 
to be'the best from this point of view and samples of it were used in most 
of the experimental work described in Chapter 5. 
61 
The ICRU formula for hard bone (with 6.0% by weight 
hydrogen) was easier to simulate. 
Table 2-11 also gives the formulae for three inner bone and 
nine red marrow substitutes, Inner bone substitutes need only be 
covered with an outer layer of hard bone to simulate real bones on 
a macroýCopic, scale. 
2.5C VARIOUS BODY, ORGANS I- 
The formulation and manufacture of tissue substitutes for 
various body organs was considered important for the construction 
of complete body phantoms for use in clinical dosimetry and other 
applications. E. leven substitutes were formulated for brain, two 
for kidney; two for liver, three for lung and three for thyroid 
(Table 2-111). All the liquid substitutes in this'group are "TISSUE 
EQUIVALENT" while the solids are "QUASI EQUIVALENT". 
The epoxy system CB2, on its own, was found to be acceptable 
for the simulation of kidney and liver in elemental composition but its 
relative density is higher than that of real kidney and liver (1.10 
as compared to 1.05 and 1.07 resPectively). 
2.51) ý AVERAGE TISS13ES 
Table 2-1V shows the formulae of materials dcsigned to simulate 
average tissues like "average breast", "total soft tissue"-and "total 
skeleton".. 
The four liquid substitutes coded AV. BR* were produced to 
simulate aWaverage breast formula based on 50% FAT-50%'WATER 
by weight. - Thc, formulation of the solid substitutes of average breast, 
howevcrl, was bascd on the three- combinations "of FAT-MUSCLE 'as 
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described in section 2.4. Four out of five of these substitutes are 
solid flexible, with the epoxy resin system' CB3 as base material. 
CB3, on its own, was selected as a substitute of average breast 
(WI. FAT-50%, MUSCLE) and is coded as AV. BRU/SF3. Its 
relative density is 1.02 instead of the required 0.99. 
I-, The human body can be considered as a combination of. "total 
soft tissue" and "total skeleton"; consequently a number of 
substitutes were formulated for each. The last two substitutes for 
total skeleton (T. SK /L3 and T. SK/ L4) are not clear liquid solutions 
but suspensions of calcium orthophosphate in a solution which 
contains the remaining components. 
2.5E TISSUE COMPONENTS 
The new ICRP document "Reference Man" shows that each 
tissue or organ is composed of WATER + FAT + PROTEIN + TRACE 
ELEMENTS. ' If it were possible to formulate protein and fat 
substitutes miscible with water, then, by mixing the three under the 
right proportions one would be able to produce substitutes for any 
tissue or organý 
Gelatine was found to have elemental composition and relative 
density very close to protein; furthermore it is soluble in warm water 
(70-800C). Unfortunately none of the formulated liquid substitutes for 
fat, is miscible with water. The use of gelatine as gelling agent., 
howeverp enables the formulation of gel systems which closely 
simulate real tissues (e. g. MS/Gl, RM/G1, IB/G1). 
The need for a solid material with the same photon 
attenuation characteristics as water) for various applications in 
diagnostic radiology, led to the formulation of an epo? cy resin base& 
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substitute for water (WT/SR1). This substitute was formulated 
using the "basic data method". 
A critical theoretical evaluation was carried out for all the 
new substitutes and for most of those developed in the past. Some 
of them were selected and tested experimentally in order to verify the 
accuracy with which they simulate the corresponding real tissues. 
This will be discussed in Chapter 4 where a list of the recommended 
substitutes new and old, will also be given. 
k 
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TABLE 2-1 SUBSTITUTES FOR PRINCIPAL SOFT TISSUES 
Relativc density 
No Code Constituents andpercentage weights Measured Calculated 
(i) ADIPOSE 
1 AP/SF1 Epoxy CB3(49-90); Polyethylene (38.47); 0.92 0.92 
Glucose(8.74); PMS(2.62); Traces(O. 27). 
Compounds for traces: Na2 -904(0-156); 
S(O-037); 'K2HP04(0.071); CaHP04(0.007) 
2 AP/SF2 Epoxy CB3(100) - no traces 1.02 1.02 
3 AP/L1 'ýthoxyethanol (100) no'traces 0.93 0.93 
4 AP/L2 H20(49.23); Tr 
, 
aces(O. 21); 0.92 0.93 
Prop anol(48.28); Urea(1-71); H ? 04(2*75) 
Compounds for traces: NaC1(0.13); 
KCI(O. 06); CaC12(0.006); MgC'2(oooo8)0 
BLOOD 
1 BL/SR1 Epoxy CB2(100) - no traces 1.10 1.10 
2 BL/L1 H20(70.96); Traces(1.44); Urea(5.99); 1.08 1.07 
Glycerol(9.02) ; Acetic acid(12.65)- 
Compounds for traces: NaCl(0.45); 
KH S04(0.48); N H4 CN 3 (0.20); 
Fe(NO, 3)3(0-19); H3PO4(0.098). 
3 BL/L2 H20(71,00); Traces(1.44); Urea(5.99); 1.06 1.05 
Ethanediol(6.08); Acetic acid(15.59). 
(iii) MUSCLE 
1 MS/SR1 Epoxy CB1(62.22); Polyethylene (28.55); 1.05 1.06 
Polyvinyl Acetate(7-74); Traces(1.635) 
Compounds for traces: K211PO4(0-87); 
S(O. 50); Na2HP04(0.22); MgO(0.03); 
Ca C03(0*02). 
2 MS/SR2 Epoxy CB2(65.0); Acrylics(g. 22); 1. o6 1.07 
Urea(3.28); Polyethylene (21.06)*; 
Traces(1.635) 
SR = solid rigid, SF = solid flexible.. L- liquid, G- gel 
PMS = phenolic microsphcres 
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TABLE 2-1- cont 
Relative density 
No Code Constituents and percentage weights Measured Calculated 
(iii) MUSCLE cont. 
3 MS /SF3 Epoxy CB3(58-00); Acrylics (26.14); 1.06 . 1.06 
Polyethylene (8.88); Urea(5.51); 
Traces(l. 635)- 
4 MS/SR4 Epoxy CB4(69.30); Polyethylene (25'. 51)*; 1.06 1.05 
PMS(O. 70); Traces(1.635) 
5 MS/SR5 Epoxy CB1(62.10); Polypropylene(32-36) 1.07 1.07 
Carbon(3-95); Traces(1.635) 
6 MS/G1 H20(73-90); Trades(l. 41); 1.06 1.04 
Gelatine(19.42); Ethanol(5,27) 
Compounds for traces: K2HP04(0-t37); 
N a. CI (0.15); NH4 H2, P04(0 - 12); 
Mg(NO3), -<0.16); NaH2'PO4(0.07) 
Ca(NO3)2(0.04) 
7 MS/G2 H20(74.60); Traces (1.41);, Urea(l . 30); 1.05 1.03 
Gelatine(14.11); Propanol (6.68) 
6 MS/L1 H20(62.53); Traces(2-43); Urea(7.43); 1.07 1.07 
Ethanediol(27-18); Acetic Acid(O. 43) 
Compounds for traces: NaCl(0.13); 
NaN03(0.07); KHS04(1.36); 
H P04(0.63); Ca(NO3) (0.03); 3 2 
Mg(NO, )q*6HqO(O. 20) 
9 MS/L1A HD(62-53); no traces; -UreK7.50) 1.06 1.06 
Ethanediol(27.91) 
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TABLE 2-Il SUBSTITUTES FOR PRINCIPAL SKELETAL TISSUES 
Relative density 
No Code Constituents and Percentage weights Measured Calculated 
(i) HARD BONE 
1 HB/SR1 Epoxy CB1(. 50.00); CafNO 3)2(14. M; 1.75 1.70 
CaO. (25.43); P(10.2); Traces(l. 22) 
Compounds for trace elements: 
MgS04(1.04); Na2SO4(09lt3) 
2 HB/SR2 Epoxy CB1(44.98)'; CaHI'04(43-93); 1.66 1.6o 
CaO(9.86); Traces(1.22) 
3 HB/SF3 Epoxy CB3(35.78); Urea(7.34); 1.69 1. '60 
CaHP04(43-91); CaO(7.44); 
CaC 03(, 4.31); 'T races (1.22) 
4 HB/SR4 'Epoxy CB2(39.21); Urea(5.77); 1.67 1.6o 
CaO(9.86); CaHP04(43.93); 
Traces(1.22) 
5 HB/SR15 Epoxy CB2(43-32); Ca. H P04(33.29); 1.6o 1.55 
P(2-42); Urea(5-50); CaO(14.24); 
Traces(1.22) 
6 HB/SR6 Epoxy CB4(47-91); Ca3(PO4)2(50.05); 1.76 1.71. 
CaO(0.82); Traces(1.22) 
7 HB/SR7 Epoxy CB4(52.54); CaO(21.48); 1.58 1.55 
TIM. 61); Ca3(PO4)2(11-93); 
'Urea(5.21); Traces(1.22) 
8 HB/SR8 Epoxy CB4(48.97); CaHP04(11-83); 1.64 1.59 
CaOC26.19); P(6-37); Traces(1.22) 
9 IIB/SR9 Epoxy CB4(38.9); Ca H P04(43-93); 1.82 1.74 
lJrea(6.08); CaO(9.86); Traces(1.22) 
10 HB/ Calcium glycerophosphate(45.09); 1.77 
POWDER1 Ca3(PO4)2(22.67); Ca(N03)2(23.25); 
Polyethylene(8.61); Traces(1.22) 
SR = solid rigid, SF - solid flexible, liquid, G- gel 
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TABLE 2-11 cont.... 
Relative density 
No - Code Constitucnts and Percentage weights Measured Calculated 
(i)' HARD BONE cont. 
11 11B/ Ca3(PO4)2(51,07); CaC03(5.02); 1.96 
POWDER 2 'Urea(8.51); Polyethylene (7.20); 
Traces(1.22) 
12 HB/ Glycerol (34.15); CaC03ý4.05); 1.88 
- -PASTE Urea(7.92) C"3(PO4)2(51.07); 
Ca S04 (1-35) Traces (1.22) 
ICRU BONE 
13 HB/SF. 1 Epoxy CB3(54-30); Ca3(PO41(34.73); 1.46 1.42 
C(4-32); CaO(1.725); Urea(3-93) 
14 HB/G1 H20(34-33); Glycerol (15.70); 1.4o 
K2HP04(31.94); NaH2PO4(12.80); 
Gelatine(15.17) 
(if) INNER BONE 
1 IB/SR. 1 Epoxy CB2(76-59); Polyethylene (8.44) 1.15 1.20 
Ca3(PO4)2(13.13); NaN03(o. 243) 
2 IB/G1 H20(68.98); Glucose(3,72); 1.13 
K2HP04(10-80); NaN03(0.08); 
Mg(NO3)2(0-51); KHS04(0.47) 
Gelatine(14.05) 
3 IB/L1 H20(36.64); Urea(5-45); 1.14 1.18 
Ethanediol(41.82) K2HP04(11.107); 
H3PO4(1.62); NaN03(0.24) 
(iii) RED MARROW - 
1 RM/SF1 Epoxy CB3(69.08); Polyvinyl 1.04 1.03 
Acetate(25.42); Polypropylene (1.92); 
Urea(2.27); PMS(O. 8); Traces(O. 05) 
Compounds for traces: K2H P04(0-16); 
K2SO4(0-18) Na2-904(0-02); 
MgS04(0-01); S(O-10) 
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TABLE 2-11 cont 
Relative density 
No Code Constituents and percentage weights Measured Calculated 
(iii) RED MARROW cont... 
2 kM , /SR2 Epoxy CB2(65.13); Polyethylene (27.10); 1.03 1.05 
C(6.52); -PMS(O. 75); Traces (0.50) 
3 RM/SF3 Epoxy CB3(59-4); Polyethylene (8.28); 1.03 1.03 
Urea(2.63); Polyvinyl Acetate(28.88) 
PMS(O. 6); Traces(O. 50) 
4 RM/SR4 `Epoxy CB4(63-7); Polyethylene (34.54) 1.03 1.03 
NH4NO3(0.74); PMS(O. 57); Traces(O. 50) 
5 RM/L1 H20(12.14); Glycerol(8.08); Urea(4-385) 1.01 
Pentanediol(75-33); Traces(1.34) 
Compounds for traces: NaCl (0.20); 
KCI(O. 11); KN03(0-30); H3P04(0-09) 
(NH4)2 S04(0.634) 
6 RM/L2 H20(43.46); Ethanediol(51.21); ' f 1.05, 1.07 
Urea. (4.38); Traces(1.34), 
7 RM/L3 H20(64.. 14); Glycerol(34-42); 1.04 1.08 
Urea(4-38); Traces(1.34) 
8 RM/G1 H20(79-10); Glucose(8.04); Trace. <l., 34) 1.07 1.06 
Gelatine (12.15) 
9 RM/G2 H20(7-51); Glycerol (24.28); 1.08 
Pentanediol(55.19); Traces(1.34); 
Gelatine(12.25) 
PMS = Phenolic microspheres 
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TABLE 2-111, -, VARIOUS-BODY ORGANS 
N C d C d h 
Relative density 
o o e onstituents an percentage weig ts Measured Calculated 
(i) BRAIN 
1 BRN/SR1 Epoxy CB2(42-32); Polyethylene (33.23); 1.01 1.03 
Acrylics (22. OS); PMS(O. 60); Traces(1.82) 
Compounds for trace elements: 
NaH2P04(0.93); K2HP04(0.67); S(O. 17); 
MgO(0.02); CaCO 3(0602) - 
2 BRN/SR2 Epoxy CB2(42-32); Polyethylene (33.82) 1.04 1.06 
Acrylics (27.05); Traces(1.82) 
3 BRN/SF3 Epoxy CB3(70.00); Polyethylene (8-38); 1-03 1.05 
1 Acrylics (19.85); Traces(1.82) 
4 BRNISF4 Epoxy CB3(70.00); Polyethylene (8.03); 1.00 1.03 
Acrylics (19.86); PMS(O-30); 
Traces(1.82) 
5 BRNjL1 ýj20(67.60); Traces(2.27); 1.03 1.02 
TJrea(2-77); Butanediol (27-36); 
Compounds for trace elements: 
KHS04(0-16); Na2SO4(0-56); ' 
KCI(O. 48); H3PO4(1-07) 
6 BRN/L2 H20(69.58); Traces(2.27); Urea(2-77); 1.02 1.01 
Pentanediol(25-38) 
7 BRN/L3 H20(56.87); Traces(2.27); Urea(2-77); 1.03 1.00 
Ethanediol(24.44); Methanol(13.65) 
8 BRN/L4 H20(60., 70); Traces(2.27); Urea(2-77); 1.04 1.01 
Ethanol(9.81); Ethanediol(24.45) 
9 BRN/L5 H2(? (55.11);,, Traces (2.27); 
- 
Urea(2-77); 03, 1000 
Glycerol (18.15); Methanol(21-70) 
10 BRN/L6 H20(62.45); Traces(2.27); Urea(2-77); 1.04 1.01 
Ethanol(14.35); Glycerol(18.15) 
11 BRN/L7* H20(69-95); Traces(2.27); Urea(2-77); 1.00 0.98 
Glycerol(1.96); Propanol(23-05) 
SR - solid rigidt SF = solid flexible,, L- liquid., G= gel, PMS = phenolic 
microspheres 
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TABLE 2-111 cont 
' 
Relative density 
No Code Constituents and percentage weight s Measured Calculated 
(ii) KIDNEY 
1 KD/L1 H20(63.60); NaCl(0.47); 1.05 1.04 
K2HP04(0-87); Urea(5.87);, 
Ethanediol(29.29), 
2 KD/SR1 Epoxy CB2(100) - no traces 1.10 1.10 
(iii) LIVER 
1 LV/SR1 Epoxy CB2(100) - no traces 1.10 1.10 
2. - LV/L1 H20(64-18); KH. S04(1.02); NaCl(0.29) 1.06 1.03 
Urea(6.06); Ethanol (15.87); 
Glycerol (12.57) 
(iv) LU NG 
1 LN/SR1 Epoxy CB1(64.39); Polyethylene (26.50); 0.30 0.30 
Polyvinyl Acetate(6-72); Traces(1.09); 
Foaming DC1107(l. 00); 
Surfactant DC200/50(0.30) 
Compounds for traces: K2SO4(0.42); 
S(O. 14) Na2HP04(0.50); MgO(0.02); 
Ca C03(0.02) 
2 LN/SF3 EpoxyCBX58.00); Acrylics (33-65); 0.29 0.30 
Urea(4.00); Traces(1.09); 
DC1107(1-0); DC200/50(0.30) 
3 LN/SR4 Epoxy CB4(63-51); Polyethylene (30-56); o. 29 0.30 
Traces(1.09); Urea(2.00); 
DC1107(1.0); DC200/50(0.3) 
I- I I 
--- 
I 
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TABLE 2-111 cont 
- 
Relative density 
No Code Constituents and percentage weights Measured Calculated 
(v) THYROID 
1 TH/L1 H20(62.90); Nal(O. 90); NaCl(0.23); 1.11 1.14 
1ý2"04(0-44); Urea(4.71); iSlycerol(31-00) 
2 TH/L2 H 20(62.10); Nal(O. 90); NaCl(0.23); 1.08 1.08 
K2HP04(0*44) ; Acetic Acid(11.46); 
Urea(4-71); Ethanediol(20.58) 
3 TH/1.3 H20(62.10); Nal(O. 90); Na. Cl(0.23); -ý 1.14 1.13 
Glucose(11.46); 'Urea(4.71); 
Ethanediol(20.58) 
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TABLE 2-IV AVERAGE, TISSUES 
Relative density . No Code Constituents and percentage weights Measured Calculated 
(i) AVERAGE BREAST 
1 AV. BR. I/ Epoxy CB3(70.80); 'Acrylics(23-09); 1.00 1.01 
SF3 Urea(3.23); PMS(1.85); Traces(1.02) 
Compounds'for traces: Na2HP04(0-16); 
K2HP04(0.65); S(O. 18); CaC03(0.01); 
MgO(0.02) 
2 AV. BR. Il/ Epoxy CB4(61.50); Polyethylene (36.24); 0.99 0.98 
SR1 PMS(1.60); Traces(O. 56) 
Compounds for traces: Na2HP04(0', 11), * 
K2HP04(0.43); MgO(0.01); 
CaC03(0"01) 
3 AV, BR-OII/ Epoxy CB3(68.61); 'Urea(l. 34); 0.99 0.99 
SF2 Acrylics(14.11); Polypropylene (14.23); 
Phenolic micro spheres (0.89); 
Traces(1.63) 
4 AV. BR. II/ Epoxy CB3(100); - no traces 1.02 1.02 SF3 
5 AV. BR. 111) Epoxy CB3(54-70); Glucose(10.85); o. 95 0.94 
SF1 Polyehylene(31-93); PMS(2.11); 
Traces (0.40) 
Compounds for traces: Na2TIP04(0.05); 
K2HP04(0.22); MgO(0.01); S(O. 12), ' 
50% FAT-50% WATER 
6 AV. BR*/ H20(27.68); Ethoxyethanol(72.32) 0.97 0,96 
Ll 
7 AV. BR*/ H20(32.43); Ethanol(20-72); 0.96 0.94 
L2 Pentanediol(46.91) 
8 AV. Blý*/ H20(32.43); Propanol(27.03); 0,96 0.95 
L3 Butanediol(40.54) 
9 AY. BR*/ H20(29.72); Propanol(49.55); 0.93 0.93, 
L4 Glycerol(20.72) 
73 
TABLE 2-IV cont 
Relative density 
No Code Constituents and percentage weights Measured Calculated 
(ii) TOTAL SOFT TISSUE, 
, 
1 T. S. T/LI H20(42.06); Traces(l. 54); Urea(5.20); 1.03 
Ethanediol(39-97); Propanol(11.27) 
Compounds for traces: Na CI(O. 21); 
Na H S04(0-13); N H4 H2 P 04(0.48); 
K CN S(O. 49); Mg(NCý)2 6H20CO-13); 
Ca(NO3)2(0.08) 
2 T. S. T/L2 H20(43.27); Traces(1.54); Urea6.20) 1.02 1.01 
Ethanol (20 *'38) - Glyc6rol(29.65) 
3 T. S. T/L3 H20(40.04); Traces(1.54); Urea(5.20) 1. '04 1 0"02, 
Ethanediol(39.96); Ethanol(12.96) 
(iii) TOTAL SKELETON 
I T. SK/SRI Epoxy CB2(64-79); Urea(1.29); 1.39 1.35 
CaH P04 (24.45); Ca 3(PO4)2 (7.29) 
Traces (2.15) 
Compounds for. trace elements: 
KN03(0-38); MgSO4(0.60); NaNO3(1*17) 
2 T. SK/SF2 Epoxy CB3(60.46); Urea(3-90); 1.40 1.36 
CaHP04(31-08); CaC03(2-39); 
Traces(2.17) 
3 T. SK/SF3 Epoxy CB3(52-56); Urea(4.27); 1.36 1.33 
CaHP04(24.44); Ca3(PO4)2(7.29); 
Acrylics(9.42); Traces(2.17) 
4 T'. SK/L1 H20(51-32); (NH4)2HP04(12.96); - 1.36. 1.32 
K2H P04(22.27); Glucose(11.60) 
5 T. SK/L2 H20 (27-31); (N H4)2 H P04(12.96); 1.40 -1-36 
K2HP04(22.27); Glycerol(35.61) 
6 T. SK/L3 H20(55*39); (NH4)2H P04(7.83); 1.34 1.33 
N H4NO3(3.27); Glucose(6.19) 
Ca3(PO4)2(25.86) 
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TABLE, 2-IV cont 
Relative density 
No Code -Constituents and percentage weights Measured Calculated 
(iii) TOTAL SKELETON cont., 
7 T. SK/L4 H20(42.16); (NH4)2HP04(7.83); ^1.36 1.35 
-Urea(2.45); Glycerol (20.24); 
Ca3(PO4)2 (25.84) 
TABLE 2-V TISSUE COMPONENTS 
Relative density 
No Code Constituents and percentage weights Measured Calculated 
F AT 
1 FT/SF1 ELVAX 220(100) 0.92 0-93 
2 FT/SR2 Paraffin wax(68-57); 0.93 0.96 
Polyvinyl acetate (31.57)., -,,, -,. 
3 FT/SR3 Palmitic. acid(62.44); Borneol(37.56) 0.91 0.88 
4 FT/Ll t Ethýl ofeate(76. '6'1'); -Cyclohexanol(24.39) 0.89 0.89 
5 FT/1.2 Glycýrol triolate(100) 0.92 0.92 
(if) PROTEIN 
1 PR/SR1 Gelatine(100) 1.28 1.28 
(iii) WATER 
1 WT/SR1 Epoxy CB4(80.44). Ca CO 3(5.77); 1.00 1.00. 
Polyethylene (10.00); PMS(3-79) 
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CHAPTER 3 
MANUFACTURE AND' QUALITY TESTING 
OF THE'NEW TISSUE SUBSTITUTES 
In this chapter the various -methods used for manufacturing the new 
substitutes will be described first and then the methods used for 
testing their quality will be discussed. An account of some of the 
problems encountered during ýthe manufacture of these materials will 
also be given. 
3.1 MANUFACTURING PROCEDURES 
(i) EPOXY RESIN BASED SUBSTITUTES 
The manufacture of epoxy resin based tissue substitutes has 
been described in detail. by WHITE (1974 1977) and the necessary 
equipment is shown in Figure 3.1 One important improvement in the 
Stirrer 
(varioble 
speed) 
O-lAOO r. p. m. 
II 
To Vacuum 
Pump 4-: 
satirrer Gland 
4 Air Intake 
Control 
Resin 
Mixture 
Figure 3.1 'Equipment for manufacturing epoxy resin 
based substitutes 
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control of the homogeneity of the substitutes was achieved in the 
'k by the introduction and use of the vacuum degassing and present wor 
pouring unit shown in Figure 3.2. 
I 
Figure 3.2 A vacuum degassing and pouring unit for use 
with synthetic resins 
A to vacuum pump F rotating table (23cm-diameter) 
B air intake G pouring gantry 
C lever operated vacuum H dispenser 
valves I vacuum gauge 
D handwheels for pouring j bell jar(acrylics 45cin-diam., 
gantry and rotating table with rubber seals) 
E : -Vacuum seals X: steel base(2cm-thick 
L: Implosion shield 
The necessary steps will The summarised here. Accurately -- 
measured quantities of resin hardener and fillers are poured into a 
reaction vessel (500-5000 ml) and given a short manual mix. The 
system is then closed and the variable speed stirrer is used, with 
the blades of the rotor deep in the fluid to ensure a thorough mixing. 
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Once the desired mixing has been achieved, the blades are raised to 
just below t6 top surface of the fluid and the vacuum pump, to which 
the system is connected., is switched on while the stirring is 
continued. As the pressure is reduced the mixture rises in the 
vessel, due to trapped gases, but 
Isoon 
the rotating blades cause 
the foam to collapse (1-5 minutes depending on the quantity and the 
viscosity of the mixture). The blades are then lowered to their 
previous position and mixing under vacuum is continued for another 
15-20 minutes; after that the stirrer is stopped and the vacuum 
released. 
The mixture is now transferred into the dispenser of the vacuum 
degassing and pouring unit, the vacuum applied again (pressures 
below 5 mmHg achieved), and the mixture poured into the appropriate 
mould or tray. , 
a vacuum'pouring unit is not'available, aýs the mixture is 
generally air-free, it could be cast into the mould under atmospheric 
pressure; in such case. the mixture should be poured carefully at 
one point of -the wall of the mould and left to flow slowly and fill the 
mould so that no air is trapped, 
The time that these systems take to harden varies from 15 to 24 
hours; if the sample., after it has hardened, is placed in an oven and 
heated to 800C for 2-4 hours, the curing process is completed. When 
moulds of complex shape are used, it is better to leave the sample in 
the mould for at'least 48 hours to avoid damaging it during demoulding. 
As'the curing of the resins, is moderately exothermic the heat 
evolved could present problems when large objects have to be cast; 
these problems may be overcome by casting layers of suitably small 
thickness (2-3 cm) and allowing each layer to hardenbefore pouring 
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0 
the next. If a fan is used to blow air over the sample in the mould, 
the shrinkaje, a function of the peak temperature attained, could 
be reduced to below 0.1% of the total volume. The use of moulds 
constructed of silicon rubber, PTFE, waxed aluminium, waxed 
perspex and melinex films, all with good "release" properties, 
ensures high quality end-products. 
The viscosities of the base resin systems used 
Nt. sec 
and their compatibility with some of the fillers were responsible for 
most of the problems encountered in the manufacture of solid 
substitutes. .- When the quantity of the filler was less than about'15*/o 
by weight, any difference between the densities of the filler and the 
resin resulted in separation, i. e. flotation or settlement accordingly. 
When the loading of fillers was high (e. g. hard bone), the removal of 
the air was rather difficult and this problem was overcome by using 
larger reaction ves. sels and so presenting a greater surface area 
for degassing; sometimes., however, adding the calculated quantity 
of fillers resulted in a dough rather than a pourable mixture. The 
quantity of a filler (additive) which can be dispersed into a known 
quantity of base material of a given viscosity, depends on the 
particle size of the filler; CB4, for example, can take up to 67% 
by weight of calcium carbonate OMYA BL (particle size about 50juni), 
but when "calcium carbonate BPI was used, with particle size of about 
5f1m, not more than 50% by weight could be used.. 
Compatibility of the resins and various fillers can also cause 
problems. It was noticed that nitrate compounds usually affected the 
curing process if used in quantities above 3-5*1o by weight. Ammonium 
nitratev for example., inhibited the curing of the base material CB3; 
on the other hand, calcium nitrifte seemed to catalyse the curing of 
CB1 and CB4; 10% of calcium nitrate in C131 would cause the 
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mixture to harden in less than one hour thus making the handling 
of the system difficult. 
Many formulae, otherwise ideal, were rejected on viscosity 
and compatibility grounds only. 
3.1 (ii) LUNG SUBSTITUTES 
The challenging problem of manufacturing solid, rigid or 
flexible, lung substitutes with correct elemental composition, porous 
nature and relative density if feasible, lead to the searchfor a 
suitable "blowing agent" which, when mixed with the epoxy resins 
would cause their volume to increase resulting in a foamed material 
of the required density. 
Neither the concept of using shavings of muscle substitute turned 
on a lathe, nor that of using cellulose sponge soaked with sodium 
chloride solution (SHONKA and McGINLEY, 1976) was considered 
satisfactory. Cork was also rejected because of its unknown 
composition. The lung material suggested by ROGERS (1970) 
included components which,, according to the author himself I are 
suspected carcinogenic (Moca) and- others which may contain traces 
of volatile products known to be strong irritants to the mucous 
membranes and the skin (e. g. Adiprene). 
The use of polyurethane foams was also avoided firstly because 
of the deleterious cyanate gases released during their manufacturep 
secondly because they must be contained and forced to overpack in 
strong metal moulds and thirdly because the maximum thickness 
that can be produced by this method is not more than 1 cm, if uniform 
density is to be achieved. 
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The aim, was to stay away from too complex techniques which 
involve high temperatures and pressures. The solution to the 
problem was found when it was realised that one of the liquids 
sold by the firm "Dow Corning Ltd" , namely DC 1107, and used 
mainly in the paper industry, had such chemical composition that 
it could react with acids, bases, amines , etc. , liberating hydrogen 
(see Section 2.3). The hydrosilane (S Si H) functional groups 
could, in theory, release up to 360 CM3 of hydrogen gas per gram 
of liquid. This meant that approximately 1 cm3 of this liquid would 
produce enough hydrogen to "blow" 100 grams of resin to more than 
3 times its original volume, thus giving a bulk relative density below 
0.3. By adjusting the amount of foaming agent it should be possible 
to produce lung substitutes of any required density. 
In order to establish the relationship between the relative 
density of the lung phantom produced versus percentage of'foaming 
agent, samples of muscle substitute MS/SR4 were made and different 
percentage by weight of DC1107 was added to each one of them (0.25%, 
0.5*/,,, 0.75%, etc). The experiment was repeated with the flexible 
muscle substitute MS/SF3. When the resulting lung substitutes 
cured, they were machined all to the same volume and weig'h ed so 
that their relative density could be measured. Figure 3.3 summarises 
the results. With the rigid MS/SR4 the minimum relative density 
achieved was 0.25 corresponding to 0.95-1.0% by weight of foaming 
agent; with larger concentration of foaming agent.. the sample 
originally rose and then collapsed. 
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'Figure 3.3 The lung substitute relative density as a 
function of the percentage (by weight) of 
Joaming agent 
The flexible product did not collapse even when the concentration of 
the foaming agent was increased up to 1.51/o at which a relative 
density of 0.22 was obtained, 
In order to control the size of the pores in the lung phantom, the 
liquid surfactant DC200/50 cs, was found to be the best among several 
tested The introduction of 0.25% by weight of surfactant was found 
to give acceptable results; if 1.0% by weight of foaming agent was 
used for example, the average diameter of the pores was about 
2 mm. 
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The technique of manufacturing lung substitutes was standardised 
and is as follows: 
First pre-calculated quantities of resin and fillers are 
thoroughly mixed in an open reaction vessel; then the surfactant 
is added and dispersed uniformly into the mixture by stirring at 
about 300-350 r. p. m; the stirrer is stopped when the mixing is 
considered thorough (5-10 minutes in all, depending on the quantity 
of the material) and the foaming agent is dispensed using a volumetric 
syringe or other precision dispenser (accuracy of 
4-0.01cm3desirable). 
As the reaction starts as soon as the resin and the foaming agent 
come in contact, stirring is started immediately and continued for 
30-40 sec. after which the mixture is poured into the open mould 
and left to rise under atmospheric pressure. 
The time available after the foaming agent is added is limited and 
evacuation'is precluded; consequenýly, a certain amount of air is 
always present, but its mass is so small that its effect on the chemical 
composition of the final product is negligible. 
The lung substitutes that result from the above procedure can 
easily be moulded to any desired shape and they can be removed from 
the mould 48 hours later. The rigid samples can also be machined to 
any desired shape. 
Using this procedure, reproducible results for densities over a 
wide range can be obtained. The question of uniformity of. density 
when considering large volumes was also investigated; a 30 cMx 30 cMx 
30 cm1ung phantom (LN/SR4) with the desired relative density of 0.3 
was made; when the density of several samples of it was measured., it 
was foun d to be 0.30 tO. 02. This result was considered satisfactory. 
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Figures 7.1 a and 7.1 b show some lung phantom materials produced 
and used for measurements in this study. 
3.1 (iii) L12'UIDS AND GELS 
The mixing of several liquid and solid compounds to make 
various liquid and gel substitutes did not present any serious problems 
once the formulae of these substitutes were produced and a number of 
rules derived from experience were f ollowed. The main difficulties 
encountered in this case resulted from the poor availability of 
solubility data for many compounds, especially organic liquids. 
All too often, formulae which represented elementally correct 
substitutes had to be rejected because the addition of one component . 
caused the precipitation of another compound. Consequently a 
certain amount of trial and error was inevitable. 
In an attempt to keep the total vapour pressure (to which the 
volatility of a solution is proportional) below that of waters liquids 
with vapour pressure above 23.7 mmHg at 250C, were avoided. 
Water was preferred as base material for many reasons; it is 
one of the best solvents, readily available and cheap. Apart from 
this, various organs and tissues appear to be composed basically 
of fat q protein, water and trace elements. By mixing fat and 
protein substitutes with water in the desired proportions I substitutes 
for many organs or tissues can be made. jk good step forward in 
this direction is due to the fact that gelatine, derived from bone by 
hydrolysis of collagen, has elemental composition close to that of' 
protein. Unfortunatelyp attempts to formulate fat substitutes 
miscible with water failed; the use of gelatine, however, facilitated 
the formulation of many gel substitutes useful for short term 
applications. 
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When manufacturing liquid substitutes, the calculatcd quantity 
of water should always be measured into a beaker first. Then 
the inorganic compounds required to introduce the trace elements 
should be transferred and stirred into solution one by one in the 
order given in the formulae. It is important to wait until one is 
completely dissolved before. the next is added; otherwise 
intermediate pretipitates may be formed which, sometimes, are 
difficult to bring back into solution. Urea, used in most liquid 
tissue substitutes to satisfy the nitrogen requirement, is transferred 
next; finally any other organic liquids are transferred and stirred 
into solution, 
in the case of gel substitutes., the water component with the 
trace elements already dissolved in i't should be heatedup, to about 
800C and then the calculated quantity of gelatine added and 
dissolved; once a clear uniform solution is obtained it should be 
left to cool and approach room temperature., when the remaining 
organic components and a bacteriostatic agent should be added. 
The whole mixture can then be transferred into the reaction vessel 
of the mixing unit and the vacuum applied. Stirring under vacuum 
ensures the release of any air trapped in the mixture. The 
substitute can then be poured in polythene bags heat-sealed and 
left to gel before use. Figure 7.2 shows some of the liquid and 
gel tissue substitutes produced and used in this work. 
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3.2 SOME- PHYSICAL INVESTIGATIONS FOR QUALITY TESTING 
(i) 'RELATIVE *DENSITY DETERMIN; MOIýS 
Relative density measurements were performed on the 
manufactured substitutes; these results are given with the calculated 
values in the Tables 2-1 to 2-V. The calculations of relative 
density were made assuming that the volumes of pure substances are 
additive both in solid and in liquid phase. This is not always correct, 
especially in the liquid phase, because of ionic and molecular 
interactions; "partial solution density" data, however, are sparse, 
Samples of each of the solid substitutes were accurately machined 
into cubes or parallelepipeds Of known dimensions and the relative 
density was measured by. a direct determination of mass and volume; 
the estimated error of measurement was 0.5%. The calculated 
values agreed with the measured ones to within 1% except in the case 
of the bone substitutes where disagreement up to 50% was observed. 
Samples of these bone substitutes were manufactured many times 
both in small quantities (100- 200 g) and larger quantities (1-2 kg) 
and the results were reproducible indicating that the disagreement 
was not due to dispensing errors. It is likely that the density of 
the various grades of calcium compounds used was not the same as 
that quoted in the literature. 
In the cases of liquid and gel substitutes, a 40 ml Hubbard 
Density Bottle was employed and occasionally the measurement was 
repeated with a 100 ml volumetric flask. The difference between 
calculated and measured density values here was about 2%. Most 
of this discrepancy is probably accounted for by the fact that the 
density of each component "in-soltition" is not the same as that of 
the pure substance. which is found in the literature and was used in 
the calculations. 
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3.2 (ii) HOMOGENEITY TESTS 
The homogeneity of the manufactured solid substitutes was 
investigated mainly by using conventional radiography. Xeroradiography, 
end-of-range proton radiography and computerised axial tomography 
were used only in a few occasions. The end- of -range proton 
radiography proved to be superior to all the other methods for 
indicating air volumes within the sample. (KOEHLER, 1968, STEWART 
and KOEHLER, 1974). 
Although most of the polymer fillers and the phenolic microspheres 
used were very fine powders with particle size of the order of 100 pm 
or less, some of the inorganic compounds used to introduce trace 
elements had to be ground and sieved; sieving to below 200 pm, 
however, . proved to be very time consuming and as the samples 
produced were not to be used in making test objects for diagnostic 
purposes., except for two occasions described in Chapter 7p 
sieving the fillers to 200 pm was considered acceptable. 
All the solid substitutes used in measurements during this work 
were tested radiographically, using 25-60 kVp ýC-rays. If bubbles 
of trapped air or pockets of undispersed high density filler were 
visible on a radiograph, the corresponding sample was rejected; 
air pockets of less than 50 pm, however, would not have been detected 
by this technique,, unless end-of-range proton radiography was used. 
If flotation or precipitation of a filler was suspected in a sample, a 
radiograph was taken and scanned on a densitometer; if the 
variation in optical density was more than 5%, the sample was 
rejected. 
A critical evaluation of the"tissue equivalence" of the manufactured 
tissue substitutes was considered to be very important and this is 
discussed in the next chapter. 
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CHAPTER 4, 
THEORETICAL AND EXPERIMENTAL EVALUATION 
OF THE VARIOUS TISSUE SUBSTITUTES 
4.1 THEORETICAL EVALUATION 
All the new tissue substitutes and most of those developed in 
the past have been evaluated theoretically by comparing the following 
radiation characteristics with similar data for the corresponding real 
tissues: 
Mass stopping powers for protons. 
Kerma fadtors. 
Electron mass stopping powers and mass angular 
scattering powers. 
Mass attenuation and energy absorption coefficients. 
The recommended substitutes for each type of tissue and the calculated 
properties of some of them will be presented after a brief description 
of the computer programs developed for this theoretical evaluation. 
COMPUTER PROGRAMS DEVELOPED DURING THIS STUDY 
Three programs were developed during this study, namely 
ELISTBq PROTON and KERMAF. These programs. were written in 
Fortran IV and run on the CDC computers of the University of London 
Computer Centre (U. L. C. Q. 
The program ELISTB is used to calculate the elemental 
composition (in terms of percentages by weight, w/o) and theyelative 
density (SG) of any mixture of compounds , provided the 
formulae or 
elemental composition, the proportion by weight and the densities of 
these compounds are known. Table 4-1 shows an example of the 
output of ELISTB., obtained in the form of microfilm. 
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TABLE 4-1 TYPICAL OUTPUT OF THE COMPUTER 
- PROGRAM ELISTB 
I MATERIAL 
BRM/LG ' (SG 1.01 
WER 62.45 C3H8O3 18.1s ETHANOL 14.35 Nk2CONW2 2.77 
KHS04 . 16 hA2SG4 . 56 KCL *48 H3P04 1.07 
SUBSTITUTE O-VO) REAL TISSUE GLOV RATIO (SUBSTAZEAL) 
N 10.6822 10.7000 . 9983 ) 
c 1S. 1308 15.3300 . 9876 ) 
h 1.2902 1.29W C 1.0002 ) 
a 71.6741 71.4000 ( 1.0038 ) 
hAl . 1813 . 1790 C 1.0127 ) 
p M76 . 3400 MM ) 
5 . 1652 . 1700 . 9717 ) 
CL . 2292 . 2290 ( 1.0009 
K . 3001 . 3000 ( 1.0003 
The program PROTON uses elemental proton mass stopping 
power data at 38 energy points in the region from 0.01 MeV io 
1000 MeV, the elemental or compound composition of the substitute 
and the Bragg additivity rule to compute the partial and total mass 
stopping powers of each substitute material. Stopping powers for 
the real tissue are then computed together with the ratio 
(1) 
subst/ 
(1) 
tissue * 
The elemental stopping power data PP 
were stored on magnetic disc for convenience. Two subroutines 
are called by the main program, namely MM and GRAFFX. The 
first is used to determine the minimum and the maximum of an array 
of numbers (stopping powers or stopping power ratios). It then 
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prints the results with the appropriate headings. The second 
subroutine interacts with a plotting package for the line printer, 
written by the staff of the University College Hospital, London. 
This subroutine is called twice per substitute material. The first 
for the total mass stopping power of the substitute and the second 
for the stopping power ratios. Once these graphs are plotted on 
a linear-log scale, the mean, standard deviation and variance are 
computed and printed together with the minimum, maximum and range 
of values for each set. 
The program KERMAF has a structure very similar to that 
of PROTON and uses the same subroutines. The 116 kerma factor 
values for each one of nineteen elements, including all of those which 
exist in real tissues, taken from ICRP report 26, were stored on 
magnetic disc and used to compute the total kerma factor values for 
each substitute in the energy range 10 eV to 30 MeV. - The total 
kerma factor ratios (substitute /real tissue) are also computed and 
plotted against energy on a linear-log scale. The mean and 
standard deviation of these ratio values are. also calculated and 
used to indicate how accurately each substitute simulates the 
corresponding real tissue for neutron interactions. 
Figures 4.1a and 4.1b show examples of the graphical output of 
the programs PROTON AND KERMAF. The basic flow chart 
for these programs is shown in Figure 4.2. The program TABLE 
used for the computation of the photon and electron data for real 
tissues and tissue substitutes was developed by WHITE (1974). 
The data and formulae used in this program have been discussed 
in Chapter 1 (section 1.2 (iii) ). 
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4.1 (ii) RECOMMENDED TISSUE SUBSTITUTES AND THEIR I 
CALCULATED RADIkTION CHARACTERISTICS 
The results of a comprehensive analysis of the radiation 
characteristics of all the new tissue substitutes, and of most of those 
published in the past (summarised in Appendix 4), for photons and 
electrons of 0.01 MeV 100 MeV, protons of 0.01 MeV 1000 MeV 
and neutrons of 11 eV 30 MeV, led to the classification of these 
materials according to the magnitude of the discrepancies in their 
radiation characteristics, when compared to those of the corresponding 
real tissues: 
CLASS A materials :. errors 5Y. 
CLASS B materials : errors from 5*1o to M/c, 
CLASS C materials : errors > 20% 
All those substitutes which are "Class A for all types of radiations" 
are recommended for use in clinical dosimetrv. Some of the 
"Class A" substitutes become Class B or even Class C when 
considered for photon energies below 0.1 MeV and such information 
is given in the classification. Similarly, some of the substitutes 
are Class A for one type of radiation but Class B or C for other 
radiation modalities. Tables 4-11 (A to E) summarise the results 
of this classification and show the recommended substitutes. The 
calculated coefficient ratios, power ratios and kerma factor ratios 
of some of the recommended tissue substitutes are given in 
Tables 4-111 and 4-IV. 
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I 
4.2 EXPERIMENTAL EVALUATION OF-THE "TISSUE 
EQUIVALENCE" OF THE NEW SUBSTITUTES 
The general objectives of the experimental work carried out 
during this study were two-fold, namely,, to determine how accurately 
the new tissue substitutes. simulate the corresponding real tissues 
II 
and then to use these materials to measure the dose distributions 
from beams of various radiation modalities in tissues like muscle, 
brain, etc. , and to investigate the effect of tissue heterogeneities 
on these dose distributions. 
The experimental verification of the tissue equivalence of 
the new substitutes is described in this section while the dosimetric 
investigations using the new substitutes are discussed in Chapter 5. - 
Comparative measurements were made for the follo, -Adng: 
a) Muscle equivalent liquid (MS/Ll) and solid muscle substitutes 
(MS/SR1 and MS/-SR4) versus human muscle, beef steak and 
pork; 
b) Brain equivalent liquid (BRN/L6) and brain solid substitute 
(BRN/SR2) versus human brain; 
c) Fat equivalent solid (FT/SF1) versus beef fat; I 
d) Solid and liquid bone substitutes versus human bone. 
The human tissues used in these comparisons were obtained from 
post-mortem investigations. 
The cells shown in Figure 4-3.. made of muscle or brain 
substitute accordingly, with cross sectional area 10 cm x 10 cm and 
variable thickness, were filled with the real tissues and immersed 
into the appropriate tissue equivalent liquid to displace an equal 
volume of that liquid; central axis depth doses and beam profiles 
were then measured in the liquid behind the cell and the results 
100' 
compared with those obtained in the liquid alone and with those 
obtained when other solid substitutes were pro-sent in the liquid. 
The result will be discussed in the followi-ng sections of this 
chapter. 
Figure 4.3 Cells used in the comparison of 
substitutes versus real tissues 
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4.2(i) HIGH ENERGY PROTONS 
The 160 MeV proton beam from the synchrosyclotron of 
the Atomic Energy Research Establishment, U. K. v was 
s cattered with a0- 317 cm -thick copperplate. The resulting broad 
beam was about 5 cm, diameter at the front face of the phantom, 
1m away from the end of the beam pipe line. When liquids were 
used, they were contained in a 15 cm x 15 cm x 25 cm perspex tank 
whose front wall was 0.3 cm thick. 
A flat ionisation chamber (MC78), which is described later, 
was used to measure depth doses in MSILl. A5 cm-thick cell of 
human muscle was then immersed in the muscle liquid in the plateau 
region and, the depth dose measurements in the liquid behind the 
muscle cell were repeated; the human muscle was sequentially 
replaced by beef steak,... solid MS/SR1 and solid MS/SR4 muscle 
substitutes and each time the depth doses in the liquid behind them 
measured. The results are shown in Figure 4.4. The maximum 
difference in the position of the Bragg peak between any two of the 
above sets of measurements was less than 1 mm and if a correction 
for the slightly higher relative density of MS/Ll (1-07 instead 
of 1.06) was made, this difference was reduced to less than 0.270 of 
the peak depth. When MS/Ll with no trace elements in it was used 
(relative density 1.06), the results were identical with those obtained 
when the fixed human muscle sample was immersed in it. 
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Figure 4.5 shows similar. measurements for 5 cm-thick 
samples of beef fat and the solid fat -substitute FT/SFI placed., 
in turn, in the plateau region; the agreement between the two 
is good. The depth dose in MS/Ll is also plotted on this graph 
so that the displacement of the Bragg peak for fat, relative to muscle 
can be estimated. 
Another similar"cell, made of brain substitute (BRN/SR2). 
was filled with human formalin-fixed brain and immersed in brain 
equivalent liquid (BRN/L6). The central axis depth ionisation 
curves in tRN/L6, with and without the real brain in it, are 
shown in Figure 4.6.1 The two sets of measurements are nearly 
identical; when a5 cm-thick BRN/SR2 sample was immersed in 
BRN /L6, in the plateau region , however , the depth of the, Bragg 
peak was reduced by about 1 mm. 
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Figure 4.5 Fat substitute versus beef fat 
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Figure 4.6 Brain substitutes versus real human brain 
The slightly higher relative density (1.04 instead of 1.03) was found 
to be responsible for most of this displacement. 
A preliminary series of measurements with various bone 
substitutes and sections of an ox tibia, showed that a density 
correctiony when bone, was present in the beam, would give the 
required position of the Brdgg peak with an error not exceeding 
4-5*/,,. It was not possible to find areas of real bone to make absorbers 
of cross sections large enough to minimise experimental errors, so. the 
above finding was accepted. The effect of bone as well as the 
correction necessary when bone is present in a proton beam are 
discussed later in the thesis. 
1 nc 
4.2 (ii) FAST NEUTRONS 
A series of measurements similar to those described in the 
previous section was carried out using the fast neutron beam of the 
Medical Research Council cyclotron at the Hammersmith Hospital., 
London. Central axis depth doses were measured in muscle- 
equivalent liquid (MS /41) and then 5 cm-thick samples of human 
musclcpbeef steak, pork and MS/SR4 were immersed in turn, and 
the depth doses measured each time. 
The total dose (Dn +Dy) was measured with a1 CM3 
spherical ionisation chamber (EG & G) whereas the gamma ray 
component of the dose was measured with a Geiger Muller counter 
covered with a6 Li foil *to absorb the slow neutrons. The total 
dose was norm. alised-to the dose at 1.5 cm depth and the, results., 
plotted versus depth, are given in Figure 4.7(a). Dose distributions' 
perpendicular to the beam 
-axis 
(beam profiles) were also measured 
in MS/L1 (at 9 cm. depth) and then repeated. with each of the above 
mentioned samples immersed in the liquidg in front of the dosemeter. 
The dose at points off the axis was normalised to the central axis 
dose which was taken as 100%. (Figure 4.7(b) ). 
The difference between any two measurements at the same 
point, but with different samples, was generally of the'order of 
tO. 5/. * 
and in no case greater than 
2-0.8%. A statistical analysis of the 
differences observed in all, the above measurements was made and 
these differences were found not to. be significant; differences - 
resulting from the variability of the, machine itself (e. g. deuterons 
hitting the Be target off centre) , amount 1%; this aiso accounts' 
for the fact that beam profiles measured under identical conditions 
are not always symmetrical. 
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(b) 
Brain substitutes were compared to human brain (both 
formalin fixed and unfixed), in the same way as above. The gamma 
ray component of the dose was also measured and subtracted from 
the total dose. The neutron depth doses, expressed as a percentage 
of the maximum neutron dose (at 2 mm depth for this neutron energy), 
are shown in Figure 4.8. Unfixed human brain and BRN/L6 gave 
nearly identical results whereas formalin fixed brain gave slightly 
higher and BRN/SR2 gave slightly-lower depth doses than unfixed 
brain. In general., however., the-neutron depth doses behind any- 
brain sample, substitute or real,. were found-not to differ by more 
than 1%, i. e. they were within experimental error, ýthe same. 
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Figure 4.9 shows the ýcomparison of beef fat with FT/SFI with the 
same beam of neutrons. 
In this case the solid muscle substitute MS/SR4 was 
used as main phantom material and the fat samples placed infront of 
it, keeping the distance from the front surface of the composite 
phantom to the target unaltered (i. e. 120 cm). The neutron depth 
doses behind the beef fat sample are slightly higher (but not more 
than 1%) than those obtained, with, equal thickness of, FT/SF13 mainly 
because of the difference in, the-_width and height of the two samples 
(beef fav: 10 cm x 10 cm, x5 crn , FT 
/SF 1: 15. rm x 15 crn x5 cm), ý 
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This difference in geometry was cancelled out when the tissue cells 
were immersed in the'liquids in all the previous examples. 
It is evident that the higher hydrogen content of fat, 
although it may result in higher neutron absorbed dose in the fat 
itself. is, more than compensated by its lower density; the net 
effect is that the neutron doses behind it are higher than in muscle 
alone., without any fat present, 
Finally, a comparison between bone substitutes and real 
bones was attempted. For this, a cylindrical container with 5 cm, 
internal diameter and 0.5 cm-thick wall, made of MSISR4 was placed 
in the perspex tank touching its front wall and displacing muscle 
equivalent liquid (MS /Ll). Thi. s allowed the introduction of liquid 
bone substitutes into the muscle equivalent liquid (MS/Ll). The 
ionisation chamber could move behind'the cylinder, 'in th-A liquid', the 
movement being controlled remotely (Figure 4.10). 
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Figure 4.10 Setup used for the comparison of real 
bones with bone substitutes 
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Three real bone samples and three cylinders of solid bone substitutes, 
(T. SK/SF3, HB/SF3 and HB/SR9) , machined to dimensions similar 
to those of the real -bones 
(femur, about., 3 cm diameter) were 
immersed, in turn,, into the cYlindert displacing the liquid bone 
substitute. The depth doses -were measured atl two 
depths,, namely 
9 Cm and 15 cm, with the cylinder containing TSK/Ll and then a 
hard bone liquid substitute (WITT and CAMERON 1975). 
The total doses measuredýat 9, cmdepth for the various 
liquid bone substitutes and the real bone samples were all lower than 
those measured in muscle equivalent liquid alone; the difference 
between the total doses behind any combination of two bone samples., 
real or substitutes, however, (lid not exceed 0.5% of the maximum 
dose. 
An attempt to verify whether the lower total dose was clue 
to lower nVitron or lower gamma ray components of the dose, did not- 
give conclusive res 
-ults. , 
Measurements with slabs of solid bone 
substitutes, however, indicatedp consistently, that the difference 
was due to a reduced gamma ray component of the dose; this will 
be discussed in Chapter 5. 
, 
4.2 (iii) COBALT-60 GAMMA RAYS 
Although the new substitutes were designed for particulate 
radiations they were also tested with cobalt-60 gamma rays. There 
was no doubt about the accuracy of simulation for the liquid substitutes 
which have both correct elemental composition and relative density. 
It is the effect of the partial 'replacement of oVgýn by carbon in the 
solid substitutes that had to be verified experimentally, 
Since Compton scattering is the predominant process at 
the energy of cobalt-60 gamma rays, it is the electron density 
. 111 
3 (electrons/cm )'that is imp, ortant inAis casý. Consequently, no 
greai difference was to be ex'pected:, for 6xample, ', between MS/L1 
which is elementally correct and MS/SR4 in'which three'quarter's 
of the 'oxygen content of muscle have been replaced by, an equal 
amount of carbon (oxygen - 15.55, '. ' , instead of 72 * 
89%, by'weight). 
The tissue equivalence of some of the new substitutes,, 
was tested with cobalt-60 gamma rays in the same way as with, protons 
and neutrons. The field size and SSD employed were 10 cm, x 10 cm 
and 75 cm. respectively. 
Figure 4" 11 shows the results of the comparison of MS/L1, 
MS/SR41 beef steak and human muscle. On the same graph the results 
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-of 
the comparison of FT/SF1 with bccf fat, are also given for the 
same 10 cm x- 10 cm. field size It was found that in no case did. 
the readings at the same depth differ by more than 1% which indicates 
that the simulation of thereal tis 
: sues at this photon energy is very 
accurate. However, when cylinders of hard bone substitutes 
(HB/SF3, 
HB/SR4) were compared to real human bones of approximately the same 
shape$ the depth dose measured behind the substitutes was I 
tip to 2% 
lower than the aose measured at the same point behind the real bones. 
The setup and method used in this comparison was the same as 
that 
already described in the comparison of bones using fast neutrons 
(Figure 4.10). The two' bon e su 
I bs tI itu , tes themselves were found to 
be within 0.5% of'cach other. 
4.2 (iv) 1201, -,. Vp X-RAYS 
The accuracY with which the various substitutes simulate 
the corresponding real tissues at photon energies below 100 keV 
(Diagnostic'range) was tested using the general purpose EMI 
CT50042085 scanner' of -the Middlesex Hospital, London, operating 
at 120 kVpt 33 mA (4.5 mm Al filiration). 
The, 
-CT-numbers obtained 
in computerised tomography 
(CT)., for a given photon energy., appear to have a linear relationship 
with the linear attenuation coefficient of the material which'I is 
rec6nstructea in each picture -element 
(pixel) (McCULLOUGH et al.,,. 
1976., WHITE and SPELLER, 1978). 
The derivation of the -value from the mea sured CT- 
number of the various tissues is needed if these data are to be used 
in dose calculations for radiotherapy treatment planning. In order 
to find the exact analytical expression for this relationship and 
subsequently derive the p -values from the CT-numbers measured 
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during a scan, it is necessary to know the effective energy (Eeff) 
of the X-ray. beam in use. 
The Eeff of the X-ray beam of the CT-5005 scanner used, 
was measured using the "KEVLIQUID" method proposed by WHITE and 
SPELLER (1978) and was found to-, be 67 10.5 keV. Each of the 
liquids used is a two-component solution (ethanol + carbon: 
tetrachloride) denoted by keV1. The relative volume of each 
component is calculated so'that the- -value of 'each KEVLIQUID 
equals that of water only at one specific energy (water is used as 
standard material). In this way,, several' KEVLýQUID S can be 
formulated and used as - "keV indicators". 
The actual Eeff of the X-ray beam can be found by scanning 
the keV indicators CKEV1/60, KEV1/62, KEV1/64 etc) sequentially 
and selecting the one that has the same CT-number as water. 
In, practicela 20 cm diameter solid phantom was used; the 
phantom was made of the water substitute WT/SR1.2.5 cm diameter 
polypropylene tubes, each filled with one KEVLIQUID, were inserted 
in a hole of the same diameter drilled at the centre of the phantom and 
scannedg one at a time, , 
Water was also scanned on its own. After. 
each scan, the mean CT-number and the standard deviation were 
determined within a circle of radius equal to 5 pixels. The measured 
CT-numbers were plotted against "indicated keV" and the value 
Eeff = (67 ±0.5)keV was derived from the graph using the CT-number 
for water; consequently the -value. at 67 keV , for each of the 
KEVLIQIJIDS was computed. Table 4-V shows the exact values. 
iii 
TABLE 
-4-V 
MEASURED'AND COMPUTED DATA, 
FOR THE KEVLIQ'UIDS 
"Indicated keV" 
liquids 
Measured - CT-numbcr 
Standard 
deviation 
Computed p (cm-1) 
KEVI/60 -26.13 2.40 0.189 
KEV1/62 -21-50 2.36- 0.191 
KEV1/64 -16.80 2.53 0- 193' 
KEVI/66 -11-39 2-35 0.195 
KEV1/68 - 6.94 2.53 0.197 
KEV1/70 - 2.48 2.30 0.199 
KEV1/72 + 2.43 2.42 0.201 
WATER -10.77 2.30 o. 196 
A linear relationship of the form ao + al x (CT -numbpr) was 
fitted to the data of columns 2 and 4 of Table 4-V using the method 
oi least squares; the equation for the "best fit" straight line was 
found to be: 
0.1999 + 0. OOb42 x (CT -number) (4.1) 
It is evident that these KEVLIQUIDS can also be used to test the 
linearity of the scanner. 
Having established the Eeff of the machine and the exact relationship 
*between CT-numbers and -values. a series ol" tissue substitutes 
were scanned, in turn,, using the same phantom and the same machine 
working conditions; the p-values for these substitutes, derived from 
their measured CT-number using equation 4.1, were compared to those 
of the corresponding real tissues which were calculated from basic 
elemental data as suggested by WHITE and FITZGERALD (1977). 
Table 4-VI gives the -actual values and in the last column the values of 
115 
the coefficient ratios,. which indicate the accuracy of"simulation at 
thi s low energy, are given. 
TABLE 4. Vl MEASURED AND CALCULATED P-VALIJES 
FOR SUBSTITUTES AND REAL TISSUES 
Real tissue 
or substitute 
Measured 
CT -number 
Standard 
deviation 
PexperScnl- 
(67 keV 
(cm-1 Pcalc. 
(67 keV) 
Psubst. exp . er 
Ptissue calc. 
ICRU 
MUSCLE 01.198 
H20 -10.77 2.30 0.195 0.196 0.99 
MS/Ll 11.68 2.50 0.205 0.2P5 1.03 
MS/SR1 3.05 2.28 00201 0.200 1.01, 
MS/SR4 -2-33 2.30 0.199 0.197 1.00 
BLOOD 
(WHOLE) 0.206 
BL/Ll 31-99 2.41. 0.213 0.201 1.03 
BRAIN 0.201 
BRN/1.3 5.23 2.23 0.202 0.198 1.00 
BRN/I. 6 9.51 2.23 0.204 0.199 1.01 
BRN /SR2 0.13 2.59 0.200 0.200 0.99; 
HARD BONE 0.497 
HB/SR4 557.68 4.76 o. 434 0.413 0.87- 
S134 625.95 5.83 0.463 0.478 0.93 
WITTýS 
LIQUID 578-75 4.52 o. 443 o. 474 0.89 
TOTAL 
SKELETON 0.321 
S. SK/Ll 257.60 2.60 0.308 0.292 0.96 
T. SK/SF3 . 
248.10 2.70 0.304 0.297 0.95 
FAT 0.174 
FT/Ll -79.43 2.50 o. 166 0.168 
0.96 
TOTAL SOFT 
TISSUE 0.200 
TST/Ll 7.61 2.40 0.203 0.200 1.01 
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The difference between experimental and computed p-value, 
I 
for the same material is generally of the order of 1-2/., except in 
the case of hard bone substitutes where the maximum difference 
was 70/.. 
117 
N 
CHAPTER 
THE 'USE C)F THE NEW TISSUE SUBSTITUTES IN 
DOSIMETRIC INVESTIGATIONS RELEVANT 
To RADIOTHERAPY 
Beams of X-rays, gamma rays, electrons and neutrons are 
used in radiotherapy on a routine basis, while clinical trials mrith 
k 
high energy protons and negative pions are in progress in various 
countries. The formulation and manufacture of the new tissue 
substitutes for particulate, radiations., offered the opportunity for 
dosimetric measurements with these radiation modalities. It also 
made possible the investigation of the effect of air spaces, lung, fat 
and bone on the dose'distributions in composite phantoms. 
Dose distributions were measured in a muscle equivalent 
liquid (MS/L1) ,a solid muscle substitute (MSISR4) and a-brain.,: - 
equivalent liquid (BRN/L6).. Since water has been widely used as 
muscle substitute in the past, measurements were also made in water, 
so that the difference between muscle and water when the two are 
used under identical conditions could be investigated. ' In this 
chapter, the measurements carried out with beams of 150 MeV protons, 
7.5 MeV neutrons,, 10 MeV electrons, 70 MeV negative pions and 
alpha particle-s of energy up to 5 MeV will be discussed in turn. 
5.1 PRE-THERAPEUTIC MEASUREMENTS WITH HIGH 
ENERGY PROTONS 
The physical characteristics of high energy protons have -been 
reviewed by KOEHLER and PRESTON (1972); more recently, 
ARCHAMBEAU et al. , (1974) reviewed the clinical status of proton 
radiation therapy. The measurement of a number of parameters 
determining the depth dose, distribution of a high energy proton, beam 
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is a necessary pre-requisite of patient treatment. Such measurements 
would enable a credible and reproducible method of dose administration 
to be established. 
As plans to use the 160 MeV proton beam from the 
synchro cyclotron of the Atomic Energy Research establishment, 
U. K.., (A. E. R. E) for radiotherapy exist, all the relevant physical 
parameters of that proton beam were measured during this study. 
The central axis depth doses, the depth of the Bragg peak, the peak. 
width., peak/plateau ratio and beam_profiles in MS/Ll, 'BRN/L6 and 
water have been established. The effect of air spaces 'lung.. fat 
and bone on the depth doses was also investigated and a simulated 
patient treatment was attempted, with promising results. 
5.1 W MATERIALS AND METHODS 
Protons of (160 t 2)MeV were focussed onto a0 . 317 cm. 
'; 
thick copper scatterer , from which they emerged having, a roughly 
Gaussian intensity distribution with distance from the beam axis, -,, -, - 
with a mean energy of about 150 MeV. A transmission ionisation'ý', 
chamber'placed in the beam, 10 cm awak from the scatterer, 
_, 
was. 
used as beam monitor. The scatterer-phantom distance was 1 metre 
and the 500% level width of the beam profiles, measured with a silicon,, 
diode detector at 0.5 cm and 15.5 cm-depth in water, was 4.8 cm, '' 
and 6.0 cm rcspectively. 
The detectors used within the phantom could be moved by 
remote control along the horizontal axis of the beam as well as-. 
laterally and vertically in a plane normal to the beam direction. 
Figure 5.1 shows a photograph of the setup. The focussing magnets, 
scatterert traiýsmission monitor: chamber and the detector in the 
liquid phantom are clearly visible. The detector signals were fed 
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into a KEITHLEY 602 electrometer connected to a digital voltmeter. 
, -- I 'I -, Whenever týe detectors were used in a liquid phantom, they were 
inserted in special sleevcs made of th-e appropriate solid 
substitute (bone: HB/SR4, muscle: MSISR4 or MS/SR1 and 
brain: BRN/SR2), and machined to the exact shape of the detector. 
These are illustrated in Figure 5.2. The 0.2 CM3 cylindrical 
ionisation chamber was obtained from the Rutherford Laboratory. 
The plane parallel plate (flat) ionisation chamber (MC78) also 
illustrated in Figure 5.2, was made by painting the h. t. , guard and 
collector plates onto strips of a muscle substitute (MS/SR1), using 
colloidal graphite (dag). It was assembled using a1 mm-thick strip 
of Perspex as a spacer. The air-filled collecting volume was 
formed by removing a1 cm-diameter section of the spacer. The 
chamber followed the design used at the Medical College of 
St Bartholomew's Hospital and described by ELLIS and IZEAD (1969). 
The outer surface of the stem of this chamber had to be coated with 
dag which was grounded to eliminate fluctuations of the signal, 
arising from mains pick-up. A similar chamber made of Perspex 
(MC38)., gave results which agreed within t 1% with those of the 
chamber MC78 described above, provided a density correction was 
made for the presence of Perspex. 
A silicon diode (AERE) was also used at a later stage in this 
series of measurements; this diode has a surface of about 1 MM2 and 
a depletion zone of the order of 0.2 mm-thick and is encapsulated in 
a di sc of epoxy resin (diameter -I cm) at a depth of 0-5 mm. 
The polarizing voltage used was 250 Volts for the 0.2 CM3 
cylindrical chamber and 300 Volts for the flat chambers and the diode. 
The alignment of each detector in the beam was generally made 'by 
means of vertical and horizontal scans normal to the direction of the 
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beam, except in the case of measurements with_ the collimated beam, 
when a paraxial LASER beam was used Jn addition. 
5.1 (ii) MEASUREMENTS WITH A SCATTERED BUT 
UNCOLLIMATED PROTON BEAM 
Working with the 150 MeV proton beam described above, 
the ionisation produced along the central axis'of the beam'in water, 
brain equivalent liquid (BRN/L6) and muscle equivalqnt liquid (MS/Ll) 
was measured with the flat ionisation chamber (Perspex MC38). 
In practice, the signal from the chamber was integrated over the 
time needed for the "monitor" ionisation chamber to collect a preset 
electri 
Ic 
charge of 1x 10-7C (scale 1000 x 10-10C on the integrator). 
The results are summarised in Figure 5.3 and Table 5-r. 
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Figure 5.3 Central axis depth dose curves for 150 MeV protons. 
(Scattered but uncollimated beam) 
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1. WAT ER 
2. BRAIN/ L6 
3. MUSCLE/Ll 
Vk 
TABLE 5-1 VARIOUS PHYSICAL PARAMETERS 
_OF 150McV PROTONS IN MUSCLE, BRAIN 
AND -WATER- (SCATTERED BUT 
UNCOLLIMATED BEAM) 
MATER IAL 
PARAMETER, MS/Ll BRN/L6 WATER 
Depth of peak (cm) 14-73 15.04 15.57 
Peak ý'height' 
(X 10-9c) -Iý 0.71 1 0.70 1 0.68 
Range to half 
maximum (cm) 
C 
15.06 15-37 15.92 
Extrapolated 
range (cm) 15*38 15-59 16.20 
Full width 
at 80% level (cm) 0.45 0.45 o. 45 
Full width at 
half maximum (cm) 1.50 1.53 ! A6 
Peak 
ratio 3.38 3.35 3.26 entrance 
Peak 
ratio Plateau (5 cm) 
3.29 3.24 3.23 
Peak 
ratio Plateau (10 cm) 
2.90 2.91 2.93 
Drop 100 -. P- 20% 
(distance in cm) 0.45 0.46 9.47 
1. Correction for the presence of the Perspex wall of the 
tank applied. 
2. Entrance value obtained by extrapolation of the curve 
to "zero depth". 
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, The effect of hard bone and fat ý on, the depth of the -Bragg peak.. 
the peak height, the range and the other physical parameters was 
investigated by introducing various thicknesses of the tissue 
heterogeneity in muscle equivalent liquid. In order to investigate 
the effect of lung, a composite'-phantom-c'onsisting of 3 cm-thick 
solid muscle substitute (MS/SR4) and then various thicknesses, of 
lung followed by muscle equivalent- liquid (MS/Ll*. in the Perspex- 
tank), was used, as Figure 5.4 indicates (the effect of fat is shown 
in Figure 4.5). Table 5-If'-gives- a summary of the results,, 
/ 
80 . 123456 
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Figure 5.4 Effect of hard bond and lung on the central 
axis depth dose curve of 150 MeV protons. 
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Because of the importance of the effect of skull bone on the 
depth of the' Bragg peak 'when'such a proton beam is used for the 
treatment of the pituitary gland or any brain tumours,, various 
thicknesses of hard bone and total. skelcton substitutes were immersed 
in brain equivalent liquid (BRN /L6), -touching the front wall of the' 
Perspex tank-(15 cm x 15 cm x25 cm) and the scans along the central 
axis of the beam in the brain liquid were'repeated. Figure 5.5 and 
Table 5-111 give the relevant data. 
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Table 5.5 The effect of bone on the central axis depth 
dose curve of '150 MeV protons in a brain 
equivalent liquid 
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TABLE 5-111 EFFECT OF BONE ON THE DOSE 
DISTRIBUTION FROM 150McV PROTONS 
IN BRAIN' 
MATERIALS - SETUP 
PARAMETER * BRN/L6 1 cm IIB/SR4 2 cni IIB/SR4 2 cM TSK/SFZ3 BRN/L6 - BRN/L6 BRN/L6 
Depth of peak (cm) 15.04 14.59 14.14 14.59 
Peak height 
(X 10-9c) 0.70 'Iý0.71 0.72 0.71 
Range to half 
maximum (cm) 15-37 14.90 14.45 14.91 
Extrapolated 
range (cm) 15.59 15.11 14.69 15.19 
Full width at 
80% level (cm) o. 45 0.50 0.45 0.46 
FWHM (cm) J-53 1.54 1.6o 1.65 
Peak ratio 3.35 3.38 3.40 3.38 entrance . 
Peak 
ratio Plateau (5cm) 3.24 3.18 3.19 ý3.20 
Peak 
Plateau ( 10 cm) ratio 
2 . 91 2.84 2.79 2.85 
Drop 100 -. P- 20*/. 
(distance in cm. ) 0.46 0.46 0.48 0.50 
Correction for the presence of Perspex ( front wall of t ank 
and front plate of chamber MC38) applied 
I 
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As the pituitary gland is sit'u"ateil in the bony structure of 
the pituitary fossa-(sella turk-ika), the'effect of bone being very 
close to the detector was investigated; a "bony sleeve" was made 
for the 0.2 cM3 cylindrical ion chamber which had a uniform 
thickness of 0.5'cm all round'the sensitive volume of the detector 
(see Figure 5.2). The depth of the peak in MS/Ll was found to 
be 1 mm less than it was with'the "muscle sleeve for the detector and 
0.5 cm-thick slab of the same, bone substitute (HBISR4) placed in the 
plateau region". It was. assumed that the extra 1 mm reduction of the 
peak depth observed was due to backscatter from the back half of the 
"bone" sleeve. . 
The measurement 
-was 
repeated with another sleeve 
I 
whose back half was HB/SR4 (hard bone) and the front half MS/SR4 
(muscle) Again the depth of the peak and the extrapolated range 
were found to be approximately 1 mm smaller than those in the 
"muscle only" situation, which indicated the presence of some 
backscatter from the 0.5 cm-thick bone behind the sensitive volume 
of, the ionisation chamber. The, observed reduction in peak, depth, 
is possibly due to a change of the effective measuring position in the 
cylindrical volume of the chamber. This is discussed later in this 
chapter. 
The presence of air pockets in the path of the proton beam 
causes a distal. shift of the Bragg pýak in a-phantom... Two 
polypropylene tubes., closed at both ends, with internal diameters 
1.6 cm and 2.5 cm respectively were introduced, in turn, in the 
plateau region so that their long akis was perpendicular to the axis 
of the. proton beam. On both occasions.. the scans along the central 
axis of the beam showed a distal movement of the peak by 0.9t 
diameter of air tube). The observed reduction in the peak height., 
was more than the inverse square law would predict by about 
129 1. 
Urlo' of the'peak height in muscle. This is probably because'the '. 
muscle liquid ififront of the air'space acts as a second scatterer; 
this combined xvith thd presence of the air space (i. e. extra- 
distance to be travelled) result in a further spreading of the proton 
beam and so the number of protons per unit area in the peak region, 
on which the peak height depends, becomes smaller than it would 
have been without the presence of air in the beam. 
In order to study the effect of differences in chemical 
composition of the various tissue substitute materials, the depth of 
the Bragg'peak and! the e'xtrapolated range in water, BRN/L6 and 
MS /Ll were multiplied by the* density of each material, to obtain the -I 
"equivalent thickness" of both the peak depth and the extrapolated 
range in g/cm 
2. In this way, the effeci, of differences-in density 
between the various materials is eliminated (density correction). 
In the case of composite pha ntoms , the path length, in each type of 
substitute material was multiplied by the corresponding density to 
2 derive the. 'Iotal equivalent thickness" in g/cm The relevant data 
are given in Table 5-IV. 
TABLE 5-IV BRAGG -PEAK DEPTH AND EXTRAPOLATED 
RANGE -EQUIVALENT THICKNESS IN 
VARIOUS'MATERIALS 
Materials Equivalent thickness 
of peak depth(g/cm) 
Equivalent- thickness for 
extrapolated range(g/cm2) 
Water 15-57 16.20 
BRN/L6 15.64 16.22 
MS/L1 15-76 16.45 
3 cm MS/SR4 )- 
+8 cm LN/SR4) 15.88 16.55 
+ MS/L1 
5 cm FAT + MS/L1 . 15.60 
16.19 
4 cm HB/SR4 + MS/L1 16-38 16-97 
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The conclusion from this analysis is that, 'after correcting 
for density, only a very small variation in peak depth equivalent 
thickness remains to be accounted for. 'This variation could be 
attribuled to the differences in chemical composition'among'the tissue 
substitutes considered. 'Fat is probably the most effective in 
stopping protons,, on a gram for gram basis.. because of its higher' 
hydrogen content. The depth of the'Bragg peak (in'g/cmý in a 
"5 cm'fat + muscle" phantom is'about 1% smaller than that'in muscle 
alone . 
Whdn "4 cm-thick, hard bone + muscle" is consideredthe, peak 
depth 6quivalent thickness is found to be 0%, larger, than that in, "muscle 
alone"; in other words, despite its higher density, hard bone is less 
effective in stopping protons than muscle, on a gram for gram basis 
(low hydrogen content in hard bone). 
To summarise, a density correction is adequate for calculating 
the peak depth in a given phantom from measurements in water except, 
when lung or thick bones are present. 
The peak height is increased by about 0.5*/o per cm of bone 
present in'the'path of the protons, 'while it is reduced by"about 205%- 
3.0*/,, per cm of lung and by about 0.6%, per cm of fat'travýrsed., 
For clinical purposes one needs to have certain. measured 
data and a set of "isoclose shift" factors to correct the dose 
distribution for the presence of heterogeneities. Such correction 
factors have -been'derived during this work and are given in 
Table 6-I'Of next chapter. 
I- 
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5.1(iii) MEASUREMENTS WITH -A SCATTERED AND" 
COLLIMATED PROTON BEAM 
The advantage of proton beam therapy lies in the narrow 
well-defined beams which can be obtained by collimating the 
scattered beams. However, the plateau, shape, the width and height 
of the Bragg peak and the p, ýýak/plateau ratio are modified when the 
proton beam is collimated. These effects were m6asured using the 
150 MeV scattered proton beam described above but collimated with 
a 10 cm x 10 cm x 3.7 cm, block of brass which had a 0.7 cm diameter 
hole at its centre. This collimator w. as positioned between the 
beam monitor ion chamber and the phantom, and 3 cm in front of 
the latter. The intensity distribution of the collimated beam when 
it entered the phantom Was essentially uniform. 
Central axis depth doses, and beam profiles in a plane normal 
to the beam direction were measured at various depths in water, 
brain equiNlbdent liquid (BRN/L6) and muscle equivalent liquid (MS/Ll). 
Figure 5.6 shows the central axis "depth- ioni s ation" curves obtained 
from measurements in the above liquids, using the 0.2'cm3 cylindrical 
ionisation chamber. By using the appropriate calibration factor, the 
percentage depth doses can be derived from these curves. - Table 5-V 
gives the results of the above measurements. The results from 
scans. along the central axis of the beam in water and BRN/L6 using, 
the silicon diode of the AERE are also shown in this Table for 
comparison. 
Central axisl depth dose scans with mixed materials were also 
carried out in the collimated proton beam to-determine the effect of 
yarious thicknesses of bone on the depth dose distributions in 
muscle and brain. The results agreed with those obtained, 
with the uncollimated proton beam-of the same energyp i. e. a 
proximal displacement of the Iýragg peak by 4 mm per cm of hard 
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Figure 5.6 Central axis depth dose curves with a 
150 MeV scattered and collimated 
proton beam (0.2 cm3 cylindrical ion 
chamber 
bone traversed-in the case of muscle', equivalent liquid behind the 
bone, and 4.5 mm per cm of hard bone in the case of brain. - 
equivalent liquid behind the bone. 
FigUre 5.7- shows part of an isodose map of, the 7 mm diameter 
collimated beam used., derived from measurements with the 10.2 
cM3 
cylindrical ionisation chamber in the brain equivalent liquid BRN/L6. 
Although the silicon diode was found to give better spatial 
resolution, as it is expected from its size, it was also found to have 
a response which changes withdepth in the phantom (i. e. with energy 
of the beam); for this reason the beam profiles obtained with the 
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3 ion chamber signal 0.2 cm, chamber were used. When the silicon diode signal 
was measured at ao'later stage, theýrýýdings from the silic on diode' .s 
transverse scan at a depth of 5 cm in BRN/L6 were corrected and 
expressed as a percektage of the maximum peak height. The full 
width of this corrected beam profile at the 20% level (= width of the 
20% isodose at -that depth), was about 1 mm smaller than the width 
obtained with the 0.2 cM3 ion chamber. 
100 
s 80 0 0 
s 60 CL 
40 
20 
CL 0 
PROTONS 
. IIIIIII IIIIIII 
III 
10 12 13 14 15 16 
Jb 
- 6u 
100 ISODOSE DI'STRIBUTION 
100 " peak 
'E so so 
150 M*V COLLIMATED PROTON 60 
60 H BEAM (DIAMETER -7 mm) 40 40 
20 
20 0 0 
0246810 0246810 
Distance from axis Imm) Distance from axis (m-) 
Figure 5.7 Part of, the'isodose map of the, 150 MeY 
collimated (0.7 Cm diameter) proton 
beam of ýthe AERE, 'U. K. 
'The effect of the different chemical composition and 
density of various materials on the scattering, of the ýcollimated 
proton, bcam'%vasý also investigated. Figure 5.8 shows the beam 
profiles at the depth of the Bragg peak in -BRN JL6, measured with 
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1) 
2) 
3) 
4) 
rofiles of the collimated proton beam. 
In air, 7 cm from the collimator (silicon diode) 
In air, 18 cm from, the col limator (silicon diode) 
In BRN/L6, at the depth of the peak(silicon diode) 
In BRN/L6, at. the depth of the peak (0.2 cm3 
cylindrical ionisation chamber) 
the AERE silicon diode (3) and with the 0.2 cM3 cylindrical 
ionisation chamber (4). The profiles of the beam in air, at distances 
of 7 cm and 18 cm from the collimator (1 and 2 respectively), 
obtained with the diode,, are given for comparison. 
The silicon diode was used to measure the beam profiles 
behind various thicknesses of fat, muscle and bone substitutes. The 
diode was moved vertically (i. e. normal to the beam axis), in air,, 
2 cm behind the absorber. The results are summarised in Figures 
136 
5.9 and 5.10. Figure 5.9 shows the beam profiles behind 5 cm 
10 cm and 13 cm of MS/SR4 (muscle's relative density = 1.06) 
and 10 cm, HB/SR4 (relative density 1.67); the width of the beam 
profile (and particularly at the 6% level where the derivative is a 
maximum), is considered as a measure of the beam scattering and 
depends on the typeand the thickness of the material traversed by 
the proton beam. 
Figure 5.10 shows that as the absorberthickness is 
increased, the beam is broadened-but, the effect of the differences 
in chemical composition between the various materials is not evident. 
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Figure 5.9 Beam profiles behind samples of muscle 
and bone substitutes 
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Figure 5.10 Variation of beam profile width with 
for various thickness of absorber, 
materials 
By multiplying the thickness of each material by its density and 
looking at the beam width that corresponds to the same "equivalent 
2 
thickness" "bfeach material. ýý for. example, 10 g/cm 'one finds that 
muscle causes more scattering than any other Material (see Table 5-VI). 
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TABLE 5-VI BEAM PROFILE WIDTH AT THE 6001. " 
LEVEL FOR THE SAME EQUIVALENT 
THICKNESS. OF VARIOUS MATERIALS 
M aterial 
Profile width for 10 g/cm 
2 
of absorber (mm) 
MS/SR4 6.55, 
HB/SR4 6.35 
FT/SFI 6ý30 
Al 6.10 
From the results of the measurements presented in this 
section a comparison between the collimated and uncollimated 
150 MeV protoii beam used was miade'and revealed the following 
(in summary). ' 
a) By comparison with the uncollimated, proton beam, the peak 
height is. reduced when the beam is collimated. IJ sing the 
3 0.2, cm cylindrical ion chamber. for example, the peak 
height in, water was found 2.22 x 10-9C for the uncollimated, 
beam and 0.76 x 10-9C for the collimated beam. 
Peak b) The ratio in water is reduced from 1.85 for Plateau (10 cm) 
the uncollimated to 1.64 for the collimated proton beam 
(0.2 CM3 ion chamber). 
c) The width of the Bragg peak and-the slope of the post-peak 
part of the depth dose curve do not change significantly. 
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COMPARISON BETWEEN SILICON DIODES AND 
IONISATION CHAMBERS USED IN PROTON 
DOSIMETRY -EFFECTIVE MEASURING POSITION 
FOR A CYLINDRICAL IONISATION CHAMBER 
Small silicon diodes can be used as detectors for particulate 
radiations but radiation damage limits their application to low 
intensity beams (a few nanoamperes). The plan to plot isodose 
curves of the proton beam used in this work in various tissue 
equivalent materials,, prompted a comparison between the silicon 
. diode available at the AERE and the three air-filled ionisation 
chambers described in section 5.1(i), namely two plane parallel 
plate ionisation chambers (MC38 and MC78) and a 0.2 cM3 cylindrical 
ionisation chamber. 
All four detectors were used, in turn, to measure the depth close 
distribution in a water phantom* `Beam profiles were measured in 
the plateau and the peak region anicifused foý the'alignm'en't-'of 'the' 
detector in each case. The agreement between the two flat 
ionisation chambers was, VeFy good; afier the necessary corrections 
for the presence of Perspex (of which the MC38 is made), the 
differences in the various parameters measured by the two chambers 
were smaller than 0.5%, of the corresponding average value. 
Figure 5.11 shows the "relative ionisation versus depth" curves, for 
the MC78 plane paral 
' 
lel plate (flat) ionisation chamber (1) , the 
0.2 CM3 cylindrical chamber (3), and the, silicon diode (2), obtained 
by scanning along the central axis of the uncollimated proton, beam, 
in water., The signal of, the 0.2 CM3 chamber was divided, by, 4 in 
order to read on the same. scale. 
A similar comparison was made between the'0.2 CM3, 
cylindrical chamber and the silicon'diode in water, using the 
0.7 cm-diarr. eter collimated beam. The relevant data are summarised 
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Figure 5.11 Central axis "relative ionisation versus 
depW curves for 150 MeV protons in water, 
measured with three different detectors. 
in Table 5-VII. These measurements indicated that the silicon 
diode has better spatial resolution than the ionisation chambers 
used in this work, but that its response varied with depth (hence 
proton energy). Secondly, the effective point of measurement in 
the cylindrical ionisation chamber is neither at the front face nor at 
the centre of the sensitive volume of the chamber but in between the 
two. Table 5-VII (and Figure 5.17) also, indicate that the depth of 
the peak and the extrapolated range of the collimated beam used, were 
about 2 mm smaller than those of the uncollimated beam. The above 
observations are discussed in turn. 
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The most probable. reason for the difference in the peak depth 
and, extrapolated range values, betweenAhe collimated and uncollimated 
beam, would be a small variation in the energy of the proton beam, 
The measurements with. the, collimated beam were made on a different 
day, with slightly modified "beam focus conditions". (fonsequently, 
a change of about 1 MeV in the energy of the proton beam, enough to 
account for the above discrepancy, would be possible. 
The improved spatial resolution of the silicon diode is due 
2 
to its smaller area (aboutj mm ); the ionisation chambers integrate 
2 3- their signal over a wider area (about 36 mm. for the 0.2 cm cylindrical 
chamber and about 80 mm 
2 for the two plane parallel plate ionisation 
chambers). No convincing explanation has been foundp however, for 
the variation of the diode's response with proton energy. Figure 5.12 
shows the variation of the ratio 
ion chamber signal for the three silicon diode signar- 
gnal detectors under discussion', ' '-(Note that the'ratio' 
MC78 chamber si. 
silicon diode signal 
was multiplied by, 2.5 in order, to read on the same scale). 
KOEHLER (1967) also worked with ionisation chambers and 
silicon detectors and investigated the possibility of columnar 
recombination in-the ion chamber by varying the bias voltage. He 
concluded that recorpbination in the ion chamber is not the cause 
of the variation in the signal ratio. He also found that pre- 
6 
exposing the diodes to massive doses (- 10 rads) of radiation, 
reduces the change in their sensitivity during subsequent use at 
low beam intensities. 
Other reasons which could be partly responsible for the 
above effect are a change in the energy needed per ion pair in the 
diode (W-value for silicon =3.6cV), or excitation of the crystal 
lattice or nuclear interactions, the possibility of ývhich increases 
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Figure 5.12 Variation of the ratio 
ion chamber signal 
silicon diode signal with 
depth in water 
A), Uncollimated beam: 
1) 0.2 cOcylindrical chamber signal, 
-silicon diode signal 
2) MC78 flat ion chamber signal x 2.5 silicon diode signal 
B) Collimated beam (0.7 cm diameter) 
3) 0.2cm3c4indrical chamber siqnal 
silicon diode signal 
14,14 
as the protonsslow down. Whatever the reason, the sensitivity 
of the silicon diode is reduced in the plateau region where the energy 
of the protons is higher. 
Figure-s5.13 and 5.14 illustrate our measurements with the 
silicon diode of the AERE in water and BRN/L6 respectively. 
The beam profiles show the progressive broadening of the beam as 
the depth in the phantom increases. At the depth of the Bragg peak 
the beam profile approximates in shape to a Gaussian (noiýmal) 
distribution. 
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Figure 5.13 Variation of beam width and diode 
signal with depth in water 
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Figure 5.14 Variation of beam width and diode 
signal with depth in a brain equivalent 
liquid 
3 The effective measuring position for the 0.2 cm ion chamber 
was found to be different in the collimated and. uncollimated proton 
beam. The diameter of the cylindrical cavity of the chamber is 6 mni 
and Figure 5.15 shows that the depth of the peak and the extrapolated 
range for the collimated beam, measured with the cylindrical ion 
chamber are greater than those measured with the silicon diode by' 
2.0-2.5 mm, i. e. about 0.7 to 0.8 times the radius of the chamberi's' 
sensitive volume. Thexelationship is illustrated in the schematic 
diagram of Figure 5.16. 
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Figure 5.15 lonisation along-the central axis of the, 
collimated proton beam (150 MeV) 
1.0. -2 cM3 cylindrical ion chamber in water 
2. Silicon diode in water 
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scale indicating the position 
of the centre of each detector It 
in the phantom 
detector movement 
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OP silicon diode 
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depth cm 
Figure, 5.16 The silicon diode gives the true position 
of the Bragg peak. When "maximum signal" 
is recorded with the 0.2 cm3 cylindrical 
chamber, its centre is at a depth greater 
than the depth of the peak 
With the uncollimated beam, the difference in the peak depth and the 
extrapolated range, derived from measurements with the cylindrical 
and the flat ion chambers (as well as the diode) is about 1.5 mm; 
i. e. the effective measuring point for the cylindrical ion chamber lies 
approximately 0.5 x Radius in front of its centre; the difference from 
the collimated beam situation is probably due to the presence of extra 
scatter* when the beam is not collimated. In the case of the plane, 
parallel platelonisation. chamber., the effective plane of measurement 
is at the front face of.. the sensitive-volurne, as the proton fluence is the 
same through the volume. 
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The values of "range to half maximum" and "extrapolated 
range" derived with the flat ion chamber in water, using the uncollimated 
beamt are about 2.5% and 4% respectively larger than the calculated 
range values given by BICHSEL (1960) and BARKAS and BERGER 
(1964) for the same proton energy (150 MeV). When thd values 
measured with the collimated, beam are considered., however, the 
above differences are reduced to 1.0% and 2.5% respectively. 
Figure 5.17 shows the results of'measuiements with the silicon diode 
in water, with the uncollimated (1) and w-ith the collimated beam (2). 
The experimental error in the measurement of the correct position of 
the diode -was'less than 0.5 mm as repeat experiments showed. 
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Figure 5.17 Central axis "ionisation versus depth" 
curves for 150 MeV protons, in water 
1. Broad beam 
2. Collimated beam 
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5.1 (v) -A SIMULATED PATIENT 'TREATMENT 
The Bragg peak of a high energy proton beam is narrow 
and has a sharp cutoff; by suýerimpo sing many such beams, , 
extended tumour volumes can be treated to a uniform dose. The 
dose distribution obtainable with parallel opposed field irradiation 
is shown schematically in Figure 5.18. Plans designed to irradiate 
a2 cm-thick tumour centered in a 20 cm slab of tissue a) with 
cobalt-60 gamma rays and b) with 150 MeV protons are compared. 
By the use of bolus material the proton Bragg peak can be made to 
coincidý with the tumour area. The advantage of protons over 
photons in this respect is obvious; in the photon isodose distribution., 
the normal tissues outside the tumour volume receive about. the same 
or even more dose than the tumour while with protons the normal 
tissue dose is greatly reduced. 
In view of the proposedU"Se of the AERE symchrocyclotron 
for pituitary proton radiotherapy, an experiment- was carried out to 
discover how accurately the Bragg peak can be p0sitioned"'on target" 
in practice. A Perspex tank, with 1 cm-thick front wall was filled 
3 
with brain equivalent, liquid (BRN /L6) and the 0.2 cm cylindrical 
ion chamber was used to scan along the central axis of the collimated 
proton beam (0.7 cm diameter). At the position of the maximum 
signal (Bragg peak) the dial indicated a depth of 14.90 cm. A real 
skully with average thickness of the temporal bone at the level of the' 
pituitary equal to 3 mm, was mounted'on a Perspex circular base so' 
that it could be rotated round a vertical axis through the centre of the 
pituitary fossa. 
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Figure 5.18 Dose distributions with parallel opposed 
fields. Comparison of 150 MeV protons 
to cobalt-60 gamma rays 
Our previous measurements' indicated that a3 mm-thick bone 
in front of brain tissue would reduce the depth of the Bragg peak by 
1.5 mm (4.5 mm per cm of bone in front of BRN /L6). Consequently., 
the skull was immersed in the brain equivalent liquid., with the centre 
of the pituitary fossa at 14.90 cm -0.15 cm = 14-75 cm from the entry 
3 
face of the tank (Figure 5.19). The 0.2 cm chamber was then 
clamped so that its sensitive volume was "sitting" in the pituitary 
depression. The presence of the anterior and posterior clinoid bony 
processes allowed 3-4 mm movement of the ion chamber on either side 
of the centre, but this was enough to find the pre-pýak$ peak and 
i 
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Figure 5.19 Setup for test of "positioning the Bragg 
peak on target" 
post-peak positions. Wien the proton beam was turned on, the remotely 
controlled movement of the ion chamber along the axis of the beam 
indicated that the iordsation was maximum when the detector was at 
a depth of 14.75 cm, i. e. exactly as planned. The close to the 
pituitary, for a preset 1x 10-7C on the transmission chamber used 
as boam monitor., was calculated from the measured peak height and 
the calibration factor of the 0.2 cm3 ion chamber. . 
It was found 
equal to 10.87 rad. With the available beam intensities, howevery 
doses of 10,000 rad could be administered in a few minutes. For 
a 15 cm wide skull, the skin dose would be about 64.0% of the peak 
dose as F igure 5.15 indicates (i. e. 6.96 rad in this case). 
The above exercise was repeated 4 times, but each time the 
skull was rotated by 10 
0 clock-ývise. The maximum displacerýent of 
tbc Bragg peak obsorvod was 0.5 mm and this was mainly due to a 
small varizil ion in the thickness of the skullbone. Based on the 
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N 
above results, the skin dose for a tumour dose of 5000 rads was 
calculated. Table 5-VIII gives the results for the case of 1,4" 
8 and 12-portal treatments; & inherent advantage of the multi- 
portal treatment with high energy proton beams is obvious. 
TABLE 5-VIII YUMOUR AND SKIN DOSES FOR A 
MULTIPORTAL PITUITARY TREATMENT 
WITH 150 MeV PROTONS 
Number of 
portals 
Tumour 
dose 
(r4ds) 
Skin dose 
(rads) 
Skin dose as 
a percentage 
of tumour close 
5000 3200 64. o 
4 5000 800 16.00 
8 5000 400 8.00 
12 5000 
1 
266 
1 
5.33 
In practice, a plastic bag stuck on to a thin Perspex plate 
and filled with brain equivalent liquid could be used as a variable- 
length energy degrader for the adjustment of the position of the 
Bragg peak. The mechanics of the proposed patient treatment on 
the AERE synchro cyclotron have been described by WHITEHEAD 
(1974). 
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5.2 FASTNEUTRON DEPTH DOSES IN VARIOUSTISSUE 
SUBSTITUTES AND IN COMPOSITE PHANTOMS 
In view of the current use of fast neutrons in cancer' therapy, 
it is desirable to know the depth dose characteristics oý fast'neutron 
beams in various tissues. , The new tissue substitutes were used to 
study the physical characteristics of the fast neutron beam produced 
by the cyclotron of the Medical Research Council (MRC) at the 
Hammersmith Hospital, London. 
5.2(i) DOSIMETRY ANDEQUIPMENT 
The contamination of fast neutron beams ,,,, -ith gamma I 
radiation and the complex manner in which neutrons. interact with 
tissue makes neutron dosimetry more difficult than the dosimetry 
of photons and electrons. Gamma rays result from neutron production 
processes in the target, from interactions of neutrons with the 
collimators and from interactions in the tissue being irradiated 
(probably mainly 2.2 MeV gamma rays from thermal neutron capture 1, ý 
in hydrogen). 
The measurement of the total dose (neutrons + gamma rays) 
is usually made with a "tissue equivalent" chamber. Uncertainties 
in the knowledge of the Wn value, the energy required. tIo produce an 
ion pair in the gas of the chamber, and the replacement of most of the 
oxygen content- of the plastic from which the ion chamber is made by 
ciLrbon, may result in errors of up to 10%, in. the neutron component -of 
the total, close. 
The gamma ray component of the total dose varies with field 
size and. -tvith depth in the phantom and. is usually measured with 
detectors of low sensitiv-fty to neutrons. For examplev ionisation 
chambers constructed from non- hydrogenous., matexials, specially 
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designed Geiger counters and photographic films may be used. 
Whenever relative dose measurements are required, activation 
methods can be used for neutron dosimet'ry, for example, 
32S (nlp)32 P, 
in which the product is a beta-emitter with a half life of 14.3 days. 
The dose in the patient during treatment can be measured by using 
activation of aluminium pellets or by exposing thermolumines cent 
dosimeters in lead and polythene to record the neutron dose and the 
gamma-ray close separately. 
(The product in the 
27AI(np) 27Mg 
reaction has a half life of '9.5 minutes 
4nd emits a gamma ray of 0.83 MeV). 
The M. R. C. cyclotron accelerates deuterons up to 16.7 MeV 
and these hit a 0.8 mm-thick beryllium target backed by copper. The 
fast neutron beam produced, has a spectrum extending from zero to 
about 17 MeV with a mean energy of 7.5 MeV. The dose rate at 
120 cm from the target is 40-50 rad per minute (BEWLEY and 
PARNELL, 1969, PARNELL, 1971). The total dose was measured 
with a1 CM3 spherical ionisation chamber (EG&G , Wellesley, Mass). 
A tissue equivalent gas was flowing through the chamber during the 
measurements (64.0% methane; 32.4% carbon dioxide; 3.2% nitrogen; 
percentages by volume). The signal from the ionisation chamber was 
integrated using a Keithley 61OR electrometer for a preset number of 
divisions on the beam monitor. The ionisation chamber was operated 
at a bias voltage of -300 volts. 
When used in a solid phantom, this ion chamber was first 
covered with a sleeve specifically made from the same material as 
the phantom and then inserted in the appropriate hole of a 20 cm x 
20 cm x3 cm slab of that material (see Figure 5.20). The chamber 
was moved back through the phantom by changing the position of the 
slab (in which it was inserted) in the stack. When used in a liquid 
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phantom, the chamber (without build-up cap) was enclosed in a water 
tight Perspex cylinder and moved along the central axis of the beam 
by a remote control mechanism, readings being taken at discrete 
depths. The total dose (Dn +Dy) at each point was obtained by 
multiplying the integrated signal (nC) with the factor 3.049 rad/nC, 
obtained from a calibration of the chamber with caesium gamma rays 
(BEWLEY and PARNELL, 1978). 
The gamma-ray component of the dose was measured with a 
Geiger counter (Mullard GM D6) which was covered with a2 mm- 
thick 
6 Li foil to absorb the slow and thermal neutrons. The setup 
was the same as above except that when the counter was used in 
liquids it was protected with a plastic tube cover. The number of 
counts for a preset 1 division on the beam monitor was measured 
with an Ortec dual counter-timer, corrected for the resolving time 
of the counter (dead time = 15 y sec) and, after subtraction of the 
background counts, converted into rads /division using the calibration 
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Figure 5.20 Sleeves and plates for the 1 cm3 EG&G 
spherical ion chamber 
1.26 x 10 
6 
counts/rad. (BEWLEY and PARNELL, 1'978). The bias 
used for the Geiger counter was +50OV. ' 
5.2(ii) NEUTRON DEPTH DOSES IN MUSCLE, BRAIN, 
AND WATER, 
The penetration of the neutron beam in tissue is the most , 
important physical parameter for radiation beam therapy. In 
Figure 1.9, ý among others, the central axis percent neutron depth 
close from the MRC cyclotron is compared to that of cobalt-60 
radiation (our measurements). The neutron depth dose ýurve 
(9.5 cm x 9.5 cm field, at a target-skin distance of 120 cm) shows 
that the 50*/. dose is at 8.5 cm depth and on this account the range 
of tumours which can be treated with this machine is limited to head 
and neck or superficial and breast tumours. In order to match the 
t 
penetration of cobalt-60 gamma rays, it is necessary to use either 
14 MeV neutrons from the T(d, n) 
4 He reaction(but unfortunately 
dose rates of only few rads per minute have been achieved with this 
reaction so far), or neutrons generated by deuterons of at least 
30 MeV energy on beryllium. " To, match the skin sparing given by 
cobalt-60 radiation it is necessar - deuterons of at least Y, to use 
50 MeV energy on beryllium (BEWLEY, 1971). 
The effect of field size-on the percentage neutron depth closes 
was studied using a 20 cm x 20 cm x 20 cm phantom 
- 
made, of. solid 
muscle substitute (MS/SR4). The smallest depth at which measurements 
were made in this phantom was 1.5 cm and'the neutron dose at this 
depth., for a 9.5 cm x 9.5 cm field, was estimated to be 93.5% of the 
maximum neutron dose (Dn. max at 0.2 cm, BEWLEY and PARNELL, 
1969). Consequently, - all readings obtained with a 9.5 cm x 9.5 cm 
fields were normalised to 93.5% at 1.5 cm deep. The neutron dose 
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was derived by subtracting the gamma -ray dose (D from the total 
dose On +D Figure 5.21 shows the results of these measurements 
for three field sizes; the gamma ray dose expressed as a percentage 
of Dn maximum is also given, while Figure 5.22 shows the gamma-dose 
as iL percentage of the local neutron dose. The percentage rises 
steadily with depth. As the RBE of photons relative to neutrons is 
about one-third, a 12-15% gamma-dose at 15 cm-depth represents 
4-5*/o of the biologically effective dose. 
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Figure 5.21 Central axis neutron and gamma ray depth doses as a percent of the maximum neutron 
dose (P-n - 7.5 MeV, TSD = 120 cm). I : - Closed circles : in MS/SR4 
Open circles : in MS/L1 
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Figure 5.22 - Dose due to gamma. -rays . as a-percentage 
of the local neutron dose in muscle 
(En = 7.5 MeV, TSD - 120 cm) 
Measurements of the neutron dose repeated in the same phantom 
on different days gave an average difference of 0.51/o of the maX 'imum 
neutron (lose and in no case did the difference between any two sets 
of measurements at the same depth differ by more than 1%. The 
calibration of the cyclotron output on 7 diff erent days gave a mean 
value of 0.98 neutron-rad per division, with a standard deviation of 
0.019 i. e. the variability of the machine output is about 1% (calibration 
at 120 cm TSD, in air,, at 22 0C and 760 mmHg, for a 9.5 cm x 9.5 cm 
field). 
Beam profiles''in muscle for a 9.5 cm x 9.5cm field obtained 
by scanning transversely at 9 cm depthp- have already been given in 
Chapter 4 (Figure 4.7). 
Ii 
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A comparison between muscle and brain equivalent liquids 
(MS/L1, BRN/L6) and water was, made and the- corresponding 
neutron depth dose curves. measured with a 9.5 cm x 9.5 cm field 
at. 120, cm TSD, are' given -in Figure 5.23. The curves show that 
muscle, despite its lower hydrogen content attenuatO-s neutrons 
more, effectively thanwater because its higher relative density more 
than compensates for the difference in hydrogen. The curve for 
brain equivalent liquid lies between the two. The difference between 
MS/L1 and water at 15 cm depth is 1.5% of the maximum neutron dose 
while the difference between MS/Ll and BRN/L6 at the same depth is 
0.71o of the maximum neutron dose. Table 5-IX gives the measured 
neutron depth doses in water and in muscle and brain equivalent 
liquids. 
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Figure 5.23, Comparison of'muscle, brain and water 
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TABLE 5-IX CENTRAL AXIS PERCENTAGE 
NEUTRON DEPTH DOSES IN MUSCLE, 
BRAIN -ANI) WATER 
(iEn = 7.5 MeV, 10 cm x 10 cm, TSD - 120-cm) 
DEPTH 
(cm) 
MUSCLE 
(MS/Ll) 
BRAIN 
(BRN/L6) 
WATER 
0.2 100.0 100.0 100.0 
1.0 96.0 96.0 96.0 
2.0 90.8 90.9 91.0 
3.0 84.5 84.8 85.0 
4.0 77.5 77.8 78.0 
5.0 71.9 72.3 '8 720 
6. o 65.0 65.5 66.2 
7.0 58.5 59.1 60.0 
8.0 52.5 53.1 54. o 
9.0 47.0 47.6., 48.5, 
10.0 '42.0 42.7 43.5 
12. o 33.5 34.2 35.0- 
14.0 - 26.5 27.2 28.0 
16.0 21.0 21.7 22.4 
18.0 16.8 17.3 18.0 
20.0 13.3 13.8 
. 
14.5 
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In an attempt to compare water with "unit density" muscle, 
the measurements in MS/L1 were used. * In order to derive the 
neutron percentage depth dose. in "unit density" muscle, the actual 
depth of the'chamber wa's multiplied by the density of the muscle 
substitute and the corirespondifig neutron dose was reduc'ed by .a 
factor (f + d) 
21 (f + 1.06 cl)' 
2, 
to allow for the inverse'square law' 
effect between'the'true and the "corrected" depths (f = TSD, 
d-= true depth in MS/LI). ' Tfiýe-results are shown in Figure 5. '24. 
The neutron depth doses in "unit'density" muscle quoted in 
supplement 11 of the British journal of Radiology and used at the 
Hammersmith Hospital, are also shoW'"n. The neutron depth doses 
in"water are -closer to those in muscle equivalent liquid than the 
corresponding -doses in unit density muscle. 
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Figure 5.24 Muscle, unit density muscle and water 
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5.2(iii) NEUTRON DEPTH DOSE CURVES IN COMPOSITE 
PHANTOMS 
The effect of various ihicknesses of lung, fat and bone on the 
neutron depth doses in ph-antoms consisting of muscle + heterogeneity 
+ muscle, was investigated using the MRC cyclotron neutron beam. 
Isodose shift factors derived from these measurements for use ih manual 
and computerised treatment planning., are presented and discussed in 
Chapter 6. The presence of lung may result in neutron doses in the 
tissues behind it higher by a factor of up to 2 or even more than the dose 
at the same depth, in '-muscle alone". depending on the thickness of lung 
traversed by the beam and the distance of the point behind the lung 
(see. Figure 6.1, and Table 6-ID. 
The effect of fat is much less pronounced. The neutron 
depth doses in muscle behind a. 5 cm-thick fat sample have been given 
in Figure 4.9. As far as bone is concerned, our measurements 
showed that the total dose in muscle behind various thicknesses of 
"hard bone" and "total skeleton" substitutes is slightly reduced. 
4 cm of TSK /SF3 or 3 cm-thick slabs of HB/SR4 (10 cm x 10 cm) 
caused a reduction in the total dose behind them, in MS/SR4 of about 
1% of the maximum dose. (see Figure, 5.25). Repeated measurements 
of both the total and the gamma-dose indicated that the above reduction 
was due to a lower gamma-dose while the'neutron depth doses were not 
affected by the presence of bone (s ee Figure 5.26) Similar results 
were obtained when the depth doses in brain and "bone + brain" were 
measured. McGINLEY and McLAREN (1975), however, used the 
Naval Research Laboratory cyclotron (35 MeV deuterons on a thick 
beryllium target) and from their measurements they concluded that 
bone (B100 plastic) attenuates neutron's of that energy (about 16 Mev) 
more effectively than muscle and therefore produce a shadowing 
effect (up to 15% reduction in the total dose at S. '6cm behind the 4.8 cm- 
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thick bone samples used). 
The absorption of energy per gram of bone is only about 
half that in soft tissue but as the density of bone is higher the 
energy absorbed per unit volume in bone relative to soft tissue is 
about 0.85, while in fatty tissue it4s about 1.15 (BEWLEY.. 1963, 
1975). 
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Figure 5.25 Total dose normalised to the close at 
1* 5 cm depth. 
(En = 7.5 MeV. TSD = 120 cm) 
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Figure 5.26 Effect of bones in the neutron beam 
(En = 7.5 MeV, TSD = 120 cm) 
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I 
5.3 DOSE- DISTRIBUTIONS FROM 
-A 
lb'MeVELE&RON 
BEAM -IN VARIOUS TISSUE SUBSTITUTES 
AND METHOD OF MEASUREMENT 
The electron beam of the - MEL SL75 linear accelerator 
of the London Hospital. was mainly used for this series of measurements e 
The only detector used here was a flat ionisation chamber made of 
Perspex, as described by NAYLOR and WILLIAMS (1972). The 
II 
air-filled disc shaped cavity of this "electron chamber" has 1 cm 
diameter and 3 mm depth. The holder on which the electron chamber 
was mounted was bent so that the front flat surface of the chamber's 
cavity is at right angles to the axis of the electron beam. This 
holder was clamped on a system which allowed remote control of - 
the horizontal movement of the electron chamber, both along the', 
central axis of the beam and normal to it. The 45 cm x 45 cm x 45 cm 
Perspex tank-used was filled with water and theelectron'chamber was 
immersed in it. - -At the-beginning of'each measurement, the chamber , 
was touching the inner surface of the tankýs front wall, which was 
machined to a thickness at the centre of 2.5 mm. As the'thickness 
of the front wall of the chamber itself is 1 mm, 'the first measurement 
in each set corresponded to a depth of 3.5 mm. The -front face of the 
I 
phantom was in'contact with the -end of the collimator in use. 
A built-in transmission chamber was used to monitor the 
electron. beam. - The signals from the monitor and the electron 
chamber were fed into an ionisation current comýarator (ratiometer, 
circuit). - The ratio of the signal, of ýthe electron chamber to that'of 
the monitor, was taken from the output of the comparator and used 
to control the Y-axis movement of an X-Y plotter. In the X 
direction, the plotter moved as a slave of the corresponding movement 
of the electron chamber in the water tank, i. e. alo, 19 the central axis 
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of the beam for depth dose measurements and transversely to it when 
beam profiles were taken. The plotter was adjusted to, 100% where 
the signal 'ratio' was maximum in each case. 
The electron beam from the linear accelerator of the Medical 
College of St Bartholomew's Hospital was also used and the depth 
doses from this beam in muscle were measured with thermolumines cent 
dosimeters (TLD chips). The results'will be presented and discýssed 
in the next section. 
5.3(ii) DOSE DISTRIBUTIONS IN WATER, MUSCLE 
AND BONE 
The central axis depth dose curve from the 10 MeV electron 
beam was measured first in water -for a 10 cm x 10 cm field. Then the 
central axis depth dose curve for the same field in water was measured 
using the 8 MeV electron beam of the same accelerator (MEL SL75). 
The results are shown inFigure 5.27 in which the data given by Jones 
in supplement No. 11 of. the -British journal of -Radiology (1972) for 
15 MeV and 20 MeV are given in addition. The discrepancy 
between the data given in the above reference for 10 MeV electrons 
and our measurements for the same energy, expressed as "depths 
of percentiles", was less than 1 mm. I 
Figure 5.28 shows the isodose distributions for 10 MeV 
electrons and cobalt-60 gamma rays (SSD = 75 cm) derived from our 
measurements in water. Figures 5.27 and 5.28 make the advantage 
of electron beams up to 10 MeV in the treatmentof superficial 
'tumours obvious. 
I 
The effect of field size was investigated by using various 
applicators from 3 cm x3 cm up to 12.5 cm x 12.5 cm. The central 
axis percentage depth dose curves changed slightlý by increasing the 
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field size from 3 cm x3 cm to 7 cm x7 cm but were nearly identical 
for field sizes larger than 7 cm x7 cm. Tigure 5.29 sý-hows the 
I 
central axis depth dose curves for two applicator sizes., namely 
3cmx3cmandl0cmxlOcm. This "saturation" in the effect of 
field size on the depth doses would be expected from the finite 
range of 10 MeV electrons in water. The measurement of central 
axis percentage depth closes in muscle was made by adding, se quentially 
0.5 cm-thick slabs of muscle substitute MS/SR1 in front of the tank 
and taking readings with the electron chamber immersed in water and 
kept in contact witli the inner surface of the front wall of the Perspex 
tank. The measurement of the percentage depth doses in bone was 
carried out in a similar way. Figure 5.30 shows the results. In 
Table 5-X the percentage'depth do s-'es from 10 MeV electrons in- water, 
muscle and bone are expressed as depths of percentiles. In order to 
find out what the effect of the different chemical composition of the 
above materials on the depth doses is, the 5% percentile depth and 
the extrapolated range were multiplied by the density of the corresponding 
material and the results are given in Table 5-XI. The depth at which 
2 
the dose is 50*/* of the maximum, when expressed in g/cm . differs 
bctweenýwater and bone by only 4% of the value in water, while the 
difference between water and muscle is less than 1%. 
Figure 5.31 shows the central axis depth dose curve in muscle 
(MS /SR4) derived from measurements in the pulsed electron beam of 
the linear accelerator at the Medical College of St Bartholomew's 
Hospitalv Londong using thermolumines cent dosimeters (TLD chips). 
The dose rate obtainable from this machine is in, the Krad/sec range . 
The data for 15 MeV electrons., 10 cm x 10 cm field, given by 
JONES (1972) are plotted on the same graph for comparison. The 
differences between ýthe two curves -Could be due to. the following reasons: 
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TABLE 5-X ''CENTRAL AXIS PERCENTAGE DEPTII'DOSES 
EXPRESSED AS DEPTHS OF -PERCENTILES',. 
10 MeV ELECTRONS (10 cm x lo cm) 
PERCENTILE DEPTHS OF PERCE NTILES(cm) 
IN WATER IN MUSCLE IN HARD BONE 
100 2.0 1.7 1.4 
90 3.0 2.8 1.9 
3.4 3.1 2.1 
'70 3.6 . 3.4 2.3 
60 3.8' 3.6 2.4 
50 '4.0 3.8 2.5 
40 4.2 3.9 2.6 
30 4.4 
. 
4.1 2.7 
20 4.6 4.3 2.9 
10 4.9 4.6 3.2 
TABLE 5-XI DEPTHS OF THE 50% DOSE AND EXTRAPOLATED 
RANGES IN WATER, MUSCLE, BONE. 
1OMeV ELECTRONS (10cmxlOcm) 
MATERIAL 
DEPTHOF, 
cm 
50%DOSE 
g/CM2 
EXTRAPOLATED RANGE 
cm g/CM2 
Water 
. 
4. '00 4.00 5.00 
Muscle 3.80 4.03 4.70 5.03 
Hard Bone 2.50 4.17 3.10 5.15 
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i) The distance from the scatterer to the front surface of the phantom 
was about 5m and no beam defining applicator was used. The scatterer- 
phantom distance for the data given by JONES (1972) was much smaller, 
hence the divergence of the beam was more pronounced, resulting in the 
maximum being at a smaller depth. 
ii) The average energy of the pulsed electron beam used at the 
position of the phantom was (15.3 ± 0.4) MeV instead of 15 MeV 
(LOVELL and SHEN, 1976) 
iii) The dimensions of the. phantom used were only 10 cm x 10 cm 
x 10 cm. 
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Figure 5.31 Central axis percentage depth doses from 
15 MeV electrons 
Data from supplement 11 of British journal 
of Radiology (1972) 
2. Measured in muscle (MS/SR4) at 5m 
distance from the scatterer , 
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,, 5.3(iii) DOSE DISTRIBUTIONS, IN COMPOSITE PHANTOMS 
Central axis percentage depth (lose measurements with 10 MeV 
electrons were made in composite phantoms consisting of various thicknesses 
of bone + water., fat + water, muscle + lung + water, muscle + air + water 
and finally muscle + bone + lung. The resulting depth dose curves were 
used to derive the "isodose shift factors" discussed in the next Chapter 
(Table 6-1). Figures 5.32 to 5.36 illustrate the results of these 
measurements. The solid curves were plotted by the X-Y plotter, 
and give the percentage depth doses at various depths in water with 
different thicknesses of "overlying tissue heterogeneity",., From 
Figure 5.32 it is evident that the dose in water immediately behind 
0.5crnorl cm -thick bone is, slightly higher than the dose in" water 
I 
-only" 
but this increase in dose, is sufficiently small to be neglected 
under most clinical conditions. The isodose shift factor for lung was 
found to depend on the thickness of the lung traversed but, it was found 
to be the same irrespectivi-- of the position of the lung in the composite 
phantom. Figure 5.34 shows the case of 2 cm muscle followed by 
various thicknesses of lung and this followed by water. SiMllarly 
Figure 5.35 shows the effect of I cm, 2 cm and 4 cm air gap in the 
composite phantom. Again, the*position, of the air gap in the phantom 
was not found to have any influence on the "shift" of the depth dose 
curve. - 
Finally, Figure 5.36 shows a comparison of ýthe depth dose 
curve in water with that obtained when 1.3 cm of muscle is followed by 
1 cm, of hard bone and this followed by lung.: It is obvious that unless 
I 
corrections are made for the presence of tissue heterogeneities , the 
dose distributions obtained from measurements in a water phantom alone 
are not satisfactory for accurate patient dosimetry. 
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Figure 5.34 Effect of lung on the central axis depth 
doses from 10 MeV electrons 
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5.4 DEPTH DOSE DISTRIBUTIONS OF A 70 MeV 
_Tr- 
MESON BEAM IN VARIOUS TISSUE 
SUBSTITUTES 
(i) EQUIPMENT AND METHODS 
The depth dose distributions of negative pions in various 
tissue substitutes were measured on the IT 11 beam line of the 
proton synchrotron NIMROD (Rutherford High Energy Laboratory, 
IJ. K). NIMROD was used to accelerate protons to 7 GeV; a6 x6x 10 cm 
copper target was placed in the proton beam and the negative pions 
produced were extracted at an angle 940 1 with an average momentum 
160 MeV/c, corresponding to a kinetic energy of 70 MeV. Figure 
5.37 illustrates the beam line used. (PERRY and HYNES, 1971). 
Sending Quadrupole 
magnet triplet 
Target Quadrupole 
pair 
A. rradiation area 
LI 
Figure 5.37 The Tr 11 beam line at the Rutherford Laboratory 
Quadrupole pair Initial collimation and 
focussing of the pion beam. 
Quadrupole triplet Final focussing on the 
irradiation position at 1m 
from the last element of the 
triplet 
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The 0.2 CM3 air-filled cylindrical ionisation chamber (made 
of A-150 plastic) of the Rutherford Laboiýatory was used and its 
signal was fed into aK eithley 602 electrometer. Central axis 
measurements were carried out in various tissue substitutes., with 
at least two readings being taken at each depth. The average ratio 
(TE 
where TE is the charge collected, bythe cylindrical 
TC 
)AV. 
ionisation chamber and TC is the charge collected simultaneously 
by the monitor transmission chambers was plotted against depth in 
each material. 
MEASUREMENTS 
Figure 5.38 shows the central axis depth close curves 
from the 70 MeV pion beam in Perspex, in a muscle substitute 
(MS/SR4) and in water. Measurements were also ,,, carried out 
in a 
muscle equivalent liquid (MS/Ll) and then repeated in a liquid which' 
has approximately the same C, H, N, O contents as MS/L1 but includes 
no trace elements (MS/L1A). The effect of the trace elements was 
found to be insignificant2 since the two sets of measurements werewithin 
experimental error, the same. 
The effect of hard bone, lung and an air gap placed in the 
plateau region were investigated and are shown in Figure 5.39,5.40 
and 5.41 respectively. Table 5-XII summarises the results. 
expressing the peak depth in g/cm 
2 (i. e. by correcting for J:; Iy 
density), the difference in "equivalent thickness" between water and 
muscle was found to be less than 30%. When bone is present in the 
muscle phantom, however, the peak depth-equivalent thickness is 
larger than that in "muscle only" by about 6% for -a 4 cm-thick hard 
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Figure 5.38 Central axis depth dose curves from 
70 MeV negative pions in Perspex, 
muscle (MS/SR4 and MS/L1), and 
water 
bone slab (HB/SR1) placed in the plateau. This is because bone 
with low hydrogen content, and hence lower electron density, is 
less effective than muscle in stopping pions on a gram for gram basis. 
Howeverl the peak was found to be lower when bone was present. This 
could be due either to increased stopping of pions in bone (per cm of 
path) or increased scattering in bone. 
1. PERSPEX 
2. MUSCLE 
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Figure 5.39 Effect of bone on the central axis depth 
doses of 70 MeV negative pions in muscle 
In the case of lung and air gap, increased transmission 
and inverse square law effect result in an overall reduction of the peak 
height and the peak/entrance ratio. A density correction for lung 
would give the depth of the peak in muscle with less than 1% error. 
If the heterogeneity is in the pre-peak region, the effect is more 
pronounced. The. corresponding shift of the peak position is given 
in Table 6-1, Chapter 6. 
In summary, the peak/plateau ratio was found to be reduced: 
a) by about ZY., per cm of lung 
b) by about 5*,,. ' per *cm of air gap, 
c) by 1.5-2.0% per cm of hard bone 
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Figure 5.40 Effect of lung on the central axis depth 
doses of 70 MeV negative pions in muscle. 
1) In muscle 
2) 3 cm, lung in plateau 
3) 6 cm lung in plateau 
4) 10 cm lung in plateau 
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Figure 5.41 The effect of air spaces on the. pion depth dose curves 
The full width of the Bragg peak af the 801% level in MS/SR4, 
in the direction of the central axis of the beam was found to be 3.6 cm. 
A lateral scan of the pion beam at the depth of the peak, gave a beam 
profile with full width, at the 80% level, equal to 2.2 cm. Consequpntly, 
the volume enclosed by the 80% isodose surface, (assuming symmetry 
in the vertical and lateral directions), would be 3.6 cm x 2.2 cm x 
2.2 cm. The volume given by ELLIS. et al. , (1976) for the 80% 
dose contour of the same pion beam, is 4.0 cm x 2.3 cm x 2.3 cm. 
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TABLE 5-Xii PHYSICAL DATA FOR 70McV NEGATIVE PIONS 
TISSUE SUBSTITUTES - 
Material Peak depth . 
Peak height Peak Full width 
cm g/cm 
2 (TE/TC)AV Plateau at80%level 
(cm) 
Muscle i5.0 15.90 0.73 1.59 3.6 
Perspex 13.0 15.50 0.71 1.55 3.2 
Water 15.5 15.50 0.70 1.62 3.5 
Muscle with: 
a) 4 cm hard 13.0 16.54 0.69 1.47 3.9 
bone in plateau 
b) 6 cm lung 19.5 15.87 o. 65 1.39 3.6 
in plateau 
c) 2 cm air 16.8 15.90 0.67 1.44 3.2 
in plateau 
* Relative density of lung used-0.26 
**Materials used: LN/SR4 for lung, MS/SR4 and MS/L1 for 
muscle, HB/SRI for bone. 
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5.5 LOSS BY ALPHA PARTICLES TRAVERSING 
VARIOUS LIQUID TISSUE SUBSTITUTES 
The charged particles which contribute to the ionisation in 
the gas of ionisation chambers frequently used in neutronproton and 
pion dosimetry, are mainly protons, pions , alpha particles and ions 
of carbon, nitrogen and oxygen. It is through the stopping of these 
particles that energy is deposited when heavy charged particles and 
neutrons interact with matter. A series of measurements using 
alpha particles emitted from an Americium-241 source was performed 
during this work, with the purpose of establishing the residual energy 
of these particles when they traverse known thicknesses of various 
liquids simulating different biological tissues. Such information 
can be used to determine the stopping powers of real tissues for alpha 
particles in the energy range from I MeV to 5 MeV. There are few 
published results of experimental measurements of the stopping power 
of liquids for alpha particles. and these were restricted mainly to 
hydrocarbon liquids., ethanol, carbon tetrachloride and water 
(PALMER and SIMONS, 1959; PALMER.. 1973 and 1978). 
5.5(i) EXPERIMENTAL PROCEDURE AND MEASUREMENTS 
An alpha particle source consisting of 
24'Am deposited in a 
thin layer on a 0.317 cm diameter platinum disc., was positioned on 
top of a multihole collimator consisting of 26 holes of 0.35 mm diameter 
and 2.2 mm depth (see Figure 5.42). This collimator lay above. a 
silicon detector (Dý and could be moved vertically vrith the help of a 
micrometer system. As the detector was cemented in position in the 
base of the cell containing the liquid under'investigationt the thickness 
of the liquid layer between the detector and the lower end of the 
collimator could be varied in increments of Ipm. A more detailed 
description of the system used, which is the property of the City 
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University, London, was given by PALMER (1973). 
1 M Mi ro tttr 
icromtttr 
Magnet shaft Magnet 
Ot-active 
source 
Collimator P-n junction detector 
Pulse to 
pre-amp 
Figure 5.42 Apparatus used for the measurement of 
the energy loss by alpha particles 
traversing various liquids (PALMER, 1973) 
The lower surface of the collimator was covered with a 
1-2 pm-thick Melinex film, in order to prevent liquid from rising 
into the collimator holes by capillary action. The pulses produced 
in the detector by alpha particles traversing a liquid layer, were 
fed through a charge sensitive pre-amplifier to a calibrated 400 
channel Laben pulse height analyser (PHA) and so their residual 
energy could be derived. Allowance was made for the initial energy 
loss of the particles in the air path in the collimator., in the Melinex 
film covering the collimator and in the window of the detector. The 
initial energy of the alpha particles was 5.48 MeV but their energy 
just before they entered the liquid was Ea=5 MeV (PALMER 1978). 
The channel number corresponding to the peak of the spectrum on the 
pulse height analyser indicated the residual energy of the particles 
and could be found within 
t2 channels. This meant an uncertainty 
in the measurement of the residual energy of tO. 02-MeV. 
ý85 
With the liquid under investigation in the cell, the micrometer 
was first set as close to the "zcro liquid path" position as practicable, 
and the residual energy of the dlpha, particles measured. Then the 
liquid path was increased in 2m increments, the residual energy 
being measured each time. A list of the liquid substitutes used and 
the energy loss AE. in. a 20 pm-thick layer of each, are given in 
Table 5-XHI. 
An attempt to measure the same energy loss AEa with 
20 pm-thick sections of human fat, brain and muscle, for 
comparison purposes.. failed. The real tissues were frozen with 
"carbon dioxide ice" and a microtome in a freezing cabinet was used 
to cut sections from the real tissues. All these sections had too 
many pinholes for the resulting spectrum on the pulse height analyser 
to have a clearly. defined peak. An estimated position of a broad 
peak corresponded to the energy of the alpha particles passing 
through the pinholes rather than the solid material. 
5.5(ii) RESULTS AND DISCUSSION 
The energy loss A ECL suffered by the alpha particles 
in 20 p m-thick layer of each of the liquids used, is given in Table 5-XIII. 
In the last column, the value of AEa, divided bj, the relative 
density of each liquid, i. e. normalised to "unit density material" is 
given. The maximum difference between any two of the normalised 
valucs of A ECL is 1.36% of the energy of the alpha particles just 
before they enter the liquid (E 5 MeV). However, if. 'the a 
measured values are comparedi the most significant differences are 
between FAT and MUSCLE (8.20/. of Ea). WATER and MUSCLE 
(2.50/. of Ea) and TOTAL SKELETON and MUSCLE (15.32% of E a) * 
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TABLE 5-XIII ENERGY LOSS AEaIN 20 jim 
OF SUBSTITUTE 
TISSUE SUBSTITUTE EXPERIMENT 
A EcL(MeV) 
INUNIT DENSITY 
MATERIAL 
A EcL (McV) 
FAT FT/Ll 2.248 2.498 
WATER H2 0 2.535 2.535 
MUSCLE MS/Ll*, 2.656 2o506 
BLOOD BL/L2 2.603 2.479 
BRAIN BRN/1.6 2.566 2.467 
TOTAL SOFT 
TISSUE TST/Ll 2.575 2.500 
TOTAL 
SKELETON TSK/Ll 3.422 2.516 
Measurements in two muscle substitutes, namely MSILI - 
I 
and MS/LlAj the first with and the second withput trace elements, 
showed that the effect of trace elements is negligible. It appears 
that the difference in density and not in chemical composition among 
the various tissues is mostly responsible for their different effectiveness 
as far as stopping alplia particles from radioactive ýources is concerned. 
Using the same method and apparatus., PALMER (1978) measured the 
stopping powers of water and a muscle equivalent liquid (FRIGERIO, 
1972).. for alpha particles of energies 0.5 MeV to 8 MeV and found 
similar results; the maximum difference between the stopping powers 
of water and "unit density muscle,, was about 5*/,, at 0.75 McV. 'For 
measurements below 1.0 MeV., however, the data analysis may not 
have been accurate. At these low energies, the residual range is 
less than 10% of the total range and statistical fluctuations and noise 
affect tile resolution of tile system and reduce the accuracy. 
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Figure 5.43 shows the variation of the alpha particles' 
residual energy with thickness of liquid layer traversed, for four of 
the - liquids used. - , By using the slopes of these curves, the values of 
the stopping powers given in Table 5-XIV were derived. (Forthe 
stopping power at 2 MeV. for example, the average of the slopes at 
1.8t 2.0 and 2.2 MeVI was considered). 
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Figure 5.43 Relation of alpha particle residual energy 
with thickness of liquid traversed. 
The stopping power values for water and MS/L1 are within 
+ 
. 20,,. ' 
of those measured by PALMER (1978) but both sets are lower in 
general than calculated values given by OLDENBURG and BOOZ (1972) 
and by BARKAS and BERGER (1964). The difference between the 
calculated and measured stopping power of water for alpha particles 
of 4 MeV, for example, is 5%/. 
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TABLE 5-XIV STOPPING POWERS Or-, VARIOUS TISSUE 
SUBSTITUTES FOR . ALPHA . PARTICLES OF 1-4 M ev 
ENERGY STOPPING POWER 
(McV/ pm 
MeV FAT WATER MUSCLE TOTAL SKELETON 
1.0 0.193 0.218 0.230 o. 296 
2.0 0.151' 0.169 0.179 0.230 
0.115 0.128 0.137 0.175 
ý, 4.0 0.086 0.103 0.108 0.136 
Such measured data are sparse and because of the complexity of 
the interactions and processes involved (shell corrections, charge 
exchange etc) 'it is difficult to calculate them with acceptable 
accuracy. Now that suitable TISSUE EQUIVALENT liquids exist, 
further experimental measurements should be carried out using the 
most important of them, in order to establish their stopping'power 
for alpha particles of energies- encountered in neutron, proton and 
pion therapy. 
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, CHAPTER 
THE EFFECT OF TISSUE HETEROGENEITIES ON 
THE DOSE DISTRIBUTIONS -IN RADIOTHERAPY 
6.1 SOME GENERAL COMMENTS 
The standard isodose curves and depth dose tables apply to 
beams of radiation entering a homogeneous unit density piiantom. 
The presence of tissue heterogeneities, however, can alter the close 
distribution. Body heterogeneities may be defined as those tissues 
whose interactions with radiation differ from that of muscle. 
If a beam has passed through a heterogeneity, the absorbed 
dose at any point beyond it, is modified. Apart from that, the energy 
deposited at points within the heterogeneity itself, for a given exposure, 
is not the'same as in muscle. tI 
It is sufficient in practical dosimetry to take into account 
only the heterogeneities of lung, air spaces, bone tissue and fat. 
In lung tissue, owing to its lower density and, therefore, 
lower absorption, there is greater transmission of radiation than 
in soft tissue of the same thickness. Although the amount of radiation 
scattered by-the lung is smaller, for points beyond it, the increase in 
dose due to extra transmission is always greater than the loss in 
scattered radiation dose. 
In the case of air cavities, there is a further effect to note; 
the removal of virtually all the absorbing material results in a loss of 
complete charged particle equilibrium for narrow beams. This 
means that., in spite of the increased transmission of radiation, 'the 
dose at a point just beyond an air cavity can be less than the dose at 
a corresponding point in a complete phantom. MAýSEY (1962) found 
190 
that with 4 MeV X-rays, the loss of dose does not exceed 10% at the 
most, but unfortunately occurs just where the tumour may bc. At 
1 cm beyond the air cavity, however., the small increase due to extra 
transmission of radiation'is observed. 
If the heterogeneity in the irradiated tissue is bone, the depth 
dose at points lying in its "shadow" will be different from whatAt 
would have been, had the bone not been present. The change depends 
mainly on the thickness of the bone and the type and energy of the 
radiation beam. With X and gamma rays the dose at points behind the 
bone is reduced and this reduction is more pronounced in the case of 
I 
soft X-rays. In the case of electrons, due to the strong dependence 
of scattering on the atomic number, there is increased scattering in 
bone relative to its mass and this results in a slightly elevated dose 
in bone and at points lying in the tissue close to the distal interface 
of the bone. With fast neutrons , the low hydrogen content of bone 
counterbalances its higher density and so the effect of the presence 
of bone on the depth doses beyond it, is greatly reduced. 
A set of "i'sodose shift factors" for different types of radiation 
as well as lung correction factors for clinical use with 7.5 MeV neutrons 
and cobalt-60 gamma rays, derived from measurements during this study, 
will. noxv be presented. 
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6.2 MEASURED ISODOSY SHIFT FACTORS FOR THE 
, EFFECT OF. AIR, 
__ 
LUNG, FAT* AND BONE ON THE 
DOSE- DISTRIBUTIONS, WITH VARIOUS RADIATION 
MODALITIES 
It is usual in radiotherapy to estimate the close at various 
points by first assuming that the body consists of homogeneous soft 
- -tissue and then -to ýcorrectýthc dose distribution thus obtained, -for the 
presence of heterogeneities. 
When such corrections are carried out either manually or by 
means of a computer, the volume and composition of the heterogeneities 
must'be known as accurately as possible. The' accuracy with which 
this information is obtained, affects the overall accuracy'of the isodose 
plan. 
An empirical method of correcting for the effect of heterogeneities 
consists in merely displacing the isodose curves by a fraction of the 
thickness of the heterogeneity traversed by the beam, according to 
the rules given in Table 6-1. Thie'value's given in this'Table were 
derived by comparing the depth dose curve -in muscle substitute- alone, 
to those obtained when part of the. homogeneous substitute was replaced 
with various thicknesses of the heterogeneity. The displacement of 
the depth dose curve was divided by the thickness of the heterogeneity. 
used.. to give the corresponding isodose shift factor. 
The muscle substitutes used for the measurements'with fast 
neutrons, high energy protons-and pions, -were MS/SR4 and MS/Ll. 
In the case of cobalt-60 gamma rays and electrons , water was used as 
the muscle substitute. The lung, substitute (LN/SR4) used for the 
measurements with 1T-ý me'sons had a relative density of 0.26, wher .e as 
the lung sample'used for all the other measurements had a relative 
density of 0.30. Most of the experimental depth dose data used for the 
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I 
-derivation of the isodose shift factors, have already been given* in 
the previous chapter. ' 
TABLE'6'1 ISODOSE' SHIFT' FACTORS FOR VARIOUS 
TYPES OF RADIATION AND VARIOUS BODY 
HETEROGENEITIES 
Type of Position of point Isodose shift 
Direction of 
movement 
radiation Heterogene#y with respect to (t=thickness of ofisodose 
and energy heterogeneity heterogeneity) curve 
Air Behind 0.60t Distal 
Lung Behind'd <5 cm 0.35t Distal. Cobalt -60 d>5cm 0.45t Distal 
gamma rays 
Fat Behind 0.10t Distal 
Average skeleton Behind 0.25t' Proximal 
Cortical bone Behind 0.40t Proximal 
Air Behind 0.75t Distal 
Within(first half) 0.10t Proximal 
Lung (second tr) 0.20t Distal Neutrons Behind d<5 cm 0.50t Distal 
E=7.5 MeV 
n 
d>5cm . , 
0.60t Distal. 
Fat Behind no shift 
Cortical Bone Behind no shift 
Air Behind 1.00 t Distal 
Electrons Lung Behind 0.70t Distal 
10 MeV Fat Behind 0.10t Distal 
Cortical Bone Behind o. 6o t -Proximal 
Air Behind 0.90t Distal 
7T - Mesons, Lung Behind 0.75 t Distal 
70 Mev Fat Behind 0.10t Distal 
Cortical Bone Behind 0.50t Proximal 
Air Behind 0.90 t Distal 
Lung Behind 0.75t Distal 
Protons Fat Behind 0.10t Distal 
150 MeV Total Skeleton Behind 0.25ý Proximal 
I Cortical Bone Behind 0.40t Proximal 
Tor points behind the lung, a single isodosc shift factor of 0-4t for Cobalt 
&mm 
'a 
rays would give the true doses with an crro'r of the order of ± 2percent 
With 7.5 McV neutrons, a single distal shift of 0.5t, would give doses 
behind. the lung within 2 percent. 
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When the effect of air spaces present in, the phantom,, on, 
the dose distributiom from high energy, protons, fast'neutrons and 
cobalt-60'gamma rays was investigated, polypropylene -tubes 
with 1 mm-thick walls. and diameters of 1 cm to 4 cmwere used,, 
covering onlypart of the beam cross section. All the other experiments 
. were made with the heterogeneity covering the. entire cross section of 
the radiation beam. 
,, z. SUNDBOM (1965),, experimented with cobalt-60 gamma rays 
and suggested a 0.5t distal displacement of the isodose curves for 
lung (t=thickness of heterogeneity traversed). GREEN and 
STEWART (1965), suggested a 0.4t distal shift for lung and a 0.5t 
proximal shift for bone; the substitutes they used, however, were 
cork of unknown composition for lung and aluminium which is 
considerably denser thanýbone. 
With'& use"of 
'computers' in treatment planning, it is possible 
to produce accurate isodose distributions provided that a set of 
correction factors is available for each type of heterogeneity and 
that the shape, location and density of the internal organs is 
accurately known; information about the shape and position of the 
internal organs'is now'easily obtained'with computerised tomography 
scannerse 
The lung correction factors for 7.5 MeV neutrons and cobalt-60 
gamma rays measured during this work will be given in the next 
section. 
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6.3 LUNG CORRECTION FACTORS FOR- USE -IN 
COMPUTERISED ISODOSE PLANNING 
It was not until the beginning of the past decade that computers 
have really been used to obtain dose distributions corrected for tissue 
heterogeneities., Today the problem can be approached bý. using 
either a set of measuiýed correction factors or mathematical models. 
If no correc: tion is made, errors well in excess of t 5% Of the 
average tumour dose, considered as clinically acceptable, could result. 
The new lung and muscle'substitutes were used to'meas-4re lung 
I correction factors' and to'investigate the effect of field size and position 
of the lung in the phantom on-these correction -factors in the cases of I 
cobalt-60 gamma rays and 7.5 MeV neutrons. 
Unlike cork and other materials used to approximate lung in 
the I past, the porous nature and elemental composition of the lung 
substitute formulated and used in this work, are very close to'those 
of real lung. 'III, I" ý- . 1,1 ý 
6-3(i) - LUNG CORRECTION FACTORS FOR FAST NEUTRONS 
I 
The measurement's for the derivation of the lung correction 
fc, I, - f6ý fa tors r fast neutrons were made in a 20 cm-cube phantom made'6f 1 cm 
and 2 cm-thick slabs of a solid'muscle substitute (MS/SR4), using the 
neutron beam of the Medical Res6arch Council cyclotron, at Hammersmith., 
London. The slabs of the solid lung substitute (LNG/SR4) used, were 
I 
flat and had. lateral dimensions larger than the largest field size. 
Readinas were taken at each depth with and without the presence of ýO 
_lungj 
first in the muscle in front of the lung, then within the lung 
itself and finally in the muscle behind the lung. The gamma ray 
component of the d6se was subtracted from the total dose at each depthy 
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to give the neutron dose. At each point, the neutron dose with the 
lung present was dividccl. 'tý the neutron dose without the lung, to 
give the correction factor. ', - 
Lung thicknesses from 1 cm to 10 cm 
11 
were used and the measurements were repeated for three field sizes, 
namely 4.5 cm xS cm, 9.5 cm x 9.5 cm and 14 cm. x 14 cm. 
Figure 6.1 shows the central axis neutron depth dose curve 
in muscle for a 9.5 cm x 9.5 cm field, as well as the effect of 5 cm 
'and 8 cm-thick lung on the depth doses. 
w 
The correction factors for the 9.5 cm X 9.5 cm field are 
given in Table 6-11 and plotted for 3 cm, 5 cm and, 8 cm-thick lung 
in Figure 6.2 , where the field- size effect for 8'Cm-thick'l-Lin'g- is also 
shown. - 
0 
The neutron dose in the muscle tissue lying in front of the 
lung is reduced by 2-3 percent at the most; for the first few 
centimeters within the lung, the correctim factor fell below 1.00, 
indicating that the neutron dose in lung can be lower than the neutron 
close for the same point in muscle. For points deeper in lung, the 
increased transmission of the primary beam more than compensates for 
the reduced scattered radiationand the net result is an increas ,e of 
the neutron close with increasing depth in lung. ' The close to a point 
13-ing in an 8 cm-thick lung, just 1 cm from the distal interface, would 
be larger than the dose at the-same point in muscle, by about 25 percent. 
The correction factor continues to increase in the muscle behind the 
lung nearly linearly and towards the back of the phantom it tends to 
level off, possibly duc to reduced backscatter at the end of the phantom. 
It is notable* that at a point 10, cm behind an 8 cm.; -thick- lung, the 
ncutron dose could be as much. as 100% larger than the dose that normal 
depth doýc curves would indicate. 
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TABLE 
,6- 
ii 
LUNG CORBECTION FACTORS FOR FAST NEUTRONS 
in 
= 7.5 MeV, , 
9-5cm x 9-5cm FIELD T. S. D. 120=). 
ioinýt ki muscle 
., Wcknes3 tissue before 
Point within the lung 
of lung the 1=g ý I - -1 ý traversed Distance from Distance from first interface (cm) 
CM interface (cm) 
1 .2 3 1 3 4 5 
6 789 
0.991 0.993 0.995 
2 0.989 , 0.991 0.993 1.00 
3 0.987 0-989" 0.991 0.980 
4 0.985 O-9S7 0.990 o. 96o 1.00 1.040 
5 0.982 0.985 0.989 0.940 0.980' 1.035 1.080 
6 0.979 0.993 0.988 0-933 0-970 1.015 1 . 070 1.185, 
7 0-976 0.531 0.987 0.924 0.960 1.00 1.050 1-115 1-185 
8 0.972 0.978' 0.986 0.920 0-958 0.999 1.050 1.115 1-184 1.260 
9 0.968 "0-97-5 0.98 .5 0.918 '0-944 0.980' 1.025 1.100 1'. 180 1.26o' 1.330 
10, 0.964 0.972 0.984 0.916 0.940 0.978 1-015 1.080 1.165 1.245 1.320 1.390 
-- 
Thickness Point in muscle -tissue 
behind -the lung 
of lung 
tr,,, rsea Distance from second interface (cm) 
cm 
1 2 3 4 5 6 7 9 10 
1 1.040 i. o6o 1.070 1.080 1.090 1.095 I. I(p 1.105 1-11? 
- 2 1.075 -1-100 1-110 
1.020 1.130. 1.140 1-150 1.160 1-165 1.179. 
3 1.135 1.150. 1.165 1.175 1.190 1.205 1-215 1.225 1.235 1.240 
4 1.190 1.210 1.230 1.260 1.200 1.300 1-310 1.320 1-330 1.340 
5 1.250 1.290 1.330 1.360 1.3,90 1.415 1-440 1.460 1.. 470 1.480 
6 1.320 '1.375 1.415 1 . '460 1.490 1.525 1.555 1.585' 1.610 1.635 
7 1.415 -1.460 1.510 1.560 i. 6w i. 66o 1.700 '1-735' 1.765 1490 
1-510 1.560 1.610 1.670 1-720 1.780 1.640 1.680 1-905 1.925 
9 1.590 1.650 1.710 1.770 1.830 1.890 1.980 2.000 2.050 2.070 
10 10690' 1.760 1.830 1.900' 10960 2.020 2.080 2.140 2.180 2.210 
relative density = 0-30 
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The gamma ray component of the total dose was found to be 
smaller in front of and within the lung, but it becomes larger than the 
corresponding dose in muscle just 1-2 cm behind the second interface. 
It should be mentioned that, the neutron and gamma ray doses 
were measured at points whose distance from the nearest interface 
was not less than 1 cm, because of the size of the detectors used, r 
e. g. the I cm3spherical , 
EG & G.. ionisation chwnbor. These curves. 
therefore, give no information albout transition effects at interfaces in 
the phantom. 
Table 6-111 gives the correction factors for lung as a function 
of field size. For a given depth.. the correction factor is larger for 
the smaller field size'. If one applied the 9.5 cm x 9.5 cm correction 
factors for the other field sizes, the error would be about 3 percent 
near the interface, but not more than 1 percent at distances larger 
than 6 cm behind the lung. 
TABLE 6-111 VARIATION, OF LUNG CORRECTION 
FACTORS WITH FIELD SIZE 7.5 MeV) 
Lung Field Distance from interface 
thickness size point behind the lung 
cm cm x cm 1 cm 4 cm 7 cm 10 cm 
4.5 x 6.0 1.155 1.200 1.240 1.265 
3 9.5 x 9.5 1.135 1.175 1.215 1.240 
14.0 x 14.0: 1.130, '1.170' '1.210 1.235 
I- 4.5 x, 6.0 1.310 1.400 -1.470 1.5051 5 9.5 x 9.5 1.250 1.360 1.440 1.480 
14.0 x 14.0 1.245 -1-340 - 1.410 1.460 
4.5 x 6.0 1.580 1.740 1.870 1.950 8 9.5 x, 9.5, 1.510 1.670 1.840 1.925 
14.0 x 14.0 1.485 1.650 1.820 1.920 
"By 
applying the, correction factors given in this sectionj neutron 
depth dose distributions with errors of less than 12 percent can be 
obtained. 
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6.300. LUNG CORRECTION FACTORS'FOR COBALT GAMMA-RAYS 
BATHO (1964) used for the first time Tissue-Air Ratios 
(TARs) to - calculate corrections for the ý effect of lung.. The Tissue- 
Air Ratio (TAR), defined as the ratio of the dose -to a small mass of 
tissue in the medium to the dose at the, same, point in air, is frequently 
used in the computationof dose distributions. - The correction factor, 
as Batho suggested, can be calculated from the equation, i 
CF TAR (A, d2) 
TAR (A, dl) (6.1) 
where p is the electron- density of the heterogeneity relative 
C 
to soft tissue and d, d2' are the distances from the point of interest 
to the two surfaces of the'overlying heterogeneity. This method, 
allowed only for the case of pointslying behind the inhomogeneity and 
I the above equation is valid only in the energy range where absorption 
and. scattering of the photons'is determined solely by the number"of 
electrons per cm3 of the medium, i. e. where the attenuation is due 
almost entirely to the Compton process. Batho assumed'the average 
3 density of lung tissue to be 0.35 g cm- and calculated lung correction 
factors using equation (6.1 ). 
YOUNG'and GAYLORD (1970), carried out experiments with. ' 
cobalt-60 radiation to test the validity of equation 6J. They used 
aluminium., carbon., Perspexl, and air., and found that the calculated 
correction factors c6uld be used with an error of about 3 percent. 
SONTAG- and C13NNINGIIAM (1977), gave a, gencralized formula 
for this correction factor, that allowed for correction of the "close to 
points within the heterogeneity asýwell, and accounted for the differences 
in atomic number between the heterogeneity and the tissue-like material. 
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PP Pen 
CF'- TAR (A) di ) a- 
b 
VP )a 
(6.2) 
TAR (A, C12)1 - Pb Pe P 
)b' 
where P is the density of the material in which the point of a 
interest lies at a depth d, and P is the densit of the overlvine y b 
material of thickness (d2 - d, They used cork- for lung and 
aluminium for bone and found that the agreement between-values 
measured within the aluminium and, those predicted by, the generalized 
formula was not quite as good, with differences of 4-5 percent being 
observed. 
Figure 6.3 shows the correction factors obtained with a 
phantom consisting of 4 cm-thick muscle substitute (MS/SR4) 
followed bY3 cm, 5 cm or 8 cm of lung substitute (LNG/SR4) and 
this followed by a 30 cm x'30 crn x 40 cm tank full of water. 
Measurements were repeated with 2 cm of muscle in front of the 
lung, in order to see how the thickness of overlying tissue affects 
the correction factors. The two sets of correction factors were 
within 1 per cent of each other'and it was concluded that the correction 
is independent of the thickness of the overlying I, tissue. 
The dotted lines in Figure 6.3 show the values predicted 
by the Batho 
* 
formula (equation 6.1); the maximum difference, for the 
8 cm-thick lung, is 2 percent. 
The lung correction factors derived in this 'way seem to 
vary linearly with depth; the fact that the phantom was rather 
extended behind the heterogeneity may be responsible for this 
because no measurements- were made near the exit of the phantom 
where the backscatter is gradually reduced; this reduced backscatter 
is probably responsible for the levelling off observed with the lung 
correction factors for neutrons. 
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Figure 6.3 Lung correction factors for cobalt-60 
gamma rays, (10 cm x 10 cm field, 
SSD = 75 cm). Dotted lines : values 
predicted from equation 6.1 
The effect of field size on the lung correction factors was 
also investigated by repeating the measurements for three field 
sizes, namely 5 cm x5 cm., 10 cm x 10 cm and 15 cm x 15 cm. 
Figure 6.4 shows the correction factors for the above three field 
sizes in the case of 8 cm-thick lung. Table 6-IV gives correction 
factor values for points behind 3 cm, 5 cm and 8 cm-thick lung, for 
the three field sizes. It can be seen that for a point lying 5 cm-behind 
an 8 cm-thick lung, for example, the correction factor for the 5 cm x 
5 cm field is about 3 percent larger than that of the 10 cm x 10 cm field, 
while the correction factor for the 15 cm x 15 cm field is about 2 percent 
lower. 
A single set of correction factors for each thickness of lung 
traversedq based on an average field size could probably be used. 
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Figure 6.4 Effect of field size on the lung correction 
factors for cobalt-60 gamma rays 
(Lung thickness =S cm) 
TABLE 6-IV LUNG CORRECTION FACTORS AS A FUNCTION 
OF LUNG THICKNESS, FIELD SIZE AND DISTANCE 
OF POINT FROM THE LUNG 
Cobalt-60 radiation 
Lung Field Distance of point from lung 
thickness 
cm 
size 
(cm x cm) 1 cm 5 cm 10 cm, 
5x5 I. o64 1.089 1 104 
3 10 x 10 1.059 1.800 1-o95 
15 X 15 1.055 1.074 1.087 
5x5 1.125 1.160 1.210 
10 X 10 1.110 1.144 1.193 
15xl5 1.095 1.128 1.175 
5x5 1.209 1.285 1.380 
lox 10 1.19i 1.247 1.311 
15 x 15 1.180 1.218 1.273 
, 
203 1 
Table 6-V gives the lung correction factors for cobalt-60 
gamma rays, for points lying in the tissue in front of the lung, for 
points within the lung and finally in the soft tissue behind the lung. 
The use of such correction factors in'computerised isodose planning 
would. improve the accuracy of the dose distributions thus obtained. 
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TABT, n. 
CORRECTION FACTORS FOR LMIG* 
(10 cm x 10 cm) 
COBALT-60 GAMU'RAYS 
Point in tissue Point within the lung 
before lung 
Thickness Distance from Distance from first interface 
of lung Interface(cm) (cm) 
cm 
1 2 3 1 2 3 4 5 6 7 8 9 
1 0.951 0.958 0.975 
2 0.951 0.953 0.972 0.955 
3 0.950 0.957 0.969 0.942 0.972 
4 0.950 0.957 0.966 0.935 0.965 0.904 
5 0.950 0.956 0.964 0.935 0.95S 0.984 1.009 
6 0.949 0.955 0.062 0.931 0.957 0.983 1.009 1.035 
7 0.949 0.954 0.960 0.930 0.956 0.982 1.009 1.034 1.060 
8 0.948 0.953 0.959 0.929 0.955 0.982 1.008 1.034 1.059 
9 0.948 0.952 0.958 0.928 0.954 0.981 1.008 1.034 1.059 1. OSG 1.118 
10 0.947 0.951 0.957 0.927 0.953 0.980 1.007 1.033 1.059 1.066 1.118 1.143 
Point In tissue behind the lung 
Thickness Distance from second interface (cm) 
of lung 
cm I 
1 2 3 4 5 6 7 8 9 10 11 -12 
1 1.014 1.015 1.019 1.023 1.025 1.027 1.030 1.033 1.035 1.040 1.043 1.045 
2 1.030 1.035 1.039 1.043 1.046 1.050 1.053 1.056 1.060 1.064 1.068 1.072 
3 2.059 1.061 1.063 1.065 1.068 1.072 1.076 1.080 1.084 1.089 1.094 1.098 
4 1.082 1.090 1.098 1.105 1.112 1.118 1.125 1.132 1.139 1.146 1.152 1.160 
5 1.110 1.118 1.128 1.139 1.148 1.158 lol68 1.177 1.187 1.196 1.207 1.215 
6 1.240 1.150 1.161 1.173 1.185 1.195 1.206 1.216 1.227 1.238 1.250 1.2G2 
7 1.164 1.177 1.190 1.204 1.216 1.229 1.242 1.255 1.268 1.281 1.294 1.307 
8 1.191 1.205 1.221 1.234 1.247 1.258 1.270 1.285 -1.300 
1.311 1.3 
, 
25 1.340 
9 1.233 1.250 1.265 1.280 1.295 1.308 1.320 1.335 1.350 1.364 1.378 1.392 
10 1.278 1.293 1.308 1.323 1.337 1.351 1.366 1.381 1.395 L. 410 1.425 1.440 
--A 
* relative density = 0.30 
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CHAPTER-7 
SOME kPPLICkTION S OF THE NEW TISSUE SUBSTITUTES 
Tissue substitutes 'are needed for several purposes in 
radiation dosimetry, radiotherapy, radiological protection and 
radiodiagnosis. Tor example, ionisation chambers, organ or body 
phantoms and radiographic test objects are some of theltems that 
can be manufactured using the new substitutes. Some of these 
applications will be described here briefly. 
7.1 MACROSCOPIC, MICROSCOPIC AND INTERFACE DOSIMETRY 
The experimental work carried out during this study illustrates 
the usefulness of the new substitutes in both particulate and photon 
radiation dosimetry. 'Figures 7.1 (ial and ibý) show samples of 
solid substitutes for lung, muscle and hard bone, while Figure 7.2 
shows some liquid and gel tissue substitutes produced in this work. 
Although non-conducting electrically, the new solid tissue 
substitutes can be used in the manufacture of ionisation chambers for 
use in particulate and photon radiation dosimetry, provided their 
electrodes are coated with a layer of graphite thin enough not to 
disturb the particle fluence (a few microns-thick). 
The new substitites can also facilitate interface dosimetry and 
microdosimetry. For example, small size thermolumine scent 
dosimeters (TLD chips or discs) can be placed very close to the' 
tissue interface to measure the dose distribution in this region of 
interest. Nuclear emulsions can be sandwiched between slabs of 
solid tissue substitutes and exposed to particulate radiation beams 
in order to investigate the type and the yields of charged particles 
produced in tissue by these radiations. Similarly film dosemeters 
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(a) 
au P4 t 
________________ 
b) 
Figure 7.1 Sonic, of the now solid tissue substit-Litos 
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>f 
Figure 7.2 Some new liquid, gel and solid tissue 
substitute materials 
can be used in conjunction with central axis depth dose measurements 
to plot the isodose curves from radiation beams in various tissues 
like muscle, brain or bone. The use of the liquid tissue substitutes 
to measure the stopping powers of various tissues for alpha particles 
emitted from naturally radioactive substances is another application 
of the new materials. 
Samples of lung and bone substitutes (LN/SR1 and HB/SR4) 
have been made for the Churchill Hospital Physics group (Oxford), 
at their request, in order to investigate the transmission and. back 
scattering of 4 to 40 MeV electrons from these materials. Muscle 
anJ bone substitutes have also been used to study the yields of 
charged particle--, and the corresponding dose : LET distributions 
in the reg gion of the peak of the 
70 Mo-V pion beam of the Rutherford 
Laboratory, 'U. K. (PERRIS, et al., 1978). 
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7.2 RADIOGRAPTITC TEST OBJECTS 
The new materials are also suitable for radiographic studies 
in diagnostic radiology. Lung phantoms, for example, can be used 
for the construction of realistic chest phantoms. If a number of 
lungs with the same shape, composition and density are manufactured$ 
then different types of objects (e. g. calcifications, meshes etc) can 
be incorporated in each one of them for the purpose of testing 
imaging systems such as diagnostic X-ray machines and computerised 
tomography scanners. When the same test object is radiographed on. 
different X-ray machines set to the same mAs and kVp, the amount of 
information obtained from the different radiographs can be compared. 
A radiographic test object designed and manufactured for 
comparing resolution, detail and contrast on different imaging systems 
in an objective way, is shown in Figure 7.3. Various items have 
been embedded in the base material which is the epoxy system CBI. 
Figure 7.3 A radiographic test object (diniension, s : 15 cm x 20 cin x3 cm) 
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These items include step wedges made of tissue substitutes ranging 
from fat to hard bone, aluminium oxide spheres-ranging from 0.4mm 
to 4 mm diameter, a1 cm-thick section of real bone and air spaces 
with fine wires of copper thre aded, through polyethylene tubes, the 
smallest diameter of the wires being 0.05. mm. The section of the 
head of the femur was impregnated with resin before being embedded 
so that, by excluding air, its trabecular structure could act as a 
test object for resolution and detail determinations. 
Figure 7.4 shows radiographs of this test object taken withX rays, fast 
neutrons and with high energy protons. The techniques and methods 
used in proton scattering and end-of -range proton radiography have 
been described by WEST (1974) and STEWART and KOEHLER (1974). 
It is seen that the end of -range proton radiograph (D) is the only 
one which provides information for both soft and skeletil tissues. 
It also shows bubbles of trapped air, not visualised on any of the 
other radiographs. The conventional X-ray radiograph (A) gives 
better detail of the structure of the real bone but the soft tissues 
are not visualised on it. On the neutrogram (B), apart from the air 
volumes, nothing else is visualised. 
Another test object which was designed and manufactured at the 
request of the Diagnostic X-ray Department of St Bartholomew's 
Hospitals Londonp is shown in Figure 7.5. The requirement was 
to have a solid material -which would be "invisible" on radiographs 
taken'when a rack made of this material was immersed in water. 
The purpose was to -study the changes observed on the radiographs 
when different con cent rations of contrast media were used. As it 
was not feasible to formulate an elementally correct solid water 
substitute, the Basic Data method was employed and the substitute 
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A B 
FT/SF 1 
EB/SF3 
TSK/SF3 
NS20 
ms/sRl 
APISF1 
CD 
Figure 7.4 Different radiographs of the same test object. 
A: Conventional radiograph (60 kV. X-rays, 20 mAs). p 
B: Neutrogram 7.5 MeV). 
C: Proton scattering radiograph (160 MeV protons, 3cm thick aluminium absorber). 
D: End-of-range proton radiograph (160 MeV protons, 9-85cm thick perspex absorber). 
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Figure 7.5 Object made of a solid water substitute 
WT/SR1 was formulated and manufactured. Samples of this 
substitute were immersed in water and. radiographed, but they were 
not visible on the radiographs. By using test tubes of different 
diameters the visualisation of dilated bile ducts fitled with contrast 
media could be stLidied. 
Radiographic test objects for CT scanners can also be 
manufactured using the new tissue substitutes, especially the 
liquids and gels. If epoxy resin based systems are to be used, 
then the powders added as fillers must be sieved to below 100 Jim 
if the homogeneity required for this application is to be achieved. 
However., the solid substitutes prodLICed by WHITE (1974), are 
better for this purpose bo-cause they are all class A (errors < 5%) 
for photon energies below 0.1 MeV. 
^1 r) 4-- 
7.3 BODY PHANTOMS, 
The new tissue substitutes are -suitable for the manufacture 
of organ and body phantoms for depth dose studies, for the 
assessment of the doses given to the irradiated areas of patients 
undergoing radiotherapy and for the- comparison of different' 
dosemeters. The manufacture of anatomically correct body 
phantoms (in slices) with the correct tissue substitutes, allows the 
dose distribution from the various fields used within the body to 
be accurately measured using dosemeters at different points in the 
phantom. Depending on the experimental requirements, the 
phantom employed could be either a complex reproduction of the human 
body or a simple homogeneous material. 
An application that is currently being considered is the use 
of the gel substitutes for muscle as bolus material in both photon 
and particulate radiation therapy. These gel substitutes have low 
cost and when kept in sealed polythene bags can be used for several 
months. 
The determination of the radiological hazard to patients who are 
administered racliopharmaceuticals, requires an assessment of the 
doses absorbed in various organs from a radioactive material 
deposited in another organ. For suc h applications, 2 mm-thick 
perspex. sheets can be used to produce shell replicas of the various 
organs (kidneys, liver, thyroid, etc). These models can be filled 
with the appropriate liquid substitutes and placed in a man-sized 
shell phantom which in turn, is filled with "total soft tissu&" 
liquid substitute, If a soluble radioactive material is mixed with 
one of the organ substitutes, then dosemeters placed at defined 
points within the phantom will permit the dose distribution to be 
plotted. 
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The addition of radionuclides in epoxy resin'based substitutes 
during their manufacture' and tyeir subsequent use as counting 
standards is being investigated. 
_ 
If compartmented models are used, 
the effect of non-uniform distribution of radioactive materials on 
the counting efficiency of various detectors may be studied (for 
example, plutonium in lung substitutes). 
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CHAPTER 
CONCLUSIONS AND SUGGESTED FUTURE WORK 
The radiation physicist has a large number of tissue substitutes 
available for dosimetric studies. Some of the phantom materials 
used in the past, however, should not be used any longer because 
they have unknown composition and variable density and their 
radiation absorption and scattering characteristics probably differ 
from those of the real tissues by more than 20%. Tressdwood and 
paraffin wax. -still used as muscle substitutes I sulphur and 
aluminium still used to represent bone. and sawdust, cork and 
sponge still used as lung substitutes are some typical examples of 
unacceptable materials, 
The present study had two main aims. The first was to 
formulate new tissue substitutes with the same elemental 
composition and density as the corresponding real tissues. The 
second aim was to use these systems for dosimetric studies with 
those types of radiation which are used or are likely to. be used 
for patient treatment, in order to establish their depth dose 
characteristics in various tissues andin particularto investigate 
the effect of tissue, heterogeneities on the, dose di-stributions ine 
the paticntýs boay. 
A wide range of tissue substitutes in the liquid, gel and solid 
phases have been produced as a result of this work. Most of these 
materials are "TISSUE EQUIVALENT" particularly the liquid 
and gel substitutes. In the case of epoxy resin based substitutes, 
partial replacement of oxygen by carbon had to be accepted aue to 
the fact that epoxy resins and polymers are rich in carbon and 
poor in oxygen. A similar problem exists when rubbers are 
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considered. Not only are rubbers poor, in oxygen but they normally 
require high temperatures and'pressures and elaborate equipment 
for their mixing. Until polymers 'or other base materials rich in 
oxygen are developed, no improvement is expected as far as this 
problem is concerned. However, this replacement of oxygen by 
carbon in the new tissue substitutes does not introduce significant 
errors when these, materials are used with photons of energy 
above 0.1 MeV., high energy charged particles or fast neutrons* 
The extensive series of measurements performed with, 
cobalt-60 gammaý rays , 7.5 MeV neutrons , '10 MeV electrons , 
70 MeV pions and 150 MeV protons using a selection of the -new 
tissue substitutes, resulted in-the establishment of the depth dose 
characteristics of. these radiations in muscle, brain, bone and water. 
The effect of tissue heterogeneities on the dose distributions was 
investigated and isodose shift factors for use in the planning of 
the treatment of patients undergoing radiotherapy, were derived. 
Detailed lung correction factors for cobalt-60 gamma rays and for 
neutrons of average energy E -1 7.5 MeV were also derived and 
In 
these are readily available for computerised isodose planning. 
The comparative information accumulated during the course 
of this study has added significantly to the sparse data on electron,, 
negative pion, proton and neutron depth dose distributions in 
various tissues. The measurements performed on the 160 MeV 
proton beam of the ktomic Energy Research Establishment were 
a necessary pre-requisite for the proposed proton radiotherapy I 
program using that proton beam facility. Experience has been 
gained in positioning the Bragg-peak "on target" and this problemt 
considered before as one of the main obstacles to the clinical use 
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of protons, is no longer a limiting factor. The collimator system 
of the above proton beam facility, however, should be improved so 
that scatter towards the patient is reduced. 
It is hoped that a clinical study will be undertaken in the 
. 
near future, to compare protons to megavoltage X-rays in the 
treatment of tumours for which it appears most likely that an 
improved: dose distribution will be advantageous. Silch a clinical 
trial should include enough cases to assure statistically significant 
results. The capacity to decrease the normal tissue dose relative 
to the tumour dose with proton treatment, should have merit in 
reducing the morbidity or in increasing local tumour control. 
The usefulness of the measured i. 5oclose shift factors for all 
radiations and lung correction factors for photons and neutrons 
over a wider energy range, should be established by further 
measurements. Measurements should also be performed very 
close to the tissue interfaces (distances 0-1 cm from interface) 
because the dose gradient in this region is more pronounced and 
it is in this region that the maximum errors in the estimation of 
dose usually occur. 
It is hoped that this study will stimulate more interest in the 
use of tissue substitute materials and that the experimental results 
will contribute to improvements in clinical dosimetry. 
GOD 
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APPENDIX 1 
SYMBOLS, PHYSICAL CONSTANTS AND 
ELEMENTAL DATA USED IN THE STUDY 
I 
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A (M) Atomic weight (Molecular weight) 
ai Fractional Electron content of the ith element or compound 
P v/C 
c Velocity of light 
CF Correction factor 
CT Computerised tomography 
6 Density effect correction 
e Charge on electron (1.6 x 10- 
19 C) 
Eeff Effective energy 
En Neutron energy 
E)2 Electron mean square scattering angle 
O(E) Particle fluence 
FWHM Full Width at half maximum 
Kerma 
Mean excitation energy 
Me 
Path length 
Rest mass of electron 
( 
MeC2- 0.510976 MeV 
m Percentage by weight of the i 
th compound in a mixture i 
2 
C17PI) Mass angular scattering power 
S/P Mass stopping power 
S/P )CO, Collision mass stopping power 
S/ P 
)rad Radiation mass stopping power 
'Narrow beam' linear attenuation coefficient 
P/P Mass attenuation 'Coefficient 
Pen/P Mass energy absorption coefficient 
I'tr/P Mass energy transfer coefficient 
11 T/ p Photoelectric mass attenuation coefficient 
NA Avogadro's number (6.02252 x 10 
26 kmol- 1 
no Electron density 
Pe Momentum of electron 
Tr Constant : 3.14159 
TT - Negative pions 
-15, re Electron radius (2.81777 x 10 M) 
p Mass density 
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Pe Electron density of a heterogeneity relative to soft tissue 
CF t Total neutron cross section 
SG Relative density (specific gravity) 
T Kinetic energy of a particle 
T Kinetic energy in units of me c2 
v Velocity 
W The energy required to form an ion pair in the 
sensitive volume of a radiation detector 
W/O Percentage by weight 
x 2-exponent 
z Atomic number 
z Number of protons in a charged particle 
< Z/ > Mean ratio Z/A for compound 
Z(X) Effective atomic number 
Ci 
z The term for shell corrections (equation 1.2) 
Ohm 
Weight proportion 
ELEMENTAL DATA 
I ELEMEMT AT13MIC WT. Iz ELEMENT ATOMIC WT. 
A HYDROGEN CH ý 1.00797 37 RUBIDIUM (Re) OS. 47 
2 HELIUM (HE) 4.0026 30 STRONTIUM (SR) 07.52 
3 LITHIUM 4L 1) 6.939 32 YTTRIUM CY ) Se. 90S 
4 BERYLLIUM (BE) 9.0122 40 ZIRCONIUM CZR) 01.22 
S BORON (a ) 10.011 41 "105lum (MB) 92.906 
9 CARBON CC ) 12.01SIS 42 MOLYBDENUM (MO) 95.94 
7 NITROGEN (M ) 14.0067 47 SILVER (AG) 107 70 6 
6 GXYGEM to ) IS. 0994 40 CADMIUM (CO) 112: 1 10 
9 rLUORIME (F ) J6.9904 So TIN (SH) Ile . Go 
10 NCO" (ME) 20.303 51 ANTIMONY (Sb) 7s 121 
it SODIUM (NA) 22.9098 52 TELLURIUM CTEI 
: 
121 GO 
32 MAGNESIUM (MG) 24.312 53 IODINE (I ) 126.9044 
13 ALUMINIUM CAL) 26.981S ss CAESIUM (CS) 132.90S 
14 SILIC014 (SI) 28.086 So BARIUM (BA) 137.34 
is PHOSPHORUS (P 3 30.9736 57 LA"THAHUM (LA) 138.91 
le SULPHUR (S ) 32.064 So CERIUM (CE) 140.12 
17 C14LORINE (CL) 35.4S3 62 SAMARIUM (SM) 150.35 
All ARGON CAR) 39.940 63 EUROPIUM (EU) 151.96 
39 POTASSIUM (K ) 39.102 64 GADDLIMIUM (GO) 157.25 
20 CALCIUM (CA) 40.00 Iss TERBIUM (T5) ISO 4 :2 
21 SC. AhOlUM (SC) 44.956 67 HOLMIUM (me) 1 4: 6 30 
22 TITANIUM CTI) 47.90 Go ERBIUM (ER) 167.26 
23 VANADIUM (V ) SO. 942 Go THULIUM (TM) 160.934 
24 CHROMIUM (CR) S1.995 70 YTTERBXUM (YO) S73.04 
2S MANGANESE (m) S4.9380 71 LUTETIUM (LU) 174.97 
26 IRON (rE) SS. 647 74 TUNGSTEN (W ) 283.05 
27 COBALT (CO) 56.9332 77 IRIDIUM CIR) 192.2 
26 NICKEL CHI) 68.71 70 PLATINUM CPT) los. 09 
29 COPPER (CU) 63. S4 79 G13LO CAL) 196.967 
30 limc CZH) 65.37 ao MERCURY (MG) 200.50 
31 GALLIUM (GA) 69.72 82 LEAD (PS) 207.19 
32 GERMANIUM (GE) 72. S9 03 BISMUTH 45D 200.200 
33 ARSENIC CAW 74.9216 a4 POLOMIUM (Po) 210) 
34 SELENIUM (SE) 76.96 as RADIUM CPA) 226) 
3S BROMINE (BR) 79.909 90 THORIUM (TH) 232.030 
AVOGADROS NUMBER I 5. 02252X, 026XMDL-1 
220 
APPENDIX 2 
EXAMPLES OF FORMULATING TISSUE I 
- SUBSTITUTES USING THE "ELEMENTAL 
EQUIVALENCE" METHOD 
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The two examples included in this appendix, show the 
application of the Elemental Equivalence method in the formulation 
of the new tissue substitutes, as outlined in Chapter 2. 
EXAMPLE 1 
TISSUE : MUSCLE, relative density = 1.06. 
'Elemental composition (percentages by weight): 
C (12.3); H (10.2); N (3-50); 0 (72.89); Na (0.08); Mg (0.02) 
P(O. 20); S(O. 50Y; Cl(0.08); K(O-30); Ca(0.01) 
STEP 1: Derive the number of moles of each element per kilogram of 
substitute. 
C- 10.2415; H= 101.9000; N=2.4986; 0= 45.5625; Na = 0.0304; 
. Mg - 0.0080; P=0.0646; S=0.1562-, Cl = 0.0220; X=0.3900; 
Ca - 0.200. 
STEP 2: Scan the compound library to find if there is a single compound 
with the above composition: no isingle component' muscle 
substitute was found. 
STEP 3 *. Derive a set of compounds which will introduce the trace 
elements in a water-based substitute. 
For 1 kg of substitute: 
Na CI ..:. 0.0220 moles - 1.288 g 
Na*N03 : 0.0044 mole s=0.714 
KHS04 : 0.1000 moles = 13.617g 
Mg(NO., 1)2.6H 0: 0.0080 moles - 2.051 g 
Ca(NO3)2 : 0.0020 moles = 0.328g 
H31'04 : 0.0646 moles = 6.270g 
, Total mass : 24.268 g 
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STEP 4 -' Subtract the number of mole s of CfHIN10, etc, 
already introduced with 
& 
above compounds from the 
number of moles of each element derived in STEP 1. 
What remains to be satisfied (for 1-kg of substitute).. is: 
C- 10.1415 moles; H- 100.80 moles; N=2.4742 moles; 
44-7829 moles. 
The formula of the remaining C, H9 Ns 0 can be written as: 
c 10.1415 H100.8000 1ý2.4742 044-7829 
STEP 5: The above formula can be written as the sum of two (or 
more) components with water being one of them: 
CIO. 141511100.80 N2.4742 044-7829 -** C10.1415 HI 1.2342 N2.4742(H20)44.7829 
If Urea 
[NH2CONH2 
ý CH2N2(H20)]" used to satisfy the nitrogen 
2.4742 
requirement, then 2=1.2371 moles of Urea(74.23g) will be 
needed. Consequently: 
CIO. 14151111.2342 N2.4742(1120)44,7829 = 1.2371 CH2N2(H20) + 
C8.9044H8.760(H 2 0)43-5458 
Urea 
B 
The C: H ratio in the first part of the component B is 1.016. Two 
compounds, namely, ethanediol = C2H2(1120)2 and acetic acid C2%0)2ý 
with C: H ratios bracketing 1.016, are selected from the library. 
Component B can now be written as: 
C8.9044H8.760(1120)43.5458 = 4.38 
[ CD2(H20)2] + 0.0722 
[C2(H20)2] 
+ 
34*706(H 
Ethanediol, A. cetic acid 20) 
water 
3 But: 4.380 moles Ethanediol 271.86g. (242'cm ) 
0.0722 moles Acetic acid 4.34 g (4. o CM3 ) 
34-706 moles Water = 625-30 
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Summary: The formulated MUSCLE EQUIVALENT liquid 
(MS/Ll) will have the following constituents (percentages by weight): 
MS/Ll: Water(62.53); Traces(2.42); Urea(7.42); 
Ethanediol(27-19); Acetic acid(O. 43) 
Note: After the formula in Step 4 is derived and a decision is made 
on the compounds to be used, the calculation can proceed as follows: 
STEP 6: Set up four simultaneous equations to satisfy the C, HvN90 
requirements using Water(W) + Urea(U) + Ethanediol(E) 
+ Acetic acid(A) 
[H20 
+N H2 C0N H2 + C2 H6 02 + C2 H4 02 
for H: 2W + 4IJ + 6E + 4A = 100.8000 
for C: OW+ IU+ 2E + 2A = 10.1415 
for N: OW + TU + OE + OA = 2.4742 
for 0: IW + lU + 2E + 2A = 44-7829 
The solution of the above system of equations gives exactly the same 
number of moles for the constituents of the substitute MS/L1, as the 
values derived with the previous method. 
STEP 7- Apply equation 2.6 and derive the dcnsity of the formulated 
substitute, using the known density and percentage by weight 
of each component. 
Calculated density of MS/L1 : 1.07 g/cM3 
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EXAMPLE 2 
TISSUE : ADIPOSE, relative density = 0.92 
Elemental composition (percentages by weight): 
C(64.00); H(12.00); N(O. 80); 0(22.90); Na(0.05); P(O. 02); 
S(O. 07); CI(O. 12); K(O. 03) 
STEP 1: Derive the number of moles of. each element per kg of 
substitute: 
C= 53.2844; H= 119.0476; N=0.5711; 0= 14-3146; Na-0-0221; 
P-0.0052; 5=0.0227; Cl = 0.0338; K=0.0082 
STEP 2' Scan the compound library to find if there is a single 
compound with the above composition: no "single component" 
adipose substitute was found. 
STEP 3: Derive a set of compounds which will introduce the trace 
elements in an epoxy resin based solid substitute* 
For 1 kg of substitute: 
Na2 S04 : 0.0110 moles = 1.562 g 
S 0.0116 moles = 0-373g 
K2H P 04: - 0.0041 moles= 
0.714 g 
Ca H P04 *- 0.0005 mole s=0.068 g 
Total mass = 2.717 9 
STEP 4: From the initial number of moles per kilogramme, for each 
element, subtract the quantity introduced with the compounds 
for trace elements; remaining number of moles per kilogramme: 
C- 53.2844; H- 119.043; N=0.5711; 0= 14.2522 
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STEP 5 4. Decide on the type and quantity of epoxy resin to be used: 
The low nitrogen and high hydrogen content ents make the epoxy 
resin CB3 the system of choice while at the same time it excludes 
the use of CB1., CB2 or CB4 because, due to their composition 
(see Appendix 5), less than 30% by weight of these should be used if 
the nitrogen content is not to be exceeded; such low percentage of 
base material, however, would certainly present. viscosity problems. 
The empirical formula of CB3, derived from its elemental 
composition is: 
CB3= 
[ 
C6.1776 1111.2103 No. 1142 0 0.750 CIO. 0253 
In 
0.5711 In order to satisfy the 0.5711 moles of nitrogent 0 . 5.008 . JJZ7 
moles of CB3 are needed, i. e. 500.08g'. of CB3,, a quantity in which 
an cqual mass of any filler can be dispersed without any viscosity 
problems. Now subtract the quantity of C, Hj Nj 0 introduced with 
the base material (PART A), from the number of moles per kilogramme 
derived in Step 4. The following remain to be satisfied (PART B): 
C- 22.39 moles; H= 62.98 moles; 0- 10.50 moles 
The C: H: 0 ratio here necessitates the use of compounds with high 
hydrogen and high oxygen content. Since no single compound was found 
with this C: H: 0 ratio, the compound library was rescanned, for two 
compounds with high hydrogen and, at least one of them, with high 
oxygen content; the two compounds selected were Glucose (G) and 
polyethylene (PE) but again, although it was possible to satisfy the 
hydrogen content exactlyp this was not so for carbon and oxygen. 
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STEP 6 Setup two simultaneous equations and solve the system 
to find the quantities of G and PE which would give 
correct H and* (C + 0): 
C6H12O6 ' (C2H4)n'- P '22.39 1162.98 01 10.50 
Glucose(G) Polyethylene (P E) 
for H: 12G + 4PE 62.98 
for(C+O): (6xl2.01+6xl6.0)G + (2xl2.01)PE = 22.39xl2.01+10.5xl6.0 
The solution of these two equations give 
G-0.61 moles - 109.8g Glucose 
PE = 13-81 moles = 387-39 g Polyethylene 
STEP 7 *. Find the quantity of phenolic microspheres (PMS) needed to 
adjust the relative density of the mixture to the required value 
of 0.92. 
The application of equation 2.6 showed that the mixture 4 
50.008 g (resin CB3 + PMS) + 38-739 g Glucose + 10.98 g Polyethylene 
would have a resultant density of 0.92 if the relative density of the 
component (resin CB3 +PMS) had a relative. density of 0.84. Equation 
2.6 applied to the mixture of epoxy system CB3 (relative density = 1.02): 
and PMS (relative density = 0.2), indicated that 501o by weight of PMS 
should be used, (i. e. 5g PMS in 95g of CB3). Consequently a 
total of 26.20 g of PMS was considered, their composition taken into 
account and the mass of each of the above components recalculated. 
The final composition of the substitute, which is coded AP/SF1 is: 
For I kg of substitute: I 
Epoxy system CB3 (499-00-0,; Glucose (87.40"g); Polyctliylene(384-72g); 
PMS (26.20 g); Traces (2.717g). 
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APPENDIX 
THE ELEMENTAL COMPOSITIONS AND 
RELATIVE DENSITIES OF THE REAL TISSUES 
AND THE NEW TISSUE SUBSTITUTES. 
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APPENDIX 
SUPPLIERS OF RESINS AND 
TABLE 11 : OTHER IMPORTANT COMPOUNDS 
MkTERIAL SUPPLIER 
Araldide MY750 
XD555 Ciba-Geigy Ltd 
XD716 
Synolide 960 Cray Valley Products Ltd 
Epoxide No. 7 Proctor & Gamble Ltd 
EpVr, ote 871 Shell Chemicals (U, K) Ltd 
PMS (BJO 0930) Bakelite Xylonite Ltd 
DC1107 Dow Corning Ltdz 
DC200/50 
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